GECO_Study DDI-KEN-APHRC-GEGO-2021-v1.0 African Population and Health Research Center Copyright 2024-09-02 Nesstar Publisher Version 1.0 (September 2024) Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya GECO-Kenya GECO-Kenya DDI-KEN-APHRC-GEGO-2021-v1.0 Gershim Asiki,MD,Phd Richard Sanya, MBChB, MMed, PhD Shukri Mohamed, PharmD, MPH, PhD Maurine Ng’oda, BSc, MPH Lyagamula Kisia, BSc Sally Mtenga, PhD Grace Mhalu, PhD Prof. Cindy Gray, PhD Prof. Francis Mayer, MD, PhD Christopher Bunn, PhD Elenor Gieve, PhD Muhuyi Erick, BSc Bonface Ingumba, Copyright © APHRC, 2024 Nesstar Publisher National Institute for Health Research Demographic and Health Survey [hh/dhs] N/A N/A COVID-19 Type 2 Diabetes Socioeconomic impact Healtcare access Self management Rural and Urban Kenya Healt prividers Health education Economic burden Social determinant of health Kenya National: The study was conducted across four counties in Kenya: Nairobi, Kiambu, Nyeri, and Vihiga. The survey covered all individuals diagnosed with type 2 diabetes (T2D) receiving care at selected health facilities in Kenya, including both urban and rural residents, as well as healthcare providers involved in the management of T2D patients. 500 patients with T2D were recruited from health facilities across four counties (Nairobi, Kiambu, Nyeri, Vihiga). The sample was selected based on existing patient databases from these facilities, ensuring representation from both urban and rural populations. N/A Face-to-face [f2f] Enumerators were organized in teams that included experienced research assistants. Each team had supervisors overseeing data collection. The main roles of the supervisors included ensuring data quality and adherence to protocols. There was no specific mention of upper management visits to the field. N/A Data was collected electronically using the SurveyCTO program. After each interview, the data was synchronized to the APHRC servers. Data quality checks included spot checks and automated routines to ensure completeness and consistency. There was no specific mention of hot deck or cold deck techniques used for data editing. N/A The sample size was adjusted for non-response by oversampling by 30%, leading to a total sample size of 500. N/A African Population and Health Research Center(APHRC) Disclaimer: The user of the data acknowledges that the original collector of the data, the authorized distributor of the data, and the relevant funding agency bear no responsibility for use of the data or for interpretations or inferences based upon such uses. GECO_FinalData1.NSDstat 500 1009 Nesstar 200801 African Population and Health Research Center Data was collected electronically using the SurveyCTO program. After each interview, the data was synchronized to the APHRC servers. Data quality checks included spot checks and automated routines to ensure completeness and consistency. There was no specific mention of hot deck or cold deck techniques used for data editing. The valid missing (skiped questions due to the skips pattern) were coded -9( not in universe). For invalid missing were left blank (*) Version 1.0 N/A Social Demographic Variables Perceived Risk and Actions in Response to COVID-19 Healthcare Resource Use and Expenditure Medication Hospital Admissions and Hospital Outpatient Visits Non-Hospital Visits Diabetes Self-Care Impact of COVID-19 on Income, Impoverishment, and Availability of Food Impact of COVID-19 on Productivity Impact of COVID on Formal and Informal Care Knowledge about COVID-19, attitudes towards COVID-19, Practices relevant to COVID-19 Anxiety and Quality of Life Part ii: Certificate of Consent (Hati ya Idhini) Mr. /Ms. [insert name of partic Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 500 2 No 0 "Part ii: Certificate of Consent (Hati ya Idhini) Mr. /Ms. [insert name of participant], do you confirm that you are the rightful owner of this phone line or you have permission to use it and that you are an adult of at least 18 years of age?" Do you also confirm that the study objectives and procedures have been explained The interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 500 2 No 0 "Do you also confirm that the study objectives and procedures have been explained to you, that you understand the risks and benefits, and you have voluntarily agreed to participate in the study?" Do you consent to interview and sharing phone contact for this and future resear Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 498 2 No 2 "Do you consent to interview and sharing phone contact for this and future research?" I confirm that the participant was given an opportunity to ask questions about t The interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 500 2 No 0 "I confirm that the participant was given an opportunity to ask questions about the project, and all the questions asked by the participant have been answered correctly and to the best of my ability. I confirm that the individual has not been coerced into giving consent, and the consent has been given freely and voluntarily." 3. Name of Patient Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) Name of Patient N/A N/A Patients with type 2 diabetes 500 0 The name of the patient diagnosed with type 2 diabetes. A different Shakur Ali 1 Abed ego Mwololo Kimanthi 1 Agnes Kakai 1 Agnes Njeri 1 1 Agnes Njeri Wamai 1 Agnes Nzioki 1 Agnes Wamwea 1 Agnes wairimu Ngugi 1 Ahmed sila 1 Ainea Vulimu Kiambaka 1 Ali boru 1 Alice Mwaura 1 Alice wairimu 1 Alice wangui 1 Alice wanja 1 Alivec 1 Allow Adan Ali 1 Alloys Barongo 1 1 Anastasia Njeri 1 Anastasia syokau 1 Anastasia wangui 1 Angelina Kavinya 1 Ann Kavuli 1 Ann Nyambura 1 Ann Wanjiku Thuku 1 Ann wamuyu wamae 1 AnnGakuru 1 Anna Njoki Kinuthia 1 Annah Mukami 1 Annah kivavu 1 Anne Clara 1 Anne Mbete Daudi 1 Anne wambui 1 1 Arthur kahurani 1 Assumpta Kihumba 1 Aston Inyangala Inzaberi 1 1 Barack Nyadero 1 1 Beatrice Andeyo 1 Beatrice Wambui 1 Beatrice Wambui Kiarie 1 Beatrice wanjira nderi 1 Bedina Kanaiza 1 Beltah wariara Ngenyura 1 Benerd kavoo 1 Benson Waweru Njatha 1 Betha Gathoni 1 Caroline Njambi Mbugua 1 Caroline Wambui Njuguna 1 Caroline njeri kabitau 1 Carren omwenga 1 1 Catherine Vihenda 1 Charity Kariri 1 Charity nyawira kinyua 1 Charles Kimiti 1 Charles Maina 1 Charles Muriuki Matindi 1 Chris Ngugi 1 Christopher Ngugi 1 Cicilia Wanjiru Njau 1 Cicillia wagichugu 1 Dainah Muthoni 1 Damaris Ngigi 1 Daniel Ogutu 1 1 1 1 David Kangongo 1 David kamau 1 Davine kemunto 1 Dickson Amwai 1 Domintilla richard 1 1 1 Dorothy Agneta Oduor 1 Dorothy Musimbi 1 1 1 Edith wangari 1 Edward Mwangi 1 1 Elam Adamba 1 1 Elijah Kinyua 1 Elin Asava 1 Elisheba 1 1 1 1 Elizabeth Gathoni 1 Elizabeth Mbenyi 1 Elizabeth Njoki 1 Elizabeth Wangui 1 Elizabeth wairimu 1 Elizabeth wambui 1 Elizabeth wanjiru Gitau 1 Elizabeth waruino kagai 1 Elphas Kipruto Aseneka 1 Emily Chepkemoi Yebei 1 Emily Jahenda 1 Emmanuel Yamo 1 Enos Keya Ivayo 1 Eric Igogo 1 Erika muleke 1 Ester wambui 1 1 1 1 Esther Amboye 1 Esther Nyambura 1 Esther Wairimu Wambugu 1 Esther Wanjeri 1 Esther Wanjiku 1 Esther ikinya 1 Esther kabuki kariuki 1 Esther kageya 1 Esther mumbi 1 Esther wanjiku 1 Esther wanjiru chomba 1 Estther 1 Eunice Nyambura 1 Eunice wangari 1 Eunice wayua 1 Evans Ambeva 1 Everlyne luvai 1 Faith Wathira Irungu 1 Faith muthaiga 1 Faith wariga 1 Fatuma dhahabo hassan 1 Felistar mueni 1 Felister Wariara 1 Festus Thome kabugu 1 Florence Musalia 1 Florence ilagosa Magero 1 1 Francis Mugo 1 Francis Ngene 1 Francis ireri kamanja 1 Francis mwaura 2 Francis ndungu 1 Francis wawiru 1 1 Fredrick Mungai Kiarie 1 Fredrick Nganga Muthoni 1 Gedion maina 1 Gemmy Mwangi Maina 1 Geopghy nicholas 1 1 George Andrew 1 George Rabagia Mutua 1 George gichamba 1 George njuki 1 Gerald mugathi 1 Gerald mwangi 1 Gideon Kimaili 1 Githinji wachira 1 Githuku karuga 1 1 Gladys Kavere 1 Gladys kaveza 1 Godfrey mungai 1 Grace Wairimu Wangui 1 Grace Wangui Maina 1 Grace Wanjiku Ichai 1 Grace Wanjiru Kanyari 1 Grace makena mukira 1 Grace muthoni 1 Grace wangui 1 Hadija Noor 1 Haman Kihima 1 Hannah wanjiku Gituku 1 Hannah wanjiru waireri 1 Hanney muthama 1 Hassan Ibrahim 1 Hellen Ndinda Kaloki 1 Henry Agida 1 Henry Mworia Mwaniki 1 Hiram kangethe 1 Humphrey wanjiru irungu 1 1 Irene igoki 1 Irene wanjiku 1 Isaac Njuguna Karanja 1 Jacint wanjiku 1 Jacinta Wambui kungu 1 Jacinta wanjira 1 Jackline Moraa 1 Jackline Ombeva 1 James Gathugu 1 James Gituku Gathu 1 James Mbugua 1 James Muchangi Muriuki 1 James Mungai 1 James Mwaganu Njoroge 1 James Njuguna 1 James boit 1 James wanjohi 1 1 1 Jane Atieno 1 Jane Gathigia Kariuki 1 Jane Njuguna 1 Jane Wambui 1 Jane Wanjira Mureithi 1 Jane Wanjiru 1 Jane araka 1 Jane muthoni 1 Jane mwihaki 1 Jane nyambura nderi 1 Jane thuguri 1 Jane wangari 1 Jane wathuku 1 Janet Muthoni Mbugua 1 Janet Nyaboke Nyangena 1 Japheth mugambi 1 Jennifer waruguru 1 Jeremiah Mchiri 1 Joash okali 1 John Ibwanga 1 John Kabira Kaburu 1 John Mukiri Gitau 1 John Njuguna 1 John kamau kiu 1 John mathenge kibindi 1 John wachira 1 John wainaina 1 John wandui 1 JohnRoinet Saitaga 1 Jonesi Achanga 1 Jorum Geoffery 1 1 1 Joseph Kiambuthi 1 Joseph Mwangi Wahome 1 Joseph Ndungu 1 Joseph Njunguna 1 Joseph ngugi 1 Joseph simila 1 Joseph wachira 1 Josephat Machayo Anthony 1 Josephat Muturi Mwangi 1 1 Josephine Njoki Gitu 1 Josephine Njuca Mwaura 1 Josephine kalondu 1 Josephine kamene safari 1 Josephine nyagauthie kibe 1 Josephine wambui 1 Josphat Oyando 1 Jostina Mueni Mutisya 1 Jotham Imbindu 1 Jotham Kafuna 1 Joyce Gitau 1 Joyce Njenga 1 Joyce Wairimu 1 Joyce Wangari Kamande 1 Joyce Wanja Gachuma 1 Joyce musimbi 1 Jude kimani 1 Judith Atieno Adhola 1 Judy njeri 1 Judy nyokabi 1 Julia njeri maina 1 Julia wanjiku kamau 1 Julliet Wambui 1 Justus Kaburu M'rithaa 1 Kafia Ibrahim 1 Kelvin Kipkemoi Langat 1 LYDIA CHEROP LANGAT 1 Leah Kiburi Kinoro 1 Leah Nengo 1 Leah Wamaitha 1 Lilian Wahu 1 Lillian Muthoni 1 1 Litha Mutheu 1 Loise Njeri Ndungu 1 Lonah Andisi 1 Lucas Galiavo 1 Lucia muriithi 1 1 Lucy Wamaitha Kamau 1 1 Lucy Wanjiru Nganga 1 Lucy kagiri 1 Lucy waithira 1 Lucy wamuyu 1 Lucy wanjiku 1 Lydia Wambugi Njeru 1 Mable Mideva kipruto 1 Maer 1 1 1 Margaret Amaingu 1 Margaret Kavulani Machayo 1 Margaret Wangui 1 Margaret munde 1 Margaret wairimu wamundia 1 Margaret wambui wamare 1 Margaret wanjiru 1 Margret Njoki 1 Margret Wanjiku 1 Margret wanjiku Ndungu 1 Marietta mbatha 1 Mark Mmboga 1 Martha Buchichi 1 Martha wanjiku 1 1 1 Mary Chiwai 1 Mary Kinuthia 1 Mary Mukami Kangethe 1 Mary Muthoni 1 Mary Mwaniki 1 Mary Mwanza 1 Mary Mwata 1 Mary Nduku Matheka 1 Mary Ngema 1 Mary Njeri Njuguna 1 Mary Nzilani 1 Mary Omoke 1 Mary Selly Otieno 1 1 Mary Wambui kariuki 1 Mary Wanjiku Mwangi 1 1 Mary goretti 0tieno 1 Mary karimi 1 Mary mule mutuku 1 Mary mulwa 1 Mary njeri 1 Mary nyambura 2 Mary ombeva 1 Mary wanjiku 1 Mary wanjiru kariuki 1 Mathew Muthoka 1 Matroba kaveza 1 Maurice Ouko 1 Melinia Adhiambo 1 Mellen Mochama 1 1 Mercy Muthoni 1 Mercy gathering weru 1 Mercy gathoni 1 Mercy mungechi 1 Mercy njoki 1 Mercy wanjiku mwangi 1 Michael Gatumbi 1 Michael kingori 1 Milka Wairuri 1 Millicent Atieno 1 Miriam Njeri 1 Miriam Nyambura 1 Miriam Wanjiku Ndung'u 1 Misigo Adeka Timateo 1 Molly mugure ngatia 1 1 Monica Lema Musyoki 1 Monica Mativo 1 Monica Wagio Njogu 1 Monica Wangoi Muhenia 1 1 Musali Nguneko 1 Mwainja Wanjiru 1 Mwangi Gilbert karanu 1 Mwangi nyamu muya 1 1 1 Nancy Njoki Wanjiru 1 Nancy Wacuka Gachie 1 Nancy Wairimu Kimani 1 Nancy Wanjiru 1 Nancy moraa 1 Nancy nyawira 1 Nancy nyawira waithaka 1 Naomi Muhavi 1 Naomi Musyimi 1 Naomi Ongayo Avula 1 Naomi ngendo 1 Nelly 1 Ngina Maluki 1 Nifreda Msimbi Mleri 1 Noah Thuo 1 Oliver Wakaria 1 Omar Ibrahim 1 Omar Juma 1 Pamela Akinyi 1 Patrick Kisutsa 1 Patrick maina wagura 1 Paul Odhiambo 1 Paul kibe 1 Paul muiru 1 Paulina Mutisya Wayua 1 1 1 Pauline muthoni komu 1 1 Peninah khabuchi 1 Permission Wangari 1 Peter Giteru 1 Peter Macharia 1 Peter Maina Ndirangu 1 Peter Minyaru Njuguna 1 Peter Nginyo 1 Peter Wainaina 1 Peter kamau 1 Peter kuria 1 Peter maina 1 Peter mburu 1 Peter wanyoike 1 Peterson Ngatia Kago 1 Philemon olanda 1 Philis wanjiru maina 1 Prisca kemunto 1 Priscilla Munyambo Nyakairu 1 Purity wambui 1 Queen mwikali 1 Rachel Muthoni Irungu 1 Rayan Njanguru njenge 1 Rebecca njoki 1 Regina Wambui Njau 1 Regina Wangeci 1 Reuben Magoko 1 Richard Onyambu 1 Richard iregi 1 Robert Aswani 1 Robert Kamau 2 Rose Ayuma 1 Rose Mideva Asiema 1 Rose Mulanda 1 Rose Ngere Sila 1 Rose nervous njuguna 1 1 Rufeti Chanzu 1 Ruth Nduta 1 Ruth Wanjiku Ndungu 1 Ruth oluoch 1 Ruth waithera 1 Ruth wambui wachira 1 Sadia Abdi Omar 1 Salome Asaji Daywa 1 Sammy Kibii 1 Samson Mina 1 Samuel Kiae Ngomo 1 Samuel bosire 1 Samuel burugu 1 Samuel kiae Ngomo 1 Samuel muraya 1 Samuel ngigi 1 Samuel stephen Matu Munuhe 1 Seila leititia 1 Serah Wamaitha 1 Serah Wangare 1 Serah Wanjiru 1 Simon Murigi Kirigi 1 Simon kihugu kamiti 1 Simon wachira 1 Solomon somo 1 1 Stephen Githoga Kariuki 1 Stephen Njoroge 1 Stephen kimani mwangi 1 Stephen muiko 1 Susan Mwende Muriithi 1 Susan Nyambura 1 Susan Nyambura Kinuthia 1 Susan karanja 1 Susan lugadiru 1 Susan njeri 1 Sylvia Dayo 1 Tabitha kilonzo 1 1 Teresia Mbugwa 1 Teresia Mumbi 1 Teresia Njeri Ng'ang'a 1 Teresia Wangui Njoroge 1 Teresia wanjiku mbugua 1 Timateo Misigo Adeka 1 1 Veronica Nduta 1 Veronica Nziuko 1 Veronica okututi 1 Veronicah njuguna 1 Virginia Njoki 1 Wellington Gaire Mararu 1 Wilkister jahenda 1 William muinde 1 Wilson kima 1 Wycliffe Omusi 2 Zedekiah Lubanga 1 Zipporah wanjiku 1 "3. Name of Patient" 4. Phone number Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) Phone number: N/A N/A Patients with type 2 diabetes 500 0 The Phone number of the patient diagnosed with type 2 diabetes. 700718384 1 700874742 1 701239141 1 701273350 1 701494127 1 701544272 1 702123778 1 702318598 1 702416384 1 702467756 1 702620401 1 702824149 1 703110267 1 703123789 1 703212726 1 703376762 1 703707797 1 704115049 1 704297790 1 704609046 1 704649937 1 705220803 1 705716349 1 706255129 1 706827907 1 707052643 1 707253206 1 707322065 1 707410752 1 707532491 1 707875864 1 708304557 1 708384096 1 708419264 1 708803855 1 710108314 1 710251383 1 710273355 1 710377458 1 710563574 2 710577358 1 710596596 1 710620111 1 710725089 1 710777142 1 710787199 1 710868675 1 710910413 1 711109948 1 711232745 1 711251225 1 711341133 1 711352082 1 711431762 1 711437972 1 711447201 1 711477554 1 711538292 1 711863094 1 711878028 1 711994025 1 712087968 1 712095499 1 712112495 1 712119160 1 712132416 1 712201929 1 712209462 1 712225306 1 712318995 1 712387041 1 712520895 1 712701761 1 712753431 1 712879224 1 712947934 1 712983469 1 713060305 1 713143190 1 713175013 1 713343140 1 713344001 1 713349805 1 713373380 1 713519795 1 713647439 1 713662612 1 713683978 1 713739063 1 713813178 1 713844307 1 713873018 1 714076672 1 714142934 1 714279314 1 714357057 1 714434937 1 714667361 1 714819110 1 714892202 1 715041717 1 715074430 1 715263106 1 715495651 1 715632536 1 715644062 1 715756890 1 715799429 1 715841372 1 715888261 2 716017814 1 716155219 1 716176496 1 716466253 1 716654574 1 716750341 1 716755496 1 716761868 1 716776271 1 716826494 1 716828312 1 717063699 1 717064311 1 717090107 1 717165687 1 717254612 1 717616137 1 717646147 1 717649601 1 717915110 1 717949697 1 718240186 1 718383942 1 718567841 1 718612475 1 718652906 1 718745727 1 718876865 1 718961551 1 719284214 1 719613515 1 719695179 1 720089609 1 720099724 1 720114865 1 720131741 1 720173120 1 720223138 1 720227467 2 720231491 1 720239009 1 720249862 1 720266754 1 720283504 1 720294042 1 720316813 1 720349849 1 720352648 1 720355313 1 720362010 1 720373193 1 720432930 1 720463196 1 720489460 1 720515536 1 720531853 1 720549177 1 720549236 1 720570599 1 720571975 1 720633039 1 720648438 1 720657171 1 720674179 1 720737274 1 720746218 1 720759509 1 720778748 1 720778942 1 720814255 1 720819467 1 720828230 1 720830197 1 720845595 1 720852300 1 720953649 1 720973739 1 720984707 1 720986888 1 720992246 1 720997993 1 721109493 1 721125223 1 721136926 1 721153877 1 721159218 1 721209547 1 721225454 1 721237729 1 721269746 1 721276673 1 721286686 1 721316556 1 721329482 1 721368948 1 721376967 1 721386510 1 721393543 1 721414552 1 721431889 1 721441629 1 721451568 1 721530273 1 721530358 1 721556689 1 721576177 1 721588084 1 721602413 1 721603228 1 721625629 1 721641018 1 721657600 1 721710277 1 721715605 1 721717560 1 721719499 1 721726704 1 721728724 1 721774260 1 721784197 1 721815216 1 721817085 1 721853327 1 721860404 1 721861217 1 721862205 1 721866310 1 721871479 1 721885354 1 721887807 1 721906206 1 721921680 1 721936819 1 721938699 1 721973217 1 721995652 1 722128363 1 722161925 1 722168923 1 722211344 1 722213519 2 722214068 1 722223496 1 722232673 1 722246650 1 722270168 1 722279867 1 722280189 1 722286282 1 722289528 1 722291620 1 722299673 1 722300134 1 722327401 1 722331684 1 722335930 1 722338814 1 722347537 1 722350895 1 722352701 1 722373302 1 722404061 1 722405459 1 722406783 1 722408910 1 722413437 1 722417227 1 722447910 1 722487143 1 722497052 1 722522753 1 722563219 1 722577837 1 722581939 1 722592445 1 722599812 1 722603457 1 722608633 1 722621579 1 722625517 1 722649639 1 722662554 1 722683979 1 722691857 1 722694554 1 722699233 1 722699840 1 722716327 1 722720770 1 722742603 1 722744308 1 722745333 1 722779787 1 722784310 1 722791660 1 722803240 1 722808828 1 722818756 1 722825551 1 722847445 1 722860106 1 722892896 1 722893031 1 722901460 1 722918803 1 722941189 1 722970264 1 722991150 1 722998244 1 723007331 1 723125481 1 723142049 1 723200364 1 723272575 1 723280741 2 723312984 1 723323737 1 723334112 1 723334641 1 723372844 1 723383343 1 723394046 1 723404745 1 723413352 1 723453679 1 723493715 1 723504716 1 723510159 1 723521465 1 723521892 1 723568166 1 723623693 1 723647561 1 723668274 1 723762744 1 723773163 1 723784850 1 723905783 1 723929753 1 723936925 1 724101988 1 724205885 1 724210111 1 724259274 1 724293354 1 724324619 1 724371530 1 724424706 1 724471576 1 724488251 1 724530882 1 724543367 1 724586454 1 724612213 1 724623149 1 724642014 1 724675180 1 724687148 1 724688421 1 724828198 1 724838482 1 724858326 1 724879824 1 724885554 1 724909066 1 724921528 1 724924828 1 724926609 1 724941302 1 725017708 1 725029111 1 725083622 1 725090240 1 725100466 1 725148109 1 725211087 1 725245631 1 725329862 1 725340653 1 725372969 1 725381467 1 725384187 1 725489943 1 725520311 3 725530430 1 725592842 1 725600729 1 725605773 1 725776147 1 725811113 1 725812870 1 725813971 1 725835989 1 725860810 1 725907078 1 725911143 1 726072905 1 726095375 1 726109804 1 726147902 1 726206664 1 726247355 1 726261436 1 726364748 1 726406847 1 726469766 1 726477264 1 726505085 1 726518590 1 726572724 1 726614179 1 726702957 1 726706372 1 726728247 1 726738390 1 726738786 1 726788663 1 726862802 1 726911050 1 726914772 1 726957776 1 726993734 1 727003312 1 727141730 1 727208309 1 727224090 1 727245335 1 727270739 1 727282851 1 727302996 1 727376007 1 727597157 1 727621316 1 727621396 1 727661646 1 727671316 1 727674998 1 727678087 1 727732073 1 727750362 1 727755076 1 727785120 1 727849530 1 727853959 1 727887997 1 727897876 1 728024227 1 728102989 1 728204432 1 728273450 1 728370151 1 728383755 2 728465249 1 728749037 1 729265557 1 729270550 1 729352636 1 729368127 1 729370010 1 729384531 1 729461621 1 729523771 1 729640767 1 729668245 1 729674562 1 729836763 1 729883972 1 734902849 1 740466413 1 741276428 1 742112257 1 743580019 1 746726513 1 748115481 1 748634434 1 757170180 1 792788942 1 792846146 1 794273141 1 795983435 1 796334989 1 799312112 1 "4. Phone number" 5. Are you suffering from Diabetes Type 2 Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) Are you suffering from Diabetes Type 2? N/A N/A Patients with type 2 diabetes 500 0 The question aimed to confirm if the patient was suffering from type 2 diabetes. 1 Yes 500 2 No 0 "5. Are you suffering from Diabetes Type 2" Years Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) How long you have been suffering from Diabetes Type 2? N/A N/A Patients with type 2 diabetes 500 0 0 43 9.458 6.823 N/A "Years" Months Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) How long you have been suffering from Diabetes Type 2? N/A N/A Patients with type 2 diabetes 500 0 0 98 1.28 7.754 N/A "Months" 7. Are you suffering from any other underlying conditions Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) How long you have been suffering from Diabetes Type 2? N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes if they were suffering from any other conditions. 1 Yes 355 2 No 145 "7. Are you suffering from any other underlying conditions" 8 .Apart from diabetes, do you have the following underlying conditions Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) Apart from diabetes, do you have the following underlying conditions? N/A N/A Patients with type 2 diabetes 355 0 The question was asked to patients with type 2 diabetes to determine if they have any additional underlying conditions apart from their diabetes diagnosis. 1 261 1 10 1 1 11 3 1 2 2 1 2 5 1 1 3 3 1 3 6 1 1 5 5 1 5 96 1 1 6 7 1 6 96 1 1 7 1 1 8 1 1 8 96 2 1 96 33 11 2 2 5 1 3 1 3 96 1 6 2 8 5 9 2 96 18 "8 .Apart from diabetes, do you have the following underlying conditions" Hypertension Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to determine if they have Hypertenion apart from their diabetes diagnosis. 0 No 32 1 Yes 323 Sysmiss 145 Cardiac Disease Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to determine if they have Cardiac Disease apart from their diabetes diagnosis. 0 No 351 1 Yes 4 Sysmiss 145 Asthma Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to determine if they have Asthma apart from their diabetes diagnosis. 0 No 349 1 Yes 6 Sysmiss 145 Chronic Liver Disease Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to determine if they have Chronic Liver Disease apart from their diabetes diagnosis. 0 No 355 1 Yes 0 Sysmiss 145 Chronic Kidney Disease Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to determine if they have Chronic Kidney Disease apart from their diabetes diagnosis. 0 No 347 1 Yes 8 Sysmiss 145 Chronic Neurological/neuromuscular Disease Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to determine if they have Chronic Neurological/neuromuscular Disease apart from their diabetes diagnosis. 0 No 344 1 Yes 11 Sysmiss 145 COPD/chronic obstructive pulmonary disease Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to determine if they have COPD/chronic obstructive pulmonary disease apart from their diabetes diagnosis. 0 No 354 1 Yes 1 Sysmiss 145 HIV/AIDS Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to determine if they have HIV/AIDS apart from their diabetes diagnosis. 0 No 347 1 Yes 8 Sysmiss 145 Tuberculosis Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to determine if they have Tuberculosis apart from their diabetes diagnosis. 0 No 353 1 Yes 2 Sysmiss 145 Mental Illness Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to determine if they have Mental Illness apart from their diabetes diagnosis. 0 No 354 1 Yes 1 Sysmiss 145 Cancer Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to determine if they have Cancer apart from their diabetes diagnosis. 0 No 350 1 Yes 5 Sysmiss 145 Other Specify Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to specify other underlying conditions apart from their diabetes diagnosis. 0 No 299 1 Yes 56 Sysmiss 145 Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 355 145 The question was asked to patients with type 2 diabetes to specify other underlying conditions apart from their diabetes diagnosis. 0 No 355 1 Yes 0 Sysmiss 145 Specify Other condition Patients with type 2 diabetes being interviewed. 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A Patients with type 2 diabetes 56 0 The question was asked to patients with type 2 diabetes to specify other conditions apart from their diabetes diagnosis. 9999 1 Arthritis 26 Arthritis and stroke 1 Arthtis 1 Athritis 2 Blood clot 1 Cholesterol, ulcers 1 Constant headaches 1 Gastritis 1 H pylori 1 Heart disease 1 Pancreatitis 1 Spine problem 1 Stroke and eye 1 Thyroid 1 Ulcers 11 Ulcers in the stomach 1 Ulcers,arthritis 2 Veins 1 "Specify Other condition" County where facility is located The Interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) County (Kaunti/wilaya) N/A N/A Patients with type 2 diabetes 500 0 The name of the county where the facility was located. 19 44 22 104 38 76 47 276 "County where facility is located" County where facility is located The Interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) County (Kaunti/wilaya) N/A N/A Patients with type 2 diabetes 500 0 19 47 37.968 11.401 The name of the county where the facility was located. sub County The Interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) sub County N/A N/A Patients with type 2 diabetes 500 0 The name of the Sub-county where the facility was located. Dagoretti_North 29 Dagoretti_South 1 Embakasi_East 10 Embakasi_South 63 Embakasi_West 1 Hamisi 2 Juja 1 Kabete 2 Kamukunji 1 Kasarani 10 Kiambaa 2 Kiambu_Town 31 Kibra 7 Kikuyu 5 Langata 52 Limuru 53 Luanda 18 Makadara 10 Mathare 3 Mathira_East 38 Mathira_West 2 Mukurweini 2 Nyeri_Central 1 Nyeri_South 1 Roysambu 72 Ruaraka 6 Ruiru 7 Sabatia 6 Starehe 7 Thika_Town 3 Vihiga 50 Westlands 4 "sub County" Ward The Interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) Ward N/A N/A Patients with type 2 diabetes 500 0 The name of the ward where the facility was located. Airbase 1 Babandogo 4 Biashara 1 Central_Maragoli 46 Cianda 1 Clay_City 2 Emabungo 18 Embakasi 10 Gatuanyaga 1 Gisambai 1 Githurai 65 Harambee 1 Hospital 1 Iria-ini 1 Kabete 1 Kahawa 3 Karai 1 Karatina_Town 36 Karen 2 Karuri 1 Kasarani 5 Kawangware 2 Kiamaiko 1 Kikuyu 3 Kileleshwa 25 Kilimani 2 Kirimukuyu 2 Kitisuru 1 Kiuu 6 Konyu 1 Korogocho 1 Kwa_Njenga 3 Kwa_Reuben 59 Landimawe 2 Limuru_Central 45 Limuru_East 3 Lugaga-wamuluma 3 Lyaduywa/Izava 6 Mabatini 1 Magutu 1 Mountain_View 1 Mugumo-ini 40 Mukurwe-ini_Central 1 Mukurwe-ini_West 1 Mungoma 1 Murera 1 Mwiki 1 Nachu 1 Nairobi_South 2 Nairobi_West 10 Ngara 1 Ngecha_Tigoni 5 Njiru 2 Pangani 1 Parklands/Highridge 2 Pipeline 1 Riabai 2 Roysambu 3 Rware 1 Tambua 1 Ting'ang'a 26 Township 5 Umoja_II 1 Utalii 1 Uthiru 1 Viwandani 9 Waithaka 1 Woodley/Kenyatta_Golf_Course 7 Zimmerman 1 Ziwani/Kariokor 1 "Ward" Name of health care facility The Interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) Health facility name (Jina la kituo cha afya): N/A N/A Patients with type 2 diabetes 500 0 The name of facility where the patients recieved their treatment. 10069 3 10080 2 10092 3 10110 5 10176 8 10275 1 10320 3 10329 1 10340 1 10485 1 10535 5 10582 1 10592 1 10603 1 10655 2 10665 1 10676 18 10866 1 10886 1 11027 1 11029 1 11197 1 11238 39 11331 1 11373 7 11461 2 11501 1 11519 1 11584 2 11719 2 11735 1 11759 1 11785 24 11799 6 11922 1 11958 1 12005 1 12138 3 12226 2 12293 13 12334 65 12357 1 1364 58 1387 1 1897 1 1931 3 2310 1 2350 1 2432 1 300 1 305 1 3098 46 363 1 3662 3 3793 1 3991 1 3999 1 4016 2 4031 1 415 1 4264 2 4592 1 4640 1 4660 1 467 2 4691 1 4973 1 5148 6 516 1 5292 10 5342 6 5569 2 563 1 5766 1 5770 3 6189 1 6210 1 6364 1 645 1 6453 23 711 1 80 4 832 1 8453 1 8516 1 8533 1 8668 3 9152 5 9344 1 9351 2 9460 1 9473 2 9507 22 9558 1 9605 1 9706 1 9754 1 9829 23 9869 1 "Name of health care facility" Type of the Facilty The Interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) Facility ownership type (aina ya kituo): N/A N/A Patients with type 2 diabetes 500 0 The type of facility where the patients recieved their treatment. Christian Health Association of Kenya 10 Kenya Episcopal Conference-Catholic Secretariat 38 Ministry of Health 89 Non-Governmental Organizations 9 Other Faith Based 22 Private Practice - Clinical Officer 3 Private Practice - General Practitioner 74 Private Practice - Medical Specialist 8 Private Practice - Nurse / Midwifery 5 Private Practice - Private Company 1 Private Practice - Private Institution Academic 238 Public Institution - Academic 1 Public Institution - Parastatal 2 Level of the Facility The Interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) Facility level of care N/A N/A Patients with type 2 diabetes 500 0 The facility level of care where the patients recieved their treatment. Level 2 161 Level 3 102 Level 4 222 Level 5 6 Level 6 9 The Interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A N/A Patients with type 2 diabetes 500 0 N/A Beatrice Chao 61 Catherine Awuor 55 Charles Njoroge 60 Irene Adera 56 Lucy Omumbo 56 Nicholas Agik 50 Priscillah W Kanyingi 55 Rita Kinga 50 Winnie Nyaboke 57 If date or month is unknown please indicate. The Interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A N/A Patients with type 2 diabetes 122 0 N/A 1 38 1 2 84 "If date or month is unknown please indicate." Day Unknown The Interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 0 No 378 1 Yes 122 Month Unknown The Interviewer 9.2 Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya (Madhara ya COVID-19 kwa huduma ya afya na uchumi kwa wagonja wa kisukari nchini Kenya) N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 0 No 416 1 Yes 84 Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) Age (umri) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to give information about their age. 23.079999923706055 1 23.489999771118164 1 23.860000610351563 1 24.639999389648438 1 27.760000228881836 1 28.260000228881836 1 28.590000152587891 1 28.799999237060547 1 30.5 1 31.649999618530273 1 31.700000762939453 1 31.819999694824219 1 32.25 1 32.650001525878906 1 32.790000915527344 1 32.880001068115234 1 33.369998931884766 1 33.520000457763672 1 33.779998779296875 1 33.950000762939453 1 34.049999237060547 1 34.509998321533203 1 34.639999389648438 1 34.790000915527344 1 35.459999084472656 1 35.720001220703125 1 36.209999084472656 1 36.340000152587891 1 37.450000762939453 1 38.020000457763672 1 38.150001525878906 1 38.380001068115234 1 38.450000762939453 1 38.709999084472656 1 38.729999542236328 1 39.020000457763672 1 39.119998931884766 1 39.580001831054688 1 39.720001220703125 1 40.049999237060547 1 40.610000610351563 1 40.830001831054687 1 40.889999389648438 1 41 1 41.450000762939453 1 41.659999847412109 1 41.75 1 41.779998779296875 1 41.790000915527344 1 41.840000152587891 1 41.849998474121094 1 42 1 42.069999694824219 1 42.5 1 42.830001831054687 1 43.139999389648438 1 43.459999084472656 1 43.479999542236328 1 43.540000915527344 1 43.610000610351563 1 43.740001678466797 1 43.849998474121094 1 44.139999389648438 1 44.180000305175781 1 44.709999084472656 1 44.860000610351563 1 45 1 45.189998626708984 1 45.270000457763672 1 45.470001220703125 1 45.520000457763672 1 45.639999389648438 1 45.669998168945313 1 45.720001220703125 1 45.849998474121094 1 46.080001831054688 1 46.150001525878906 1 46.310001373291016 1 46.409999847412109 1 46.509998321533203 1 46.540000915527344 1 46.580001831054688 1 47.169998168945313 1 47.299999237060547 1 47.310001373291016 2 47.349998474121094 1 47.400001525878906 1 47.5 1 47.569999694824219 1 47.680000305175781 2 47.729999542236328 1 47.790000915527344 1 48 1 48.080001831054688 1 48.110000610351563 1 48.189998626708984 1 48.290000915527344 1 48.430000305175781 2 48.509998321533203 1 48.580001831054688 1 48.669998168945313 1 48.680000305175781 1 48.860000610351563 1 48.990001678466797 1 49 2 49.020000457763672 1 49.049999237060547 1 49.099998474121094 1 49.119998931884766 1 49.389999389648438 1 49.520000457763672 1 49.689998626708984 1 49.709999084472656 2 49.819999694824219 1 50.040000915527344 1 50.130001068115234 1 50.159999847412109 1 50.189998626708984 1 50.209999084472656 1 50.310001373291016 1 50.319999694824219 1 50.369998931884766 1 50.509998321533203 1 50.639999389648438 1 50.740001678466797 1 50.869998931884766 1 51.040000915527344 1 51.169998168945313 1 51.290000915527344 1 51.330001831054687 1 51.389999389648437 1 51.639999389648438 1 51.689998626708984 1 51.700000762939453 2 51.709999084472656 1 51.729999542236328 1 51.75 1 51.799999237060547 1 51.979999542236328 1 52 2 52.080001831054687 1 52.090000152587891 1 52.150001525878906 1 52.209999084472656 1 52.340000152587891 1 52.740001678466797 1 52.840000152587891 1 52.860000610351562 1 52.869998931884766 1 52.990001678466797 1 53 2 53.020000457763672 1 53.119998931884766 1 53.139999389648437 1 53.169998168945313 2 53.189998626708984 1 53.259998321533203 1 53.380001068115234 1 53.549999237060547 2 53.560001373291016 1 53.669998168945313 1 53.700000762939453 1 54 1 54.029998779296875 1 54.169998168945313 1 54.259998321533203 1 54.279998779296875 1 54.630001068115234 3 54.669998168945313 1 54.700000762939453 1 54.740001678466797 1 55.060001373291016 2 55.069999694824219 1 55.169998168945313 1 55.279998779296875 1 55.439998626708984 1 55.470001220703125 1 55.560001373291016 2 55.580001831054688 1 55.590000152587891 1 55.619998931884766 1 55.659999847412109 1 55.680000305175781 1 55.759998321533203 1 55.770000457763672 1 55.840000152587891 1 55.930000305175781 1 56 1 56.189998626708984 1 56.200000762939453 1 56.5 1 56.630001068115234 1 56.639999389648438 1 56.709999084472656 1 56.720001220703125 1 56.830001831054688 1 56.889999389648438 1 56.990001678466797 1 57.200000762939453 1 57.229999542236328 1 57.25 1 57.279998779296875 1 57.319999694824219 1 57.380001068115234 1 57.430000305175781 1 57.439998626708984 1 57.490001678466797 1 57.610000610351563 2 57.650001525878906 1 57.709999084472656 1 57.720001220703125 2 57.740001678466797 1 57.909999847412109 1 57.930000305175781 1 58.169998168945313 1 58.200000762939453 1 58.290000915527344 1 58.409999847412109 1 58.520000457763672 1 58.590000152587891 1 58.599998474121094 1 58.619998931884766 1 58.659999847412109 1 58.669998168945313 2 58.790000915527344 1 58.830001831054687 1 59 1 59.25 1 59.270000457763672 1 59.319999694824219 1 59.5 1 59.560001373291016 1 59.580001831054688 1 59.659999847412109 1 59.689998626708984 1 59.709999084472656 1 59.900001525878906 1 60 1 60.040000915527344 1 60.110000610351562 1 60.169998168945312 1 60.180000305175781 1 60.200000762939453 1 60.610000610351563 2 60.680000305175781 1 60.720001220703125 1 60.740001678466797 1 60.840000152587891 1 60.909999847412109 1 60.939998626708984 1 60.970001220703125 1 61 2 61.029998779296875 1 61.099998474121094 1 61.270000457763672 1 61.430000305175781 1 61.560001373291016 1 61.599998474121094 1 61.650001525878906 1 61.669998168945313 1 61.680000305175781 1 61.729999542236328 1 61.759998321533203 1 61.770000457763672 1 61.979999542236328 1 62 3 62.110000610351563 1 62.139999389648437 1 62.150001525878906 1 62.159999847412109 1 62.290000915527344 1 62.5 2 62.520000457763672 1 62.549999237060547 1 62.590000152587891 1 62.619998931884766 1 62.650001525878906 1 62.659999847412109 1 62.75 1 62.959999084472656 1 63 1 63.040000915527344 1 63.060001373291016 2 63.150001525878906 1 63.189998626708984 1 63.209999084472656 1 63.25 1 63.340000152587891 2 63.459999084472656 1 63.630001068115234 1 63.669998168945313 1 63.689998626708984 1 63.770000457763672 1 63.799999237060547 1 63.819999694824219 2 63.990001678466797 1 64 4 64.069999694824219 2 64.129997253417969 1 64.19000244140625 1 64.220001220703125 1 64.25 1 64.410003662109375 1 64.589996337890625 1 64.629997253417969 1 64.660003662109375 1 64.669998168945312 2 64.680000305175781 1 64.699996948242188 1 64.709999084472656 1 64.739997863769531 1 64.800003051757812 1 64.80999755859375 1 64.839996337890625 1 64.980003356933594 1 65 1 65.089996337890625 1 65.099998474121094 1 65.139999389648437 1 65.230003356933594 1 65.410003662109375 2 65.419998168945313 1 65.540000915527344 1 65.660003662109375 1 65.669998168945313 1 65.69000244140625 1 65.709999084472656 1 65.790000915527344 1 65.989997863769531 2 66 1 66.089996337890625 1 66.180000305175781 1 66.449996948242188 1 66.620002746582031 1 66.629997253417969 1 66.660003662109375 1 66.669998168945313 1 66.730003356933594 1 66.769996643066406 1 66.819999694824219 1 66.889999389648438 2 66.930000305175781 1 67.150001525878906 1 67.169998168945313 1 67.44000244140625 2 67.620002746582031 1 67.669998168945313 2 67.709999084472656 1 67.720001220703125 1 67.919998168945313 1 68 1 68.010002136230469 1 68.199996948242188 1 68.220001220703125 1 68.269996643066406 1 68.319999694824219 1 68.650001525878906 1 68.669998168945312 1 68.699996948242188 1 68.790000915527344 1 69.160003662109375 1 69.209999084472656 1 69.290000915527344 1 69.30999755859375 1 69.330001831054688 1 69.459999084472656 1 69.580001831054687 1 69.629997253417969 1 69.660003662109375 1 69.680000305175781 1 69.730003356933594 1 69.760002136230469 1 69.769996643066406 1 69.779998779296875 1 70 2 70.089996337890625 1 70.110000610351563 3 70.120002746582031 1 70.230003356933594 1 70.290000915527344 1 70.389999389648438 1 70.410003662109375 1 70.489997863769531 1 70.779998779296875 1 71 1 71.010002136230469 1 71.129997253417969 1 71.650001525878906 1 71.669998168945313 1 71.699996948242188 1 71.730003356933594 1 71.75 1 71.819999694824219 1 71.959999084472656 1 72 1 72.169998168945313 1 72.650001525878906 1 72.669998168945313 2 72.699996948242188 1 72.989997863769531 1 73.129997253417969 1 73.160003662109375 2 73.220001220703125 1 73.660003662109375 2 73.779998779296875 1 74 1 74.19000244140625 1 74.199996948242188 1 74.580001831054688 1 74.699996948242187 1 74.870002746582031 1 74.910003662109375 1 75.05999755859375 1 75.180000305175781 1 75.19000244140625 1 75.470001220703125 1 75.660003662109375 1 75.680000305175781 1 75.709999084472656 1 76.110000610351562 1 76.19000244140625 1 76.209999084472656 1 76.220001220703125 1 76.55999755859375 1 76.569999694824219 1 76.669998168945313 1 76.680000305175781 2 76.970001220703125 1 77 1 77.480003356933594 1 77.489997863769531 1 77.739997863769531 1 77.769996643066406 1 78 1 78.199996948242188 1 78.230003356933594 1 78.650001525878906 1 78.680000305175781 1 78.919998168945313 1 79.269996643066406 1 79.580001831054688 1 79.699996948242187 1 79.769996643066406 2 79.889999389648437 1 80.069999694824219 1 80.089996337890625 1 81.050003051757813 1 81.739997863769531 1 82.519996643066406 1 82.830001831054688 1 83.180000305175781 1 83.69000244140625 1 85.730003356933594 1 86 1 93.660003662109375 1 96.879997253417969 1 98.69000244140625 1 1.2: Sex Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) Gender (jinsia) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to state their sex. 1 Female 330 2 Male 170 3 Other 0 "1.2: Sex" Other Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) Gender (jinsia) N/A N/A Patients with type 2 diabetes 0 0 The question was asked to patients with type 2 diabetes to state other type of sex. "Other" County Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to identify the county they belong to. ELGEYO/MARAKWET 1 EMBU 2 HOMA_BAY 1 KAJIADO 11 KAKAMEGA 2 KIAMBU 136 KIRINYAGA 6 KISII 2 KITUI 1 MACHAKOS 7 MAKUENI 4 MOMBASA 2 MURANGA 5 NAIROBI 194 NAKURU 7 NANDI 2 NAROK 1 NYANDARUA 2 NYERI 40 SIAYA 7 TRANS_NZOIA 2 UASIN_GISHU 1 VIHIGA 64 "County" Sub-county Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to identify the Sub-county they belong to. alego_usonga 1 bahati 2 bonchari 1 cherangany 1 dagoretti_north 5 dagoretti_south 12 embakasi_central 1 embakasi_east 16 embakasi_north 2 embakasi_south 30 embakasi_west 10 emgwen 2 emuhaya 4 gatanga 1 gatundu_north 1 gatundu_south 1 gem 4 githunguri 2 hamisi 8 homa_bay_town 1 juja 9 kabete 4 kaiti 1 kajiado_east 5 kajiado_north 5 kajiado_west 1 kandara 1 kangema 2 kangundo 1 kasarani 17 kathiani 1 khwisero 1 kiambaa 9 kiambu 34 kibra 1 kieni 2 kikuyu 14 kilome 2 kinangop 1 kirinyaga_central 2 kisauni 1 kitui_central 1 langata 27 lari 7 likoni 1 limuru 34 luanda 3 machakos_town 2 makadara 18 malava 1 manyatta 1 maragwa 1 marakwet_east 1 mathare 2 mathira 27 matungulu 1 mavoko 1 mbeere_north 1 mbooni 1 mukurweini 4 mwala 1 mwea 1 naivasha 3 narok_south 1 ndia 3 njoro 1 nyaribari_masaba 1 nyeri_town 7 ol_kalou 1 rongai 1 roysambu 40 ruaraka 5 ruiru 18 sabatia 9 saboti 1 soy 1 starehe 3 thika_town 3 ugenya 1 ugunja 1 vihiga 40 westlands 5 "Sub-county" Village Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to identify the village they belong to. 5 star 1 Baba dogo 1 Babadogo 1 Banana 3 Banana near senior chief 1 Bibilioni 1 Bokoma 1 Bondeni 1 Bumale 1 Buruburu 1 Buyayi 1 Chamadele 1 Chiambiti 1 Cieko 1 City chicken 1 Dagoreti centre 1 Diamagare 1 Donholm 2 Egago 2 Ekimo 1 Elgon view 1 Emanyinya 2 Embakasi 1 Embakasi village 1 Embulako 1 Eramba 1 Esalua 1 Fly over 1 Gachororo 1 Gacicero 1 Gaita 1 Gaitabii 1 Gakuyu 1 Gashumi 1 Gatei 1 Gathaine 1 Gatina 1 Gatitu 1 Gatudu 1 Gatura 1 Gavutia 1 Gendia 1 Gikathura 1 Gikumbo 1 Gitaru 1 Githaite 1 Githembe 1 Githembe A 1 Githongoro 1 Githurai 13 1 Githurai 44 2 Githurai 45 6 Githurai 45, slow arm 1 Githurai progresive 1 Githurai, Ruiru 1 Gitombi 1 Ichuga 1 Iduku 1 Igwai 1 Ihola kambua 1 Ikumba 1 Imbale 1 Itandaro 2 Jamaica 1 Jegerenyi 1 Jemana 1 Jonhsagah 1 Juja 2 Kabiria 1 Kabiria Kwa maji 1 Kabonyo sublocation 1 Kabuku 2 Kahawa 1 Kahawa West 2 Kahawa sukari 1 Kahawa west 1 Kalama 1 Kalanji 1 Kaleki 1 Kalimoni 1 Kamatu 1 Kamirithu, tarabana 1 Kamiti farmers 1 Kamulu 2 Kamwanya 1 Kangemi 1 Kanorero 1 Kapkangani 1 Kapret 1 Kapsegere 1 Kaptangani 1 Karai 1 Karatana 1 Karatina 4 Karatina town 4 Karen 1 Kariakor 1 Kariobangi 1 Karira 1 Karunga 1 Karuri 1 Kasarani 2 Kavuko 1 Kavumbu 1 Kawaida 1 Kawangware 2 Kayava -Gandu 1 Kayole 3 Kayole matopeni 1 Kayole soweto 1 Kejenjirova 1 Keno 1 Kenyatta Road 1 Kenyatta University (km) 1 Kenyatta road 2 Kerwa 1 Ketheini 1 Keyonzo 1 Kiagai 1 Kiambu 1 Kiambu road 1 Kiambu town 2 Kianguthu 1 Kiarithani 1 Kiawagiri 1 Kiembeni 1 Kigama 2 Kigoro 1 Kihara 1 Kikabo 1 Kikuyu makutano 1 Kilenge 1 Kimende 1 Kimwagi 1 Kimwenge 1 Kinare 1 Kinganga 1 Kingeero 1 Kingistone 1 Kingston 2 Kinogori 1 Kinoo 3 Kinungi 1 Kirenga 1 Kirinyaga 2 Kiriri 1 Kisambai 1 Kiserian 3 Kitengela 2 Kithebe 1 Kithimani 1 Kitulu 1 Kitunduni 1 Kiuu 1 Kivagala 1 Kiwanja 2 Kiwerera 1 Kizito 1 Komarock 1 Konyo 1 Kore 1 Korogocho 1 Kowala 1 Kra estate 1 Kwa dyner 1 Kwa njenga 2 Kwak Njenga 2 Kwale 1 Kwanjenga 1 Kware 1 Labor 1 Lanet 1 Langata 9 Langata southlands 1 Lari Scheme 1 Liloni 1 Limuru 4 1 2 Lironi 1 Longonot 1 Lorie estate 1 Lower Gituamba 1 Luanda 1 Luhulu 1 Lunga Lunga 1 Lunga lunga 1 Lungalunga 5 Lussigetti 1 MUKURU Kwa njenga 1 Madira 1 Magina 1 Majengo- kidundu 1 Maji mazuri 1 Makadara estate 1 Makanya 1 Malava 1 Mangu high school 1 Marango village 1 Maringo 2 Marurui 1 Maseno 1 Matara 1 Mathaithi 2 Matinyani 1 Matithini 1 Mbale 1 Mbale town 1 Mbeyi 1 Memri 1 Menyetieni 1 Mgugaa 1 Mihuti 1 Mkingi 1 Mlele 1 Moi's Bridge 1 Monzave 1 Mountain View 2 Mrengeti 2 Mtarakwa near police 1 Mugomu ini 1 Mugoro 1 Mugoya 1 Mugumo -in 1 Mugumoini 1 Mugumuini 1 Mukangu 1 Mukengesia 1 Mukore 1 Mukuru 1 1 1 1 Mukuru kwa Reuben 1 Mukuru kwa njenga 3 Mukuru-Kwa Rueben 1 Mukurweini 1 Mulundu 2 Mumandu 1 Mumbi 2 Mungoma 2 Muoki 1 Murengeti 1 Murera 2 Murira 1 Muruguru 1 Musiri 1 Muthiga 1 Mutuini 2 Muywa 1 Mwasang'ombe 1 Mwihoko 6 Mwiki 7 Mwiki ward 1 Ndeiya 4 Ndenderu 1 Nduma 1 Ndumberi 1 Near Access Afya Tasia 1 Near ruiru police 1 Nebeck 1 Nembure 1 Next to D.O hospital 1 Ngaamba 1 Ngaine 1 Ngaita 1 Ngara 1 Ngarariga 1 Ngecha 2 Ngei phase 2 1 Ngenda 1 Ngong station 1 Njenga 4 Njenga mukuru 1 Njiru 1 Njuguini 1 Nyambare 1 Nyamweru 1 Nyang'ori 1 Olekasas 1 Ololulunga 1 Omega 1 Ondim 1 Ongata Rongai 2 Ongata rongai 1 Otienda 1 Otiende 1 Pipeline 4 Progresive githurai 1 Rabura 1 Ramacha 1 Rangau 1 Riabai 1 Rironi 1 Rongai 3 Rotengo 1 Roysambu 1 Ruai 1 Rubia 2 Ruguru 2 Rungai 1 Runyeki 1 Rurie 1 Ruthigiti 1 Samrat 1 Santon 1 Satellite 1 Siakago 1 Siaya mulaha 1 Sinai 4 Siranga kamrembo 1 Soi 1 South land 1 Southland 2 St.Paul University 1 Tambua 1 Tasia 5 Tassia 6 Thamanda 1 Theta 1 Thogoto 1 Tigomori village 1 Tin'ganga 2 Ting'ang'a 5 Ting'anga 4 Tinganga 9 Toll 1 Town 1 Transani 1 Ugenya 1 Uhuru Gardens 1 Ulumbi 1 Umoja 1 Umoja 2 1 Umoja 3 1 Uplands 2 Upperhill 1 Utawala 2 Uthiru 2 Uthiru Gishagi 1 Viala 1 Vibichio 1 Vietnam 1 Vigethe 1 Vigulu 1 Vihiga 1 Visiru 1 Viwandani 4 Viwandani/sinai 1 Vokoli 1 Vululu 1 Waithaka 2 Wamayoka 1 Wapewape 1 Warondeya 1 Witeithie 1 Yala 1 Yanga 1 Zimmerman 1 "Village" Place of Stay Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to identify their place of stay. 1 Urban 289 2 Rural 211 "Place of Stay" 1.4: Marital status Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) Marital status (hali ya ndoa) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to ascertain their marital status. 1 Never married 30 2 Currently married 319 3 Seperated 27 4 Divorced 25 5 Widowed 96 6 Cohabiting or living together 1 96 Other Specify 2 "1.4: Marital status" 1.6: Marital status other specify Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) Marital status (hali ya ndoa) N/A N/A Patients with type 2 diabetes 2 0 The question was asked to patients with type 2 diabetes to ascertain other marital status. 1 Single 1 "1.6: Marital status other specify" 1.5: Education Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) Education (kiwango cha elimu) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to ascertain their education level 1 No formal schooling 16 2 Primary incomplete 87 3 Primary complete 121 4 Secondary incomplete 65 5 Secondary complete 136 6 College/University incomplete 10 7 College/University complete 65 "1.5: Education" 1.6: Occupation Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) Occupation (hali ya ajira) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine their current occupation. 1 Public servant 14 2 Private formal sector 17 3 Subsistence farmer 76 4 Large scale farmer 2 5 Self employed/small business 153 6 Self employed / large business 9 7 Homemaker (housewife/husband) 14 8 Student 0 9 Retired 55 10 Unemployed 116 96 Other 44 "1.6: Occupation" 1.6: Occupation other specify Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) Occupation (hali ya ajira) N/A N/A Patients with type 2 diabetes 44 0 The question was asked to patients with type 2 diabetes to identify any other occupations they may have. A days job 1 Baby sitting 1 Babysitting peoples children 1 1 Casual laborer 1 Casual work 7 Cateress 1 Currently sick 1 Driver 5 Employed in asmall Hotel 1 Evangelist 1 Farming 1 He does masonry 1 Househelp 1 Husstling 1 Hustling 1 Informal employment 3 Juakali craftsman 1 Lab technicians 1 Landlord 1 Logistics clearing and fowarding 1 Lorry Driver 1 Mechanic 1 Painter 1 Patients attendant 1 Preacher 1 Salon hairdresser 1 Sells wines and spirits 1 She washes clothes for others 1 She washes clothes for people 1 Washing clothes for others 2 "1.6: Occupation other specify" 1.7: Does your family have a history of diabetes? Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) Does your family have a history of diabetes? N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if their family has a history of diabetes. 1 Yes 267 2 No 233 "1.7: Does your family have a history of diabetes?" 1.8: What is your religion? Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) What is the religion of the household head? N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine the category of religion they belonged to. 1 1. Catholic 104 2 2. Protestant/other Christian 379 3 3. Hindu 0 4 4. Muslim 11 5 5. Traditional 1 6 6. No religion 1 96 96. Other 4 "1.8: What is your religion?" 1.8 b: Religion other specify Patients with type 2 diabetes being interviewed. Section 1: Socio-demographic variables (vigezo vya kijamii) N/A N/A Patients with type 2 diabetes 4 0 The question was asked to patients with type 2 diabetes to identify any other religion they may practice. Jehova witness 1 Jehovah witnesses 1 Mokorino 1 Seventh-day adventist SDA 1 "1.8 b: Religion other specify" 2.1: Have you heard of COVID-19 or Coronavirus Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 Have you heard of COVID-19 or Coronavirus N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have heard of COVID-19 or the Coronavirus. 1 Yes 496 2 No 4 "2.1: Have you heard of COVID-19 or Coronavirus" 2.2: Have you been in close contact with someone confirmed to be infected with C Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 Have you been in close contact with someone confirmed to be infected with COVID19 N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to ascertain if they have been in close contact with someone confirmed to be infected with COVID-19. 1 Yes 71 2 No 374 98 Don’t know 55 "2.2: Have you been in close contact with someone confirmed to be infected with COVID19" 2.3: Where did this contact take place? Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 If yes, where did this contact take place? N/A N/A Patients with type 2 diabetes 71 0 The question was asked to patients with type 2 diabetes to determine where the close contact with the COVID-19 infected individual took place. 1 4 1 2 2 2 40 2 3 4 2 96 1 3 10 4 1 5 4 96 5 "2.3: Where did this contact take place?" Healthcare setting Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was asked to patients with type 2 diabetes to determine if the close contact with the COVID-19 infected individual took place in a healthcare setting. 0 No 65 1 Yes 6 Sysmiss 429 At home Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was asked to patients with type 2 diabetes to determine if the close contact with the COVID-19 infected individual took place at home. 0 No 24 1 Yes 47 Sysmiss 429 Workplace Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was asked to patients with type 2 diabetes to determine if the close contact with the COVID-19 infected individual took place in workplace. 0 No 57 1 Yes 14 Sysmiss 429 Public transport Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was asked to patients with type 2 diabetes to determine if the close contact with the COVID-19 infected individual took place in public transport. 0 No 70 1 Yes 1 Sysmiss 429 Dont Know Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was asked to patients with type 2 diabetes to determine if the close contact with the COVID-19 infected individual took place in any setting, or if they do not know where it occurred. 0 No 67 1 Yes 4 Sysmiss 429 Other (Specify) Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was asked to patients with type 2 diabetes to identify any other place where the close contact with the COVID-19 infected individual may have occurred. 0 No 65 1 Yes 6 Sysmiss 429 Other Specify Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 6 0 The question was asked to patients with type 2 diabetes to identify any other place where the close contact with the COVID-19 infected individual may have occurred. At a funeral 1 At home was taking care of Covid relative 1 Church 1 Coffee date 1 Neighbour 1 1 "Other Specify" 2.4: What did you do after realizing you had been in contact with someone infect Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 What did you do after realizing you had been in contact with someone infected with COVID19 N/A N/A Patients with type 2 diabetes 71 0 The question was asked to patients with type 2 diabetes to determine what actions they took after realizing they had been in contact with someone infected with COVID-19. 1 12 2 9 2 3 2 2 3 4 7 2 3 4 5 4 2 3 4 5 96 2 2 4 1 2 4 96 1 2 5 3 3 1 3 4 6 3 4 5 1 3 4 96 1 3 5 2 3 5 96 2 3 96 1 4 1 4 5 1 5 5 5 96 1 96 8 "2.4: What did you do after realizing you had been in contact with someone infected with COVID19" Did Nothing Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was asked to patients with type 2 diabetes to determine what actions they took after realizing they had been in contact with someone infected with COVID-19, including if they did nothing. 0 No 59 1 Yes 12 Sysmiss 429 Isolation Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was asked to patients with type 2 diabetes to determine what actions they took after realizing they had been in contact with someone infected with COVID-19, including if they chose to isolate themselves. 0 No 42 1 Yes 29 Sysmiss 429 Washed Hands Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was asked to patients with type 2 diabetes to determine what actions they took after realizing they had been in contact with someone infected with COVID-19, including if they washed their hands. 0 No 42 1 Yes 29 Sysmiss 429 Used Sanitizer Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was asked to patients with type 2 diabetes to determine what actions they took after realizing they had been in contact with someone infected with COVID-19, including if they used hand sanitizer. 0 No 46 1 Yes 25 Sysmiss 429 Took Treatment Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was aimed at determining if the patients sought treatment after realizing they had been in contact with someone infected with COVID-19. 0 No 50 1 Yes 21 Sysmiss 429 Other Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 71 429 The question was aimed at determining if the patients took any other actions after realizing they had been in contact with someone infected with COVID-19. 0 No 55 1 Yes 16 Sysmiss 429 Other Specify Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 16 0 The question was aimed at determining if the patients took any other actions after realizing they had been in contact with someone infected with COVID-19. Did take the infected to hospital and I got tested 1 Got Tested 1 1 She prayed 1 She wore her mask and maintained social distance 1 Tested 3 Tested and it was positive 1 Took garlic and ginger 1 Took test 1 Weared mask 2 Weared mask,social distance 1 Went for covid 19 test 1 Went for test and stayed home for 1year 1 "Other Specify" 2.5: Have you noticed any of the following since the start of the pandemic (sele Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 Have you noticed any of the following since the start of the pandemic (select all that apply) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have noticed any specific changes or symptoms since the start of the pandemic. 0 173 1 6 1 2 11 1 2 3 4 1 2 3 4 1 1 2 3 4 5 6 7 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 9 5 1 2 3 4 5 6 9 5 1 2 3 4 5 7 9 1 1 2 3 4 6 7 9 1 1 2 3 4 7 8 9 1 1 2 3 5 6 1 1 2 3 5 6 7 9 3 1 2 3 5 6 9 3 1 2 3 5 7 8 1 1 2 3 5 7 9 1 1 2 3 5 8 9 2 1 2 3 5 9 4 1 2 3 6 1 1 2 3 7 8 1 1 2 3 8 1 1 2 3 9 1 1 2 4 9 1 2 4 5 8 1 1 2 4 5 9 2 1 2 4 6 1 1 2 4 6 7 8 1 1 2 4 6 9 1 1 2 4 7 1 1 2 4 7 8 2 1 2 5 4 1 2 5 6 8 9 1 1 2 5 6 9 3 1 2 5 7 1 1 2 5 8 9 1 1 2 5 9 5 1 3 2 1 3 4 2 1 3 4 5 6 7 9 1 1 3 4 5 6 9 2 1 3 4 5 9 1 1 3 4 9 1 1 3 5 6 7 9 2 1 3 5 6 8 1 1 3 5 7 8 1 1 3 5 7 8 9 1 1 3 5 7 9 1 1 3 6 9 1 1 4 4 1 4 5 1 1 4 5 6 9 1 1 4 5 9 1 1 4 9 3 1 5 6 1 5 6 1 1 5 6 7 1 1 5 6 9 3 1 5 7 1 1 5 7 9 3 1 5 8 1 1 5 9 4 1 7 2 1 8 1 1 9 8 2 16 2 3 2 2 3 4 3 2 3 4 5 6 1 2 3 4 5 6 7 1 2 3 4 5 7 1 2 3 4 5 7 8 9 1 2 3 4 9 2 2 3 5 6 9 3 2 3 5 7 9 1 2 3 5 8 9 1 2 3 5 9 6 2 3 6 7 9 1 2 3 6 9 1 2 3 7 9 1 2 3 9 2 2 4 2 2 4 5 2 2 4 5 6 7 9 1 2 4 5 7 9 1 2 5 3 2 5 6 1 2 5 6 7 8 9 1 2 5 6 7 9 1 2 5 6 9 2 2 5 7 2 2 5 7 9 1 2 5 8 1 2 5 9 6 2 7 9 2 2 8 1 2 8 9 1 2 9 6 3 3 3 4 5 8 9 1 3 4 9 1 3 5 6 1 3 5 9 5 3 9 1 4 6 4 5 4 4 5 9 1 4 7 1 4 9 1 5 7 5 6 2 5 6 9 6 5 7 1 5 7 8 9 3 5 7 9 5 5 8 1 5 8 9 1 5 9 28 6 1 6 7 1 6 7 8 1 6 9 2 7 3 7 8 1 7 8 9 1 7 9 3 8 1 8 9 1 9 10 "2.5: Have you noticed any of the following since the start of the pandemic (select all that apply)" High Temperature >=38oC or subjective fever? Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have noticed a high temperature (38°C or subjective fever) since the start of the pandemic. 0 No 354 1 Yes 146 Persistent dry cough? Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have experienced a persistent dry cough since the start of the pandemic. 0 No 340 1 Yes 160 Sore throught or pain when swallowing? Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have experienced a sore throat or pain when swallowing since the start of the pandemic. 0 No 406 1 Yes 94 Breathlessness or difficulty in breathing? Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have experienced breathlessness or difficulty in breathing since the start of the pandemic. 0 No 419 1 Yes 81 pain in your body, especially your muscles hurting more than usual Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have experienced pain in their body, particularly if their muscles have been hurting more than usual since the start of the pandemic. 0 No 318 1 Yes 182 Recent changes in your ability to taste or smell things? Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have noticed recent changes in their ability to taste or smell since the start of the pandemic. 0 No 432 1 Yes 68 Unusual nausea or vomiting? Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have experienced unusual nausea or vomiting since the start of the pandemic. 0 No 431 1 Yes 69 Diarrhoea Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have experienced diarrhea since the start of the pandemic. 0 No 465 1 Yes 35 Feel more tired/sleepy/unable to concentrate/physical weakness than usual Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have felt more tired, sleepy, unable to concentrate, or experienced physical weakness than usual since the start of the pandemic. 0 No 315 1 Yes 185 None Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 Have you noticed any of the following since the start of the pandemic (select all that apply) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have experienced any symptoms since the start of the pandemic, including if they took no action in response to their symptoms. 0 No 327 1 Yes 173 None Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 Have you noticed any of the following since the start of the pandemic (select all that apply) N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have experienced any symptoms since the start of the pandemic, including if they took no action in response to their symptoms. 0 No 500 1 Yes 0 2.6: Have you ever been told you have COVID-19 by a professional health worker? Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 Have you ever been told you have COVID-19 by a professional health worker? N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have ever been informed by a professional health worker that they have COVID-19. 1 Yes 45 2 No 455 "2.6: Have you ever been told you have COVID-19 by a professional health worker?" 2.7: Have you been tested for COVID- 19? Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 Have you been tested for COVID- 19? (SELECT ONLY ONE) N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have ever been tested for COVID-19. 1 Yes 179 2 No 321 "2.7: Have you been tested for COVID- 19?" 2.8: Have you ever tested positive for COVID-19? Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 Outcome of the test (SELECT ONLY ONE) N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to determine if they have ever been tested positive for COVID-19. 1 Yes 32 2 No 147 Sysmiss 321 "2.8: Have you ever tested positive for COVID-19?" 2.9: Have you ever received a COVID-19 vaccine? Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 Have you been vaccinated for COVID-19? N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes to determine if they have ever received COVID-19 vaccine. 1 Yes 375 2 No 125 "2.9: Have you ever received a COVID-19 vaccine?" worstMonths Patients with type 2 diabetes being interviewed. SECTION 2 Perceived risk and actions in response to COVID-19 N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 2019-11-012020-01-01 1 2019-12-012020-02-01 3 2020-01-012020-03-01 3 2020-02-012020-04-01 4 2020-03-012020-05-01 132 2020-04-012020-06-01 72 2020-05-012020-07-01 55 2020-06-012020-08-01 29 2020-07-012020-09-01 13 2020-08-012020-10-01 13 2020-09-012020-11-01 6 2020-10-012020-12-01 4 2020-11-012021-01-01 1 2020-12-012021-02-01 6 2021-01-012021-03-01 11 2021-02-012021-04-01 6 2021-03-012021-05-01 18 2021-04-012021-06-01 11 2021-05-012021-07-01 14 2021-06-012021-08-01 11 2021-07-012021-09-01 11 2021-08-012021-10-01 14 2021-09-012021-11-01 7 2021-10-012021-12-01 14 2021-11-012022-01-01 17 2021-12-012022-02-01 17 2022-01-012022-03-01 4 2022-03-012022-05-01 3 Please think about the [PRE–COVID] period Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about how they typically monitored their blood sugar levels before the COVID-19 pandemic. 1 At home 148 2 Health facility (Hospital/non-hospital) 197 3 Both 154 96 other 1 "3.1a: Please think about the [PRE–COVID] period, where did you usually test your blood sugar?" specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 1 0 The question was asked to patients with type 2 diabetes to specify how they typically monitored their blood sugar levels before the COVID-19 pandemic. Chemist 1 "specify" 3.1b: Has this changed in the [COVID] period? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about whether their method of monitoring blood sugar levels changed during the COVID-19 pandemic. 1 Yes 174 2 No 326 "3.1b: Has this changed in the [COVID] period?" 3.1c: Please think about the [COVID] period, where do you usually test your bloo Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 174 326 The question was asked to patients with type 2 diabetes about where they usually tested their blood sugar during the COVID-19 pandemic. 1 At home 100 2 Health facility (Hospital/non-hospital) 55 3 Both 12 96 other 7 Sysmiss 326 "3.1c: Please think about the [COVID] period, where do you usually test your blood sugar?" specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 The question was asked to patients with type 2 diabetes to specify other places where they usually tested their blood sugar during the COVID-19 pandemic. Chemist 1 Don't do the testing 1 During covid the participant has never been to any health facility she stopped taking her drugs 6 months before even covid came about she is managing through her diet and change of lifestyle. 1 Never 1 Never did any test 1 Not tested 1 Stopped testing 1 "specify" 3.2a: How often did you test your blood sugar pre covid period? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about how often they tested their blood sugar before the COVID-19 pandemic. 1 (a) More than twice a day 15 2 (b) Twice a day 73 3 (c) Once a day 79 4 (d) Once or twice a week 226 5 (e) Once a month 77 6 (f) Once in 3 months 6 96 other 24 "3.2a: How often did you test your blood sugar pre covid period?" specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 24 The question was asked to patients with type 2 diabetes to specify how often they tested their blood sugar before the COVID-19 pandemic. 3 times a month 1 3 times aweek 4 3 times in amonth 1 After 4 days 1 After every 2 weeks 1 After two days 1 Every 2 weeks 1 I went for testing anytime I felt sick 1 I went to Itando to test for sugars whenever I felt unwell, or during my monthly clinic visits, whichever comes first 1 Once a week 1 Once after 2 weeks 1 Once aweek 1 Once in 2 months 2 Three times a week 3 Twice a month 1 Twice amonth 1 Twice week 1 When going to hospital 1 "specify" 3.2b: Has this changed in the [COVID] period? Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about whether the frequency of their blood sugar testing changed during the COVID-19 pandemic. 1 Yes 164 2 No 336 "3.2b: Has this changed in the [COVID] period?" 3.2c: How often do you test your blood sugar during the [COVID] period? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 164 336 The question was asked to patients with type 2 diabetes about how often they tested their blood sugar during the COVID-19 pandemic. 1 (a) More than twice a day 8 2 (b) Twice a day 24 3 (c) Once a day 14 4 (d) Once or twice a week 45 5 (e) Once a month 40 6 (f) Once in 3 months 10 96 other 23 Sysmiss 336 "3.2c: How often do you test your blood sugar during the [COVID] period?" specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 23 0 The question was asked to patients with type 2 diabetes about any other specific changes in how often they tested their blood sugar during the COVID-19 pandemic. 3 times a week 1 4 times a week 1 After 3 days 1 After every 2 months 1 After every 2 weeks 1 Didn't test 1 Don't do the testing 1 Four times aweek 1 I only test when I feel unwell 1 Never tested cause I feared covid 1 Not tested for more than a month 1 Not tested in a while 1 Once a week 1 1 Once after 2 months 2 She no longer takes medication for Diabetes 1 Sikuweza kwenda hospitalini kupima 1 Twice a month 2 Twice a week 1 When money is available 1 When she feels sick 1 "specify" 3.3c: If during the [COVID] period you experienced a decrease in the frequency y Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 97 403 The question was asked to patients with type 2 diabetes to identify the main reasons for a decrease in the frequency of their blood sugar testing during the COVID-19 pandemic. 1 Testing strips not available/not managed to get all testing strips needed 18 2 Testing strips too expensive/cannot afford 46 3 Unable to access the clinic 6 4 Nurse/doctor not available 2 96 Other (please explain) 25 Sysmiss 403 "3.3c: If during the [COVID] period you experienced a decrease in the frequency your blood sugar was tested, could you please indicate the main reasons:" 3.3c: Other specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 25 The question was asked to patients with type 2 diabetes to specify other reasons for a decrease in the frequency of their blood sugar testing during the COVID-19 pandemic. Blood sugar was high than usual and so he was testing it everyday because he was worried and concerned 1 Expensive to test.can only go for test when he has money 1 Feared because of covid 19 infection 1 Glucometer broke down 1 Glucometer broke down and could only afford to go for testing at the hospital once or twice a week 1 Glucometer stopped working 2 He was sick and admitted in hospital due to conditions related to diabetes 1 Instructions from the doctor 1 Lack of batteries for the gadget 1 Lack of funds 1 Lost the testing gadgets 1 Machine has no battery 1 Never wanted to interact with people outside 1 No money to go for testing 1 Own decision 1 Sugar level getting better/stable 1 Sugars stabalized 1 Testing machine is not working and testing strips finished 1 Testing was only done when going for clinic 1 The participant stopped taking her Diabetes drugs she manages through her diet and lifestyle 1 1 Ukosefu wa pesa 1 Unable to pay for testing 1 1 "3.3c: Other specify" 3.4a : a) At hospital, KES Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 351 149 0 9999 2287.584 3878.954 The question was asked to patients with type 2 diabetes about the typical cost they incurred for blood sugar testing at a hospital or non-hospital facility before the COVID-19 pandemic. "3.4a : a) At hospital, KES" 3.4a : b) At other facility, KES Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 351 149 0 9999 418.14 1767.675 The question was asked to patients with type 2 diabetes about how much they typically paid for blood sugar testing at a hospital or non-hospital facility during the pre-COVID period. "3.4a : b) At other facility, KES" 3.4c i: a) At hospital, KES Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 66 434 0 10000 1371.303 3093.357 The question was asked to patients with type 2 diabetes about how much they typically paid for blood sugar testing at a hospital facility during the COVID-19 pandemic. "3.4c i: a) At hospital, KES" 3.4c ii : b) At other facility, KES Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 65 435 0 150 17.692 40.918 The question was asked to patients with type 2 diabetes about how much they typically paid for blood sugar testing at a non-hospital facility during the COVID-19 pandemic. "3.4c ii : b) At other facility, KES" 3.5a: In the [pre-COVID] period, how much did you usually spend to have your blo Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 302 198 0 15000 880.616 2039.645 The question was asked to patients with type 2 diabetes about how much they typically paid for blood sugar testing at home during the pre-COVID period. "3.5a: In the [pre-COVID] period, how much did you usually spend to have your blood sugar tested at home? (Consider cost of test)" 3.5c: In the [COVID] period, how much do you usually spend to have your blood su Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 110 390 0 9998 1044.364 2172.688 The question was asked to patients with type 2 diabetes about how much they typically paid for blood sugar testing at home during the COVID period. "3.5c: In the [COVID] period, how much do you usually spend to have your blood sugar tested at home? (Consider cost of test)" 3.6a: What type of medication did your doctor prescribe for the treatment and ca Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about the type of medication their doctor prescribed for the treatment and care of their diabetes during the pre-COVID period. 1 (a) Insulin only 45 2 b) Oral Hypoglycaemic drug only (e.g Metformin, Glibenclamide) 415 3 (c) Both insulin + Oral Hypoglycaemic 40 "3.6a: What type of medication did your doctor prescribe for the treatment and care of diabetes in the [pre-COVID] period?" 3.6a: i If the reply is (b) (Hypoglycaemic drug), please insert name of drug bel Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 415 0 The question was asked to patients with type 2 diabetes about the type of medication their doctor prescribed for the treatment and care of their diabetes during the pre-COVID period. 2 white tablet and 2 yellow tablets 1 9998 9 Calvas 1 Damicron, X-forg 1 Doesn't know 1 Don't know the drug names 1 Dyamicron, Glucofej and poday 1 Enpiget and glucphive 1 Fosyga , treciamet , and Dominican 1 Galvasmet 1 Galvusmet 1 Glocoment 2 1 Glocomet 5 1 Glocomet ,nogloc 1 Glocomet ,noglue 1 Glocomet 1000mg 1 Glocomet and diaphage 1 Glocomet and nogloc 1 Glocomet and nogluc 3 1 Glocomet, nogluc 1 Glocophage 1 Glocophage, glocomet, nogluc and adison1 1 Glomet and nogluc 1 Glucment 7 1 2 1 3 Glucment 1x2 1 Glucment 500g 2 1 Glucment Norgluc 2 Glucment, Nogluc 2 Glucment, Norgluc 6 Glucment, Norgluc, 1 Glucment, nogluc, metformin 1 Glucment500, Norgluc 1 Glucment500Gg, Norgluc 1 Glucofej 3 Glucofer 500mg,nogluc 500mg 1 Glucogen 1 Glucoment 4 Glucoment 500mg 1 Glucoment and Nogluc 8 Glucoment, Glucowell 1 Glucomet 33 1 1 Glucomet (500) and Nogluec 1 Glucomet , nogluc 2 Glucomet ,nogluc 3 Glucomet 500,nogluc 1 Glucomet 500mg 10 2 Glucomet 500mg ,nogluc 1 Glucomet 500mg and nilstand 1 Glucomet 500mg and nogluc 9 Glucomet 500mg and nogluc 2mg 1 Glucomet 500mg and nogluc 5mg 1 Glucomet 500mg nesaret 1 Glucomet 500mg,furosemive,Nevin 1 Glucomet 500mg,nogluc 9 Glucomet 500mg,nogluc 5mg 1 Glucomet 850 1 Glucomet 850 and Nogluec 1 Glucomet 850mg 2 Glucomet 850mg, 1 Glucomet 850mg,nogluc 1 Glucomet and Metformin 1 Glucomet and Nogluc 1 Glucomet and Nogluec 10 Glucomet and metformin 1 Glucomet and nogluc 8 Glucomet ang Nogluec 1 Glucomet nogluc 4 4 Glucomet, Dinamil 1 Glucomet, Nogluec,Hppz 1 Glucomet, Norgluc 5 Glucomet, lipitact 1 Glucomet, nogluc 3 Glucomet, other drug 1 Glucomet, trivia 1 Glucomet,Glucophage 1 Glucomet,Nugluke 1 Glucomet,nogluc 5 Glucomet: Norgluc 1 Glucomet; Norgluc 6 Glucopen 1000 and pioglu 30 gramms vilpagliptin 50 gramms 1 Glucophage 12 1 1 Glucophage 1000 1 Glucophage 1000mg 1 Glucophage 1000mg,nogluc 1 Glucophage 500 1 Glucophage 500 nogluc 1 Glucophage 500mg 1 Glucophage 500mg,nogluc 1 Glucophage 850mg,glucomet 500 1 Glucophage 850mg,nogluc 1 Glucophage and Glucomet 1 Glucophage and Nogluec 1 Glucophage nogluc 7 1 Glucophage, Norgluc 2 Glucophage, diamacron 1 Glucophage, diamacron,nogluc 1 Glucophage, metformin 1000mg 1 Glucophage, nogluc 1 Glucophage,nogluc,lasartan- h, 1 Glucophage; Norgluc 1 Glucophat and Nogluec 1 Glucophat xr 1000 and losartas 1 Glucowel 1000*50,nogluc 1 Gludown 1 Glughage 850mg,nogluc 1 Glument 1000 1 Glument 500mg 1 Glument 500mg,nogluc 20mg 1 Glypin, glucomet 1 Hypolycaemic 1 Inositol plus, atorvastatin,ascard 1 Insulin, Metformin 1 Megaphone and noglue 1 Mertamorphine 1000g 1 Metfomin and glocophage 1 Metfomin nogluc 1 Metformin 17 1 1 Metformin ,Glucophage 1 Metformin ,Nogluec and plynogluec 1 Metformin 500mg 2 Metformin 500mg and Glypin 1 Metformin 500mg and Nogluc 1 Metformin 850mg and Nogluec 1 Metformin Norgluc 1 Metformin and Nogluc 1 Metformin and Nogluec 5 Metformin and Nunglo 1 Metformin and losartan hydrochlorothiazide 1 Metformin and nogluc 4 Metformin hydrochloride 500mg, Glibenclamide 1 Metformin nogluc 1 2 Metformin, Glibenclamide 6 Metformin, Glimide 1 Metformin, Glinede 1 Metformin, Norgluc 6 Metformin, nogluc 1 Metformin,Glibenclamide 1 Metformin,nogluc 2 Metrophomine 1 1 Nogluc 2 1 1 Nogluc ,Glucomet 1 Nogluc ,glucomet 1 Nogluc 500mg and Glucomet 500mg 1 Nogluc Glucomet 1 Nogluc Glucophage 3 1 Nogluc and Glucoment 2 Nogluc and Glucomet 4 Nogluc and Glucomet 850mg 1 Nogluc and Metformin 1 Nogluc and glocomet 2 Nogluc and metaformin 1 Nogluc and metformin 1 1 Nogluc, Glucomet 1 Nogluc, glucomet 1 Nogluc,glocomet 1 Nogluc,glucoment500mg 1 Nogluc,glucomet 6 Nogluc,glucomet 100mg 1 Nogluc,glucomet 500mg 1 Noglue 1 Noglue and glocomet 2 Nogluec 1 Nogluec and Ascard 1 Nogluec small white medicine 1 1 Norgluc, Glucomet 1 Norgluc, Metformin 1 Norgluc, glucment 2 Norgluc; Glucomet 2 Previanate 1 Rosavel, Glucment, Metformin 850g 1 Traviament 50/1000 1 Treviment 1 Trezianet 50/1000mg and Diamicron 60mg 1 Trimingham,glocophage diamicron 1 Trivamet 50/1000 1 Triviamed and diamacron 1 1 Triziamet 1000mg and Mpjet 10mg ,aztor 20mg 1 "3.6a: i If the reply is (b) (Hypoglycaemic drug), please insert name of drug below" 3.6a: ii If the reply is (c) ( Both insulin + Oral Hypoglycaemic drug) please in Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 40 0 The question was asked to patients with type 2 diabetes about the type of medication their doctor prescribed for the treatment and care of their diabetes during the pre-COVID period. 9998 1 Don't remember the name 1 Glocomet, mixtard and folebalable 1 Glucment 2 Glucment 500g 1 Glucoment 1 Glucoment 1000mg 1 Glucoment and Nogluc and the injection 1 Glucomet 4 Glucomet 500mg 1 Glucomet 500mg, nogluc 1 Glucomet 850 nogluc mixtard 1 Glucomet and Nogluec 1 1 Glucophage 850mg, insulin 1 Glucophage, nogluc, insulin 1 Glucophage,Lantus,humulin r 1 Glucophage; Inslun 1 Humalog and glocomet 1 1 Insulin, Glucomet 1 Insulin,Glucophage nogluc 1 Metformin 1 1 Metformin and mixcad 1 Metformin insulin 1 Metformin,insulin 1 Mistad and glophage 1 1 Mixtard Glucophage 1 Mixtard and glocophage 1 Mixtard insulin and glocophage 1 Mixtard insulin and metamophine 1 Mixtard metformin 1 Triviament 51000 1 glocomet ,nogloc and isuline 1 "3.6a: ii If the reply is (c) ( Both insulin + Oral Hypoglycaemic drug) please insert name of drug below" 3.6b: Has this changed in the [COVID] period? Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about whether the type of medication prescribed by their doctor for diabetes treatment and care changed during the COVID-19 pandemic. 1 Yes 96 2 No 404 "3.6b: Has this changed in the [COVID] period?" 3.6c: Which medication did your doctor prescribe for the treatment and care of d Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 96 404 The question was asked to patients with type 2 diabetes about the type of medication their doctor prescribed for the treatment and care of their diabetes during the COVID-19 pandemic. 1 (a) Insulin only 21 2 b) Oral Hypoglycaemic drug only (e.g Metformin, Glibenclamide) 69 3 (c) Both insulin + Oral Hypoglycaemic 6 Sysmiss 404 "3.6c: Which medication did your doctor prescribe for the treatment and care of diabetes in the [COVID] period? ( to )" 3.6c i: If the reply is (B) (Hypoglycaemic drug), please insert name of drug bel Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 69 0 The question was asked to patients with type 2 diabetes about the type of medication their doctor prescribed for the treatment and care of their diabetes during the COVID-19 pandemic. 2 white tablet and 2 yellow tablet 1 Amaleaf, Trixiament 1 Doesn't know 1 Dymicro 1 1 Galpusmet 1 Galvasmet 1 Glimepiride 1 Glocoment 1 1 Glomet XR,nogluc and glophage 1 1 1 1 Glucoment and Nogluc 1 Glucomet 6 1 Glucomet 1000mg,nogluc 1 Glucomet 500mg 2 Glucomet 500mg only 1 Glucomet 500mg,nogluc 1 Glucomet 850mg, Norgluc 1 Glucomet and Nogluec 1 Glucomet only 1 Glucomet, Norgluc 2 Glucomet,nogluc 1 Glucophage 1 1 Glucophage 1000mg and Nogluc 1 Glucophage 500mg 1 Glucophage 850,glimepiride 1 Glucophage 850,nogluc 20 1 Glucophage and Nogluec 1 1 Glument 850mg,nogluc 1 Grodown mertamorphine500mg, grimepride 1ml 1 Inosine+ 1 1 Metformin 2 Metformin ,Nogluec and ciflo 1 Metformin 500mg and Nogluec 1 Metformin and Nogluec 2 Metformin hydrochloride 850mg, Glibenclamide 1 1 Metformin, Glibenclamide 1 Metformin, nogluc 1 1 Nogluc and glocomet 1 Nogluc and glucoment 1 Nogluc triviamet 1 Nogluc,glucophage 1000mg 1 Noglue and metaphone 1 Nogluec 1 Nogluec and metformin 1 Norgluc, Glucment 850g 1 Trivia 1 Triviamed only the doctor withdrew diamacron 1 Triviomet 1 Triziamet 1000mg 1 Trreviamet 1 "3.6c i: If the reply is (B) (Hypoglycaemic drug), please insert name of drug below" 3.6c ii: If the reply is (c) ( Both insulin + Oral Hypoglycaemic drug) please in Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 0 The question was asked to patients with type 2 diabetes about the type of medication their doctor prescribed for the treatment and care of their diabetes during the COVID-19 pandemic. Glucomet 500mg,nogluc 1 Insulin, Glucomet 2 Mixtard Glucophage 2 Mixtard and glocophage 1 NA 1 "3.6c ii: If the reply is (c) ( Both insulin + Oral Hypoglycaemic drug) please insert name of drug below" Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 94 0 N/A (a) Insulin only 20 (c) Both insulin + Oral Hypoglycaemic 6 b) Oral Hypoglycaemic drug only (e.g Metformin, Glibenclamide) 68 3.7a: Did you use ${drugd} medication in the [pre-COVID] period?' Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about whether they used the prescribed medication for diabetes treatment during the pre-COVID period. 1 Yes 483 2 No 17 3.7c: Did you use ${druge} medication in the [COVID] period?' Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about whether they used the prescribed medication for diabetes treatment during the COVID period. 1 Yes 485 2 No 15 Think about the 3 months before [COVID] Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 483 17 The question was asked to patients with type 2 diabetes to indicate the medications they used during the three months before the COVID-19 pandemic, specifically between January and March 2020. 1 once a day 193 2 twice a day 290 Sysmiss 17 "3.8a Think about the 3 months before [COVID]. Please indicate medication’s: (i) Frequency" (ii) Dose (a) Mls of insulin Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 483 0 The question was asked to patients with type 2 diabetes to indicate the dose of insulin they used during the three months before the COVID-19 pandemic, specifically between January and March 2020. 0 388 00 9 1 1 10 2 10 mls morning and 10 evening 1 10 mls morning; 8 mls evening 1 1 10 morning 12evening 1 10 morning 6 evening 1 10 morning 8 evening 1 10mls 1 10mls in the evening, 22mls in the morning 1 10ms 1 11 mls morning and 12 mls evening 1 12 MIS 1 12 morning 6 evening 1 12mls morning 6mls evening 1 14ms 1 16 1 1 16ml morning and 8mls evening 1 1 18 ml in the morning 9 ml evening 1 18 morning 9 evening 1 19ml 1 2 1 20 1 1 1 20 morning 10 evening 1 20 morning 12 evening 1 20 morning,10 evening 1 20 units morning 1 20ml 1 20ml morning,10mls evening 1 20mls morning 10mls evening 1 20mls morning and 40 mls evening 1 20mls morning, 10 mls evening 1 20mls morning,10mls evening 1 20mls morning,15mls evening 1 22mls morning,11mls evening 1 1 24 morning 12 evening 1 24ml 1 24mls morning and 14 evening 1 24mls morning,11mls evening 1 25 morning and 12 evening 1 25mls morning 8mls evening 1 25mls morning,12mls evening 1 1 1 26 morning 14 evening 1 26mls 1 28 morning 18 evening 1 28MIs and 14 MIs 1 30 4 30mls morning; 18mls evening 1 34 Mls Morning: 17 Mls Evening 1 34 morning 18evening 1 34ml 1 35morning,15 evening 1 36 1 36 Mls Morning: 24 Mls Evening 1 36mls 1 36mls/20mls 1 38ml 1 1 40 mls morning and 20 mls evening 1 40mls morning,22mls evening 1 42/20 1 44ml 1 45 1 46 1 1 48ml 1 4ml 1 50ml 2 60 1 68 1 6morning 4 evening 1 70ml 1 8ml 1 1 "(ii) Dose (a) Mls of insulin" (ii) Dose (b) Number of tablets)/mg? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 483 The question was asked to patients with type 2 diabetes to indicate the number of tablets they used during the three months before the COVID-19 pandemic, specifically between January and March 2020. 0 46 1 29 1 (850mg) 1 1 a day 1 1 each 1 1 glucophage,2nogluc morning and evening 1 1 morning and 1 evening 3 1 morning and 1evening 1 1 morning and 2 evening 2 1 morning, 1 at noon and 1 evening 1 1 morning, 1 noon and 1evening 1 1 tablet 1 1(500mg) 1 1(morning 500mg) 1 1evening 2 1glucomet afternoon,1nogluc evening 1 1glucomet,1nogluc 1 1glucophage 500mg morning and evening,2nogluc morning,1nogluc evening 1 1metformin,1nogluc morning and evening 1 1mg 2 1morning 2 1morning and 1 1 1morning and 1evening 4 1morning and 2 evening 1 1tablet morning and 1tablet evening 1 1x1 9 1x2 17 1x2 glucofej, 1x1 dyamacron 1x1 poday 1 1x2, 1x1 2 1×1 1 2 118 2 (500mg) morning ,1 noon and 1 (500mg) evening 1 2 glucomet, 1nogluc morning and evening 1 2 glucophage,1glucomet morning and evening 1 2 in the morning,2 in the evening 1 2 morning (500mg)and 1 evening (500mg) 1 1 2 morning and 1 evening 3 2 morning and 1evening 1 2 morning and 2 evening 11 2 morning and 3 evening 3 2 morning and evening 2 1 2 tablets 4 2 tablets metformin, 1 tablet Glibenclamide 1 2Glocophage 1 glimepiride 1 2Glucomet,1nogluc morning and evening 1 2glucoment 1nogluc morning 1 2glucoment 1nogluc morning and evening 1 2glucoment and 1nogluc 1 2glucoment,2nogluc morning and evening 4 2glucophage 500mg,2nogluc 1 2metformin evening and morning, 1nogluc evening 1 2mg 20 2tablets 1 2x2 3 2x2 , 1x1 1 2x2, 1x1 1 3 26 3 in the morning and 3 in the evening 1 3 morning and 2 evening 1 3.5 1 3mg 7 3ml 1 4 43 4 glucowel,2nogluc 1 4 morning and 3 evening 1 4glucoment,1nogluc 1 4mg 8 4tablet 1 5 5 500mg 2 500mg metformin, 1 tablet Glibenclamide 1 6 7 6mg 6 7 1 9 tablets; Glucomet (2 tablets three times a day) (Norgluc 2 tablet morning & 1 tablets in the evening) 1 1 1 Glucment 1000g 1 1 1 Glucment 1x1, Norgluc 1x1 2 Glucment 1x2 4 Glucment 1x2, Norgluc 1x1 1 Glucment 1x2, Norgluc 1x2 3 Glucment 1×1 1 Glucment 1×2 2 1 Glucment 1×2, Norgluc 1x1, 1 Glucment 1×2, Norgluc 1x2 1 Glucment 2x1, 1 Glucment 2x1, Norgluc 2x1 1 1 Glucment 500g 1x3, Norgluc 1x2 1 Glucment2x2, Norgluc 1x1 1 1 Glucment500g 1x2 1 1 1 1 Img 1 Metamorphin 1000g 1×2 1 1 Metformin 1x2, Glinede 1x2 1 Metformin 1x2, Norgluc 1x2 1 Metformin 2 Norgluc 1 1 Metformin 500mg, Glibenclamide 1 tablet 1 Noglu1 glucment 1 1 Nogluc 1, Glucment 2 1 Nogluc2 tablets, Glucment 2 1 Norgluc 1 tablet, Glucment 1 tablet 1 Norgluc 1 tablet, Glucophage 2 tablets 1 Norgluc 1×2, Glucment 500g 1×2 1 Norgluc 2 morning, Glucment 850g one in the morning 1 Rosavel 1x1, Glucment 2x1, Metformin 850g 1x2 1 "(ii) Dose (b) Number of tablets)/mg?" (iii) Duration of use Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 483 17 The question was asked to patients with type 2 diabetes to indicate the duration they used insulin during the three months before the COVID-19 pandemic, specifically between January and March 2020. 1 (a) one month only 242 2 (b) two months 19 3 (c) three months 148 96 (96) Other specify 74 Sysmiss 17 "(iii) Duration of use" Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 74 The question was asked to patients with type 2 diabetes to specify other medications they used during the three months before the COVID-19 pandemic, specifically between January and March 2020. 1 or 2 weeks 1 1 week 5 1 week or days 1 2 weeks 5 5 1/2months 1 After 2 weeks 1 Buy as money is available 1 Didn't use insulin but diet to control her diabetes 1 Everday 1 Everyday 44 I used to buy my drugs so duration of use depends on how much I can afford to buy as long as I don't run out of drugs. If I have enough I buy to last me a week or two, sometimes I even bought daily 1 Kila siku 1 1 One week 1 The participant used to take glucoment but only took it for a short time and afterwards stopped taking medication he was managing through his diet the only time he took medication was in 2009 and he took the medication for a short time only and 1 Two week 1 Two weeks 3 When money is available 4 "Specify" Think about the first 3 months of [COVID – March to June 2020] Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 485 15 The question was asked to patients with type 2 diabetes to indicate the medications they used during the three months of COVID-19 pandemic, specifically between March and June 2020. 1 once a day 195 2 twice a day 290 Sysmiss 15 "3.8c Think about the first 3 months of [COVID – March to June 2020]. Please indicate: Options: (i) Frequency(Ni mara ngapi)" (ii) (a) Mls of insulin Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 485 0 The question was asked to patients with type 2 diabetes to indicate the dose of insulin they used during the three months of COVID-19 pandemic, specifically between March and June 2020. 0 372 00 9 10 3 10 and 12 1 1 10 morning 5 evening 1 10 morning 6evening 1 10mls evening, 22mls morning 1 10mls twice 1 11mls morning and 13 mls evening 1 12 1 12 morning 6 evening 1 12mls morning,6mls evening 1 14mls morning,10mls evening 1 14ms 1 1 16 mls morning and 8 mls evening 1 16mls morning 8mls evening 1 1 19ml 1 2 1 20 2 20 iu 1 20 mls morning 10mls evening 1 20 mls morning and 40 mls evening 1 20 mls morning, 10 mls evening 1 20 mls morning; 10 mls evening 2 20 mls morning;10mls evening 1 1 20 morning 12 evening 1 20 morning, 10 evening 1 20 units 1 20mls morning and 10mls evening 1 20mls morning,10mls evening 1 20mls morning,15mls evening 1 20mls/morning,10mls evening 1 20morning, 10 evening 1 22 MIs and 10 MIs 1 22 morning, 12 evening 1 22mls morning,11mls evening 1 1 1 24 morning 12 evening 1 24ml 1 24mls 1 24mls morning and 14 mls evening 1 24mls morning,12mls evening 1 25 morning 12evening 1 26 2 26 , morning 12 afternoon 1 26 morning 10 evening 1 26 morning, 15 evening 1 26morning, 14 evening 1 28 1 28 morning 18 evening 1 28MIs and 14MIs 1 30 4 30 mls morning: 18mls evening 1 30mls morning 10mls evening 1 30mls morning, 10mls evening 1 33 1 34 Mls Morning:17 Mls Evening 1 34 mls morning and 18mls evening 1 34ml 1 35 1 1 36 2 36 Mls morning; 24 Mls Evening 1 36mls 2 36mls/20mls 1 38 1 39 1 40 mls morning and 20 mls evening 1 40 morning 20 evening 1 40mls morning,22 mls evening 1 42/20 1 45 1 46 1 48 morning, 23evening 1 48ml 2 50ml 2 58 1 6 1 6 morning 4 morning 1 60 1 68 1 7 morning 7 evening 1 70ml 1 8ml 1 9 2 9ml 1 Glocoment,nifiat no glotoment 1 O 1 "(ii) (a) Mls of insulin" (ii) (b) Number of tablets)/mg? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 485 0 The question was asked to patients with type 2 diabetes to indicate the number of tablets they used during the three months of COVID-19 pandemic, specifically between March and June 2020. 0 58 1 28 1 Nogluc and 1glucomet 1 1 a day 1 1 1 morning 1 1 1 morning and 1 evening 4 1 morning and 1evening 2 1(500mg) 1 1(850mg) 1 1(morning 500mg) 1 1000g metformin, 1 tablet Glibenclamide 1 1each 1 1evening 2 1glucomet morning,1nogluc evening 1 1glucomet,1nogluc 1 1metformin,1nogluc morning and evening 1 1mg 4 1morning 2 1morning and 1evening 6 1morning and 2 evening 2 1x1 9 1x2 15 1x2 glucofej 1x1 dyamacron 1x1 poday 1 1x2, 1x1 2 1×1 1 2 111 1 2 (500mg) ,1 noon and 1 (500mg) evening 1 2 glucophage,1glucomet morning and evening 1 2 in the morning 2 in the evening 1 2 mg 1 1 1 1 2 morning and 1 evening 3 2 morning and 1evening 1 2 morning and 2 e 1 2 morning and 2 evening 10 2 morning and 3 evening 1 2 tablets 4 2 tablets metformin, 1 tablet Glibenclamide 2 2 tablets morning, 1 tablet evening 1 2glucoment 1000mg, 2nogluc morning and 1nogluc evening 1 2glucoment 1nogluc 1 2glucoment 1nogluc morning and evening 1 2glucoment and 2nogluc morning and evening 1 2glucoment morning and evening 1 2glucoment, 1nogluc 1 2glucoment,1nogluc 1 2glucoment,2nogluc morning and evening 2 2glucomet,2nogluc,morning and evening 1 2metformin morning and evening, 1nogluc evening 1 2mg 18 2mh 1 2x2 3 2x2, 1x1 1 2x2,1x1 1 3 25 3 in the morning and 3 in the evening 1 3 morning and 2 evening 2 3 tablets,morning,afternoon and e 1 3.5 1 3mg 4 4 45 4 morning and 4 evening 1 4glucoment,1nogluc 1 4glucowel,2nogluc 1 4mg 8 4ml 2 5 5 5 morning and 4 evening 1 500mg 2 6 6 6mg 3 6ml 1 7 1 8 1 Amaleaf 1x1, Trixiament 1x2 1 1 1 1 1 Glucment 1x1 1 1 Glucment 1x1, Norgluc 1x1 1 Glucment 1x2 2 Glucment 1x2, Norgluc 1x1 3 Glucment 1x2, Norgluc 1x2 3 Glucment 1×1, Norgluc 1x1 1 Glucment 1×2, Nogluc2×2, Metformin 1×1 1 Glucment 1×2, Norgluc 1x1 1 1 Glucment 2, Norgluc 1 1 Glucment 2x1, Norgluc 2x1 1 1 Glucment 500g 1x2 1 Glucment 500g 1×1, Norgluc 1x1 1 1 Glucment500g 1 Glucment500g 1x2 1 1 Glucophage 1x2 1 Grodown mertamorphine500mg2x2, Grimepride 1ml2x2 1 Inosita (Sitagliptin) 1x1, Glycinorm 1x1 1 1 Metformin 1x2, Glinede 1x2 1 Metformin 2, Norgluc 1 1 Metformin 2x2, Norgluc 2morning 1 evening 1 Metformin 850mg, Norgluc 1 tablet 1 1 Nogluc 1, glucment 1 1 Norgluc 1 tablet, Glucophage 2 tablets 1 Norgluc 1x1, Glucment 1x1 1 Norgluc 1×1, Glucment 1×2, Metformin 1×2, Nerve care 1x1 1 1 Norgluc1 tablet, Glucment 1 tablet 1 Rosavel 1x1, Glucment 2x1, Metformin 850g 1x2 1 Triviament 1x2 1 1 "(ii) (b) Number of tablets)/mg?" (iii) Duration of use Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 485 15 The question was asked to patients with type 2 diabetes to indicate the duration they used insulin during the three months of COVID-19 pandemic, specifically between March and June 2020. 1 (a) one month only 234 2 (b) two months 12 3 (c) three months 154 96 (96) Other specify 85 Sysmiss 15 "(iii) Duration of use" Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 85 The question was asked to patients with type 2 diabetes to specify other medications they used during the three months of COVID-19 pandemic, specifically between March and June 2020. 1 day or week 1 1 week 4 1 week or 2 weeks 1 10 days 1 2 weeks 5 After 2 weeks 1 After1week 1 As money is available 1 Buying mostly for one week 1 Daily based on money availability 1 Did use diet to control her diabetes 1 Eve 1 Everyday 45 For one week 1 I bought daily or weekly depending on how much I have 1 No specific duration. Sometimes a week, or two 1 Once a week 2 One week 4 The participant does self management of his diet and lifestyle and exercise he no longer takes medication for diabetes he also has the machine and checks his blood sugars 1 Two week 2 Two weeks 5 1 When money available 1 When money is available 2 "Specify" 3.9a i: Insulin monthly cost in the [pre-COVID] period? Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 485 15 0 15000 718.748 2271.919 The question was asked to patients with type 2 diabetes about how much they typically spent on insulin or medication in a typical month during the pre-COVID period. "3.9a i: Insulin monthly cost in the [pre-COVID] period?" 3.9a i: Medication monthly cost in the [pre-COVID] period? Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 485 15 0 36000 3125.953 4006.564 The question was asked to patients with type 2 diabetes about how much they typically spent on insulin or medication in a typical month during the pre-COVID period. "3.9a i: Medication monthly cost in the [pre-COVID] period?" 3.9c: iInsulin monthly cost in the [COVID] period? Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 485 15 0 99998 795.744 4935.612 The question was asked to patients with type 2 diabetes about how much they typically spent on insulin or medication in a typical month during the COVID period. "3.9c: iInsulin monthly cost in the [COVID] period?" 3.9c: iiMedication monthly cost in the [COVID] period? Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 485 15 0 99998 2651.895 5754.1 The question was asked to patients with type 2 diabetes about how much they typically spent on insulin or medication in a typical month during the COVID period. "3.9c: iiMedication monthly cost in the [COVID] period?" 3.10a: Were you able to obtain all the [insulin/medication] that you needed in t Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 485 15 The question was asked to patients with type 2 diabetes about whether they were unable to obtain all the insulin or medication they needed during the pre-COVID period. 1 Yes 452 2 No 33 Sysmiss 15 "3.10a: Were you able to obtain all the [insulin/medication] that you needed in the [pre-COVID] period?" 3.10c: Were you able to obtain all the [insulin/medication] that you needed in t Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about whether they are unable to obtain all the insulin or medication they need during the COVID-19 pandemic. 1 Yes 346 2 No 154 "3.10c: Were you able to obtain all the [insulin/medication] that you needed in the [COVID] period?" 3.11a: Please indicate the reasons why you were unable to obtain all the medicat Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 31 0 The question was asked to patients with type 2 diabetes to indicate the main reason why they were unable to obtain their medications or insulin during the pre-COVID period. 1 15 1 2 7 1 2 5 1 1 2 96 1 1 96 1 2 1 96 5 "3.11a: Please indicate the reasons why you were unable to obtain all the medications/insulin you needed in the [pre-COVID] period?" Too expensive-cannot afford Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 31 469 The question was asked to patients with type 2 diabetes to indicate that one of the main reasons they were unable to obtain their medications or insulin during the pre-COVID period was that it was too expensive and they could not afford it. 0 No 6 1 Yes 25 Sysmiss 469 Not available or in stock Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 31 469 The question was asked to patients with type 2 diabetes to indicate that another main reason they were unable to obtain their medications or insulin during the pre-COVID period was that it was not available or out of stock. 0 No 21 1 Yes 10 Sysmiss 469 Poor Quality Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 31 469 The question was asked to patients with type 2 diabetes to indicate that another main reason they were unable to obtain their medications or insulin during the pre-COVID period was that it was of poor quality 0 No 31 1 Yes 0 Sysmiss 469 Syringes not in Stock Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 31 469 The question was asked to patients with type 2 diabetes to indicate that another main reason they were unable to obtain their medications or insulin during the pre-COVID period was that the syrringes were not in stock. 0 No 31 1 Yes 0 Sysmiss 469 Syringes too expensive Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 31 469 The question was asked to patients with type 2 diabetes to indicate that another main reason they were unable to obtain their medications or insulin during the pre-COVID period was that the syringes were too expensive. 0 No 30 1 Yes 1 Sysmiss 469 Dont know how to inject insulin and doctor or nurse not available at the clinic Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 31 469 The question was asked to patients with type 2 diabetes to indicate that another main reason they were unable to obtain their medications or insulin during the pre-COVID period was that he/she did not know how to inject and the doctor or nurse was not available in the cliniic. 0 No 31 1 Yes 0 Sysmiss 469 Other Reason. Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 31 469 The question was asked to patients with type 2 diabetes to indicate that another reason they were unable to obtain their medications or insulin during the pre-COVID period was due to other factors not previously mentioned. 0 No 24 1 Yes 7 Sysmiss 469 Afraid to go out due to fear of Covid-19 infection Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 31 469 The question was asked to patients with type 2 diabetes to indicate that another reason they were unable to obtain their medications or insulin during the pre-COVID period was due to being afraid to go out due to fear of COVID-19 infection. 0 No 31 1 Yes 0 Sysmiss 469 Specifiy other Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 0 The question was asked to patients with type 2 diabetes to indicate that another reason they were unable to obtain their medications or insulin during the pre-COVID period was due to other factors not previously mentioned. Did not have any challenges in receiving medication. 1 1 I don't use insulin 1 Lack of finances at times to buy the drugs 1 Lack of finances to obtain the medications 1 Lack of transport money,I don't need insulin 1 Obtained all the the medication 1 "Specifiy other" 3.11c: Please indicate the reason why you are unable to obtain all the medicatio Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 0 The question was asked to patients with type 2 diabetes to indicate the main reason why they were unable to obtain their medications or insulin during the COVID period. 1 39 1 10 2 1 2 49 1 2 3 4 5 8 1 1 2 4 2 1 2 4 5 3 1 2 4 5 7 8 2 1 2 4 5 8 9 2 1 2 5 3 1 2 7 7 1 2 7 8 4 1 2 7 96 1 1 2 8 2 1 2 8 10 1 1 2 9 2 1 4 5 1 1 5 3 1 7 1 1 8 1 1 9 1 1 96 7 2 4 96 16 "3.11c: Please indicate the reason why you are unable to obtain all the medications/insulin during the [COVID] period? (multiple responses allowed)" Too expensive-cannot afford Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 346 The question was asked to patients with type 2 diabetes to indicate that one of the main reasons they were unable to obtain their medications or insulin during the COVID period was that it was too expensive and they could not afford it. 0 No 20 1 Yes 134 Sysmiss 346 Not available or in stock Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 346 0 No 71 1 Yes 83 Sysmiss 346 Poor Quality Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 346 The question was asked to patients with type 2 diabetes to indicate that one of the main reasons they were unable to obtain their medications or insulin during the COVID period was that it was of poor quality. 0 No 153 1 Yes 1 Sysmiss 346 Syringes not in Stock Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 346 The question was asked to patients with type 2 diabetes to indicate that one of the main reasons they were unable to obtain their medications or insulin during the COVID period was that the syringes were not in stock 0 No 143 1 Yes 11 Sysmiss 346 Syringes too expensive Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 346 The question was asked to patients with type 2 diabetes to indicate that one of the main reasons they were unable to obtain their medications or insulin during the COVID period was that the syringes were too expensive. 0 No 139 1 Yes 15 Sysmiss 346 Dont know how to inject insulin and doctor or nurse not available at the clinic Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 346 The question was asked to patients with type 2 diabetes to indicate that one of the main reasons they were unable to obtain their medications or insulin during the COVID period was that the patient didn't know how to inject insulin and the doctor or nurse was not available at the clinic. 0 No 154 1 Yes 0 Sysmiss 346 Afraid to go out due to fear of Covid-19 infection Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 346 The question was asked to patients with type 2 diabetes to indicate that one of the main reasons they were unable to obtain their medications or insulin during the COVID period was that he/she was afraid to go out due to fear of COVID-19 infection 0 No 139 1 Yes 15 Sysmiss 346 Lockdown restricted me from going out Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 346 The question was asked to patients with type 2 diabetes to indicate that one of the main reasons they were unable to obtain their medications or insulin during the COVID period was that lockdown restricted the patient from going out. 0 No 141 1 Yes 13 Sysmiss 346 Unable to go out for other reason Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 346 The question was asked to patients with type 2 diabetes to indicate that one of the main reasons they were unable to obtain their medications or insulin during the COVID period was that the patient was unable to go out for other reasons. 0 No 149 1 Yes 5 Sysmiss 346 Limited facility opeing hours Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 346 The question was asked to patients with type 2 diabetes to indicate that one of the main reasons they were unable to obtain their medications or insulin during the COVID period was that limited facility opening hours. 0 No 151 1 Yes 3 Sysmiss 346 Other Reason. Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 154 346 The question was asked to patients with type 2 diabetes to indicate that one of the main reasons they were unable to obtain their medications or insulin during the COVID period due to other reasons. 0 No 130 1 Yes 24 Sysmiss 346 Specifiy other Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 24 The question was asked to patients with type 2 diabetes to indicate that another reason they were unable to obtain their medications or insulin during the COVID period was due to other factors not previously mentioned. Able to obtain all medication 1 1 1 1 Financial constraints 1 He manages through his diet and nutrition he stopped taking medication in 2009 1 I didn't need insulin 1 Jobless 1 1 Lack of funds 1 Lack of money 1 Lack of money to buy drugs 1 Lack of money to buy the medications 1 Medications are not available in the hospital 1 Not on any treatment at the moment 1 She did not use any medication during the covid period she had already stopped taking medication 1 Stopped using medication and did my diabetes control through diet 1 Tenants had not paid so she didn't have money to buy drugs 1 1 The participant is self managing his lifestyle and diet he doesn't take medication for diabetes and has the machine he checks his bloodsugar level 1 1 1 1 1 "Specifiy other" 3.12: Please consider the 3 months before COVID. During this period did you ever Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about whether they visited a hospital to receive any type of medical care for themselves, including seeing a doctor or nurse or obtaining medication for diabetes-related treatment or complications, during the three months before COVID. 1 Yes 445 2 No 55 "3.12: Please consider the 3 months before COVID. During this period did you ever visit a hospital to get any kind of medical care for yourself, including just seeing a doctor or nurse or just to get medication for diabetes related treatment/complications?" Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 438 0 N/A 1 438 (a) Indicate number of times Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 445 55 0 9998 68.07 819.004 The question was asked to patients with type 2 diabetes to indicate the number of times he/she was admitted to the hospital in the 6 months before COVID. "(a) Indicate number of times" (b)Number of nights in total (summing up all admissions)- Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 0 9998 316.449 1729.442 The question was asked to patients with type 2 diabetes to indicate the number of nights in total he/she was admitted to the hospital in the 6 months before COVID. "(b)Number of nights in total (summing up all admissions)-" (c) Type of facility? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 0 The question was asked to patients with type 2 diabetes to indicate the type of facility he/she was admitted to the hospital in the 6 months before COVID. 1 36 1 2 4 1 3 1 2 51 2 3 1 3 11 "(c) Type of facility?" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 0 No 63 1 Yes 41 Sysmiss 396 "(c) Type of facility?" Private for profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 0 No 48 1 Yes 56 Sysmiss 396 "(c) Type of facility?" NGO/ Faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 0 No 91 1 Yes 13 Sysmiss 396 "(c) Type of facility?" (d)Indicate reasons: Diabetes-related tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 0 The question was asked to patients with type 2 diabetes to indicate if their reason for hospital admission was for diabetes-related tests and medications in the 6 months before COVID. 1 1 1 2 3 1 1 2 3 4 1 1 2 3 4 5 6 7 8 9 7 1 2 3 4 5 6 7 9 2 1 2 3 4 5 7 9 5 1 2 3 4 5 9 1 1 2 3 4 7 2 1 2 3 4 7 9 1 1 2 3 4 9 1 1 2 3 4 9 96 1 1 2 3 96 2 1 2 4 1 1 2 4 5 6 7 8 9 4 1 2 4 5 7 9 2 1 2 4 5 7 96 1 1 2 4 6 7 9 1 1 2 4 6 9 1 1 2 4 7 9 3 1 2 4 9 2 1 2 4 9 96 1 1 2 5 7 1 1 2 6 7 1 1 2 7 2 1 2 7 9 2 1 3 1 1 3 4 7 9 1 1 3 4 9 2 1 3 96 1 1 4 7 8 1 1 4 7 9 1 2 1 2 3 5 2 3 4 2 2 3 4 5 6 7 1 2 3 4 6 7 9 1 2 3 4 7 8 9 1 2 3 4 7 9 5 2 3 4 8 96 1 2 3 4 9 4 2 4 1 2 4 5 6 1 2 4 5 7 9 1 2 4 5 8 9 96 1 2 4 6 1 2 4 6 7 8 9 1 2 4 6 7 9 1 2 4 6 9 1 2 4 6 9 96 1 2 4 7 96 1 3 3 3 4 3 3 4 7 8 1 4 1 4 7 8 9 1 9 1 96 9 "(d)Indicate reasons: Diabetes-related tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a urine test related to their diabetes care in the 6 months before COVID. 0 No 50 1 Yes 54 Sysmiss 396 "(d)Indicate reasons: Diabetes-related tests and medications:" Blood Test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a blood test related to their diabetes care in the 6 months before COVID. 0 No 27 1 Yes 77 Sysmiss 396 "(d)Indicate reasons: Diabetes-related tests and medications:" Finger Prick Blood test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a finger prick blood test related to their diabetes care in the 6 months before COVID. 0 No 48 1 Yes 56 Sysmiss 396 "(d)Indicate reasons: Diabetes-related tests and medications:" Blood Pressure Measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a blood pressure measurement related to their diabetes care in the 6 months before COVID. 0 No 31 1 Yes 73 Sysmiss 396 "(d)Indicate reasons: Diabetes-related tests and medications:" Eye Exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo an eye exam related to their diabetes care in the 6 months before COVID. 0 No 77 1 Yes 27 Sysmiss 396 "(d)Indicate reasons: Diabetes-related tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their feet tested for feeling related to their diabetes care in the 6 months before COVID. 0 No 80 1 Yes 24 Sysmiss 396 "(d)Indicate reasons: Diabetes-related tests and medications:" Taking your weight on your scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their weight measured on a scale as part of their diabetes care in the 6 months before COVID. 0 No 53 1 Yes 51 Sysmiss 396 "(d)Indicate reasons: Diabetes-related tests and medications:" Measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their waiste measured with a tape as part of their diabetes care in the 6 months before COVID. 0 No 86 1 Yes 18 Sysmiss 396 "(d)Indicate reasons: Diabetes-related tests and medications:" collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their medication collected as part of their diabetes care in the 6 months before COVID. 0 No 47 1 Yes 57 Sysmiss 396 "(d)Indicate reasons: Diabetes-related tests and medications:" Others, specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to specify any other reasons for their hospital admission related to their diabetes care in the 6 months before COVID. 0 No 85 1 Yes 19 Sysmiss 396 "(d)Indicate reasons: Diabetes-related tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 19 0 The question was asked to patients with type 2 diabetes to specify any other reasons for their hospital admission related to their diabetes care in the 6 months before COVID. Admitted because her sugar levels were too high therefore it needed to be controlled 1 Chest xray 1 Cholesterol 1 Getting some drips 1 Getting the drips 1 He broke his leg and had to have a chuma put in 1 He had a nail pierced in his finger that affected his health and therefore was admitted in hospital 1 He reacted to some medication he took and was admitted 1 He was admitted because of getting constant headaches 1 His sugar levels were very low at 0.1 1 Kidney test 1 Leg amputation 1 Pancreatitis 1 She was admitted for one month because she lost her arm 1 She was put on drip to manage her sugar levels 1 Sugar levels were too high therefore she had to be admitted so that they control her sugar levels. 1 Surgery of the stomach 1 Xray 2 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 0 The question was asked to patients with type 2 diabetes to indicate how they covered the cost of their diabetes care, specifying the most frequently used or relevant payment option in the 6 months before COVID. 1 3 2 31 2 3 11 2 3 4 1 2 3 5 2 2 3 9 1 2 5 2 2 96 1 3 24 3 5 5 3 9 2 3 9 96 1 4 1 5 13 5 7 9 1 8 9 1 9 4 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through free treatment in the 6 months before COVID. 0 No 101 1 Yes 3 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through health insurance in the 6 months before COVID. 0 No 55 1 Yes 49 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through their own cash in the 6 months before COVID. 0 No 57 1 Yes 47 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through parental support in the 6 months before COVID. 0 No 102 1 Yes 2 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through other family support in the 6 months before COVID. 0 No 81 1 Yes 23 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by working for a provider in the 6 months before COVID. 0 No 104 1 Yes 0 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by selling an asset in the 6 months before COVID. 0 No 103 1 Yes 1 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by taking a loan in the 6 months before COVID. 0 No 103 1 Yes 1 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by getting assistance in the 6 months before COVID. 0 No 94 1 Yes 10 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through deferred payment arranged by the provider in the 6 months before COVID. 0 No 104 1 Yes 0 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months before COVID. 0 No 102 1 Yes 2 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 104 396 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months before COVID. 0 No 104 1 Yes 0 Sysmiss 396 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 2 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months before COVID. Mtiba 2 (a) Indicate number of times Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 445 55 0 9998 45.667 669.465 The question was asked to patients with type 2 diabetes to indicate the number of times he/she was admitted to the hospital in the 6 months before COVID. "(a) Indicate number of times" (b)Number of nights in total (summing up all admissions)- Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 143 357 0 9998 70.378 836.038 The question was asked to patients with type 2 diabetes to indicate the number of nights in total he/she was admitted to the hospital in the 6 months before COVID. "(b)Number of nights in total (summing up all admissions)-" (c) Type of facility? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 0 The question was asked to patients with type 2 diabetes to indicate the type of facility he/she was admitted to the hospital in the 6 months before COVID. 1 52 1 2 3 1 3 1 2 64 2 3 3 3 16 "(c) Type of facility?" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 0 No 83 1 Yes 56 Sysmiss 361 "(c) Type of facility?" Private for profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 0 No 69 1 Yes 70 Sysmiss 361 "(c) Type of facility?" NGO/ Faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 0 No 119 1 Yes 20 Sysmiss 361 "(c) Type of facility?" (d)Indicate reasons: Diabetes-related tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 0 The question was asked to patients with type 2 diabetes to indicate if their reason for hospital admission was for diabetes-related tests and medications in the 6 months before COVID. 1 1 1 2 1 1 2 3 4 5 6 7 1 1 2 3 4 5 6 7 8 9 2 1 2 3 4 5 6 7 9 3 1 2 3 4 7 8 9 1 1 2 3 4 7 9 3 1 2 3 4 9 3 1 2 3 9 1 1 2 3 96 1 1 2 4 4 1 2 4 5 6 7 8 9 1 1 2 4 5 6 7 9 1 1 2 4 5 7 9 96 1 1 2 4 6 7 1 1 2 4 7 8 1 1 2 4 9 2 1 2 4 9 96 1 1 2 6 7 8 1 1 2 9 2 1 2 96 1 1 3 2 1 3 4 1 1 3 4 5 7 9 2 1 3 4 9 4 1 3 7 1 1 9 1 2 4 2 3 2 2 3 4 4 2 3 4 5 1 2 3 4 5 7 8 9 1 2 3 4 5 7 9 1 2 3 4 6 7 8 9 1 2 3 4 6 7 9 1 2 3 4 7 2 2 3 4 7 9 6 2 3 4 8 9 1 2 3 4 9 3 2 3 5 7 1 2 3 9 3 2 4 1 2 4 5 7 1 2 4 6 7 9 1 2 4 7 9 1 2 4 9 1 2 5 1 2 5 7 9 1 2 5 9 1 2 7 9 1 2 9 4 2 9 96 1 2 96 1 3 1 3 4 9 3 4 5 2 3 4 5 7 9 1 3 4 6 1 3 4 6 7 9 1 3 4 7 1 3 4 7 9 10 3 4 9 12 3 5 6 7 8 9 1 3 5 7 9 1 3 5 9 1 3 7 1 3 7 9 96 1 3 9 1 9 1 96 4 "(d)Indicate reasons: Diabetes-related tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a urine test related to their diabetes care in the 6 months before COVID. 0 No 95 1 Yes 44 Sysmiss 361 "(d)Indicate reasons: Diabetes-related tests and medications:" Blood Test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a blood test related to their diabetes care in the 6 months before COVID. 0 No 61 1 Yes 78 Sysmiss 361 "(d)Indicate reasons: Diabetes-related tests and medications:" Finger Prick Blood test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a finger prick blood test related to their diabetes care in the 6 months before COVID. 0 No 43 1 Yes 96 Sysmiss 361 "(d)Indicate reasons: Diabetes-related tests and medications:" Blood Pressure Measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their blood pressure measured related to their diabetes care in the 6 months before COVID. 0 No 44 1 Yes 95 Sysmiss 361 "(d)Indicate reasons: Diabetes-related tests and medications:" Eye Exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo an eye exam related to their diabetes care in the 6 months before COVID. 0 No 114 1 Yes 25 Sysmiss 361 "(d)Indicate reasons: Diabetes-related tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their feet tested for feeling related to their diabetes care in the 6 months before COVID. 0 No 123 1 Yes 16 Sysmiss 361 "(d)Indicate reasons: Diabetes-related tests and medications:" Taking your weight on your scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their weight taken on scale related to their diabetes care in the 6 months before COVID. 0 No 85 1 Yes 54 Sysmiss 361 "(d)Indicate reasons: Diabetes-related tests and medications:" Measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their weight measured with a tape related to their diabetes care in the 6 months before COVID. 0 No 129 1 Yes 10 Sysmiss 361 "(d)Indicate reasons: Diabetes-related tests and medications:" collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their medication collected as part of their diabetes care in the 6 months before COVID. 0 No 53 1 Yes 86 Sysmiss 361 "(d)Indicate reasons: Diabetes-related tests and medications:" Others, specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months before COVID. 0 No 128 1 Yes 11 Sysmiss 361 "(d)Indicate reasons: Diabetes-related tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 0 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months before COVID. Added water 1 Back pain and her chest was paining 1 Cholesterol 1 1 Getting some drips 2 He was done for an Operation 1 Kidney tests 2 Stool test 1 Sugar was high and therefore was put on drip to control the sugar levels 1 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 0 The question was asked to patients with type 2 diabetes to indicate how they covered the cost of their diabetes care, specifying the most frequently used or relevant payment option in the 6 months before COVID. 1 15 1 2 3 1 2 32 2 3 6 2 3 5 2 2 5 2 3 49 3 5 11 3 5 9 1 3 9 2 3 96 4 4 1 5 9 5 9 1 9 3 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through free treatment in the 6 months before COVID. 0 No 123 1 Yes 16 Sysmiss 361 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through health insurance in the 6 months before COVID. 0 No 96 1 Yes 43 Sysmiss 361 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through their own cash in the 6 months before COVID. 0 No 63 1 Yes 76 Sysmiss 361 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through parental support in the 6 months before COVID. 0 No 138 1 Yes 1 Sysmiss 361 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through other family support in the 6 months before COVID. 0 No 113 1 Yes 26 Sysmiss 361 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by working for a provider in the 6 months before COVID. 0 No 139 1 Yes 0 Sysmiss 361 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by selling an asset in the 6 months before COVID. 0 No 139 1 Yes 0 Sysmiss 361 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by taking a loan in the 6 months before COVID. 0 No 139 1 Yes 0 Sysmiss 361 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by getting assistance in the 6 months before COVID. 0 No 132 1 Yes 7 Sysmiss 361 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through deferred payment arranged by the provider in the 6 months before COVID. 0 No 139 1 Yes 0 Sysmiss 361 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 361 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months before COVID. 0 No 135 1 Yes 4 Sysmiss 361 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 139 0 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months before COVID. 0 139 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 4 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months before COVID. Mtiba 3 Mtiba paid 40 percent 1 (a) Indicate number of times Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 445 55 0 9998 159.901 1245.124 The question was asked to patients with type 2 diabetes to indicate the number of times he/she was admitted to the hospital in the 6 months before COVID. "(a) Indicate number of times" (b)Number of nights in total (summing up all admissions)- Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate the number of nights in total he/she was admitted to the hospital in the 6 months before COVID. 0 7 Sysmiss 493 "(b)Number of nights in total (summing up all admissions)-" (c) Type of facility? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 0 The question was asked to patients with type 2 diabetes to indicate the type of facility he/she was admitted to the hospital in the 6 months before COVID. 1 137 1 2 21 1 3 6 2 182 2 3 3 3 54 "(c) Type of facility?" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 0 No 239 1 Yes 164 Sysmiss 97 "(c) Type of facility?" Private for profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 0 No 197 1 Yes 206 Sysmiss 97 "(c) Type of facility?" NGO/ Faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 0 No 340 1 Yes 63 Sysmiss 97 "(c) Type of facility?" (d)Indicate reasons: Diabetes-related tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 0 The question was asked to patients with type 2 diabetes to indicate if their reason for hospital admission was for diabetes-related tests and medications in the 6 months before COVID. 1 2 1 2 3 5 1 2 3 4 2 1 2 3 4 5 1 1 2 3 4 5 6 7 8 9 17 1 2 3 4 5 6 7 9 2 1 2 3 4 5 7 9 1 1 2 3 4 5 9 1 1 2 3 4 6 7 8 9 1 1 2 3 4 7 1 1 2 3 4 7 8 1 1 2 3 4 7 9 3 1 2 3 4 9 7 1 2 3 5 6 7 8 9 2 1 2 3 5 8 9 1 1 2 3 8 1 1 2 3 9 1 1 2 4 2 1 2 4 5 6 7 8 1 1 2 4 5 6 7 8 9 14 1 2 4 5 9 1 1 2 4 6 1 1 2 4 7 1 1 2 4 7 8 1 1 2 4 7 9 1 1 2 5 7 8 1 1 2 5 7 8 9 1 1 2 7 2 1 2 7 9 1 1 2 9 4 1 3 5 1 3 4 2 1 3 4 5 9 1 1 3 4 7 9 1 1 3 4 9 2 1 3 5 7 9 1 1 3 7 1 1 3 9 2 2 7 2 3 5 2 3 4 6 2 3 4 5 6 7 9 1 2 3 4 5 6 9 1 2 3 4 5 7 8 1 2 3 4 5 7 8 9 1 2 3 4 5 8 9 1 2 3 4 5 9 1 2 3 4 6 7 2 2 3 4 6 7 8 9 2 2 3 4 6 7 9 3 2 3 4 6 8 9 3 2 3 4 7 3 2 3 4 7 8 9 2 2 3 4 7 9 7 2 3 4 8 9 2 2 3 4 9 28 2 3 5 1 2 3 5 7 1 2 3 7 9 1 2 3 8 9 2 2 3 9 4 2 4 3 2 4 5 6 7 8 9 1 2 4 5 6 7 9 2 2 4 5 8 96 1 2 4 5 9 1 2 4 6 7 1 2 4 6 7 9 2 2 4 6 9 1 2 4 7 1 2 4 7 9 3 2 4 9 4 2 4 9 96 2 2 5 6 7 9 1 2 5 8 9 1 2 6 2 2 6 8 1 2 7 2 2 7 9 1 2 9 14 3 15 3 4 16 3 4 5 1 3 4 5 6 7 1 3 4 5 6 7 8 9 2 3 4 5 6 7 9 1 3 4 5 7 2 3 4 5 7 9 1 3 4 5 9 2 3 4 6 7 9 2 3 4 6 8 1 3 4 6 9 1 3 4 7 6 3 4 7 8 1 3 4 7 8 9 1 3 4 7 9 22 3 4 8 9 1 3 4 9 24 3 4 96 1 3 5 2 3 5 8 9 1 3 5 9 2 3 7 2 3 7 9 1 3 9 17 3 96 1 4 2 4 6 1 4 9 2 5 9 2 5 96 1 7 8 9 1 9 33 9 96 1 96 9 "(d)Indicate reasons: Diabetes-related tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a urine test related to their diabetes care in the 6 months before COVID. 0 No 308 1 Yes 95 Sysmiss 97 "(d)Indicate reasons: Diabetes-related tests and medications:" Blood Test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a blood test related to their diabetes care in the 6 months before COVID. 0 No 196 1 Yes 207 Sysmiss 97 "(d)Indicate reasons: Diabetes-related tests and medications:" Finger Prick Blood test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a finger prick blood test related to their diabetes care in the 6 months before COVID. 0 No 136 1 Yes 267 Sysmiss 97 "(d)Indicate reasons: Diabetes-related tests and medications:" Blood Pressure Measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their blood pressure measured related to their diabetes care in the 6 months before COVID. 0 No 161 1 Yes 242 Sysmiss 97 "(d)Indicate reasons: Diabetes-related tests and medications:" Eye Exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo an eye exam related to their diabetes care in the 6 months before COVID. 0 No 325 1 Yes 78 Sysmiss 97 "(d)Indicate reasons: Diabetes-related tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their feet tested for feeling related to their diabetes care in the 6 months before COVID. 0 No 333 1 Yes 70 Sysmiss 97 "(d)Indicate reasons: Diabetes-related tests and medications:" Taking your weight on your scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their weight taken on scale related to their diabetes care in the 6 months before COVID. 0 No 268 1 Yes 135 Sysmiss 97 "(d)Indicate reasons: Diabetes-related tests and medications:" Measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their weight measured with a tape related to their diabetes care in the 6 months before COVID. 0 No 336 1 Yes 67 Sysmiss 97 "(d)Indicate reasons: Diabetes-related tests and medications:" collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their medication collected as part of their diabetes care in the 6 months before COVID. 0 No 129 1 Yes 274 Sysmiss 97 "(d)Indicate reasons: Diabetes-related tests and medications:" Others, specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months before COVID. 0 No 387 1 Yes 16 Sysmiss 97 "(d)Indicate reasons: Diabetes-related tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 16 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months before COVID. Chest xray 1 Cholesterol 1 Counselling services on nutrition and personal issues 1 Diabetes management and education and seminars 1 Hboc 1 He had gone for a drip to maintain his sugar levels 1 He received treatment for hpylori 1 1 Kidney test 1 She has back and chest pains 1 She was put on drip because her sugar levels were too high 1 She was put under drip for management of her sugar levels to be controlled because they were too high 1 She would take her results for diabetes to her doctor since she was testing herself at home and afterwards the doctor would advise her and also prescribe for her medication to continue. 1 Testing kidney 1 Tests for liver and HB1C 1 Treatment for other general diseases and high blood pressure 1 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 0 The question was asked to patients with type 2 diabetes to indicate how they covered the cost of their diabetes care, specifying the most frequently used or relevant payment option in the 6 months before COVID. 0 1 1 29 1 2 1 1 2 3 5 1 2 5 9 1 1 3 5 1 3 5 1 1 3 9 1 2 111 2 3 30 2 3 5 2 2 5 3 2 6 1 2 96 4 3 142 3 4 1 3 4 5 1 3 5 20 3 5 9 1 3 5 9 10 1 3 9 6 3 96 12 4 1 5 17 5 7 9 1 5 96 2 9 2 96 1 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through free treatment in the 6 months before COVID. 0 No 360 1 Yes 43 Sysmiss 97 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through health insurance in the 6 months before COVID. 0 No 245 1 Yes 158 Sysmiss 97 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through their own cash in the 6 months before COVID. 0 No 175 1 Yes 228 Sysmiss 97 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through parental support in the 6 months before COVID. 0 No 400 1 Yes 3 Sysmiss 97 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through other family support in the 6 months before COVID. 0 No 353 1 Yes 50 Sysmiss 97 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by working for a provider in the 6 months before COVID. 0 No 402 1 Yes 1 Sysmiss 97 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by selling an asset in the 6 months before COVID. 0 No 402 1 Yes 1 Sysmiss 97 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by taking a loan in the 6 months before COVID. 0 No 403 1 Yes 0 Sysmiss 97 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by getting assistance in the 6 months before COVID. 0 No 390 1 Yes 13 Sysmiss 97 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through deferred payment arranged by the provider in the 6 months before COVID. 0 No 402 1 Yes 1 Sysmiss 97 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 97 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months before COVID. 0 No 384 1 Yes 19 Sysmiss 97 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 403 0 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months before COVID. 0 402 1 1 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 19 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months before COVID. Kenya diabetic association 1 Mtiba 14 Mtiba paid 80% 1 Mtiba paid some percentage 1 Mtiba pays half 2 3.16: Now please consider the 3 worst months during COVID period (from ${FromMo Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about whether they visited a hospital to receive any type of medical care for themselves during the three most difficult months of the COVID-19 pandemic, including seeing a doctor or nurse or obtaining medication for diabetes-related treatment or complications. 1 Yes 373 2 No 127 a. Indicate number of times Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 373 127 0 9998 27.445 517.682 The question was asked to patients with type 2 diabetes to indicate the number of times he/she was admitted to the hospital in the 6 months after COVID "a. Indicate number of times" (b). Number of nights in total (summing up all admissions Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 0 9998 206.532 1289.149 The question was asked to patients with type 2 diabetes to indicate the number of nights in total he/she was admitted to the hospital in the 6 months after COVID. "(b). Number of nights in total (summing up all admissions" (c) Type of facility? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 0 The question was asked to patients with type 2 diabetes to indicate the type of facility he/she was admitted to the hospital in the 6 months after COVID. 1 19 1 3 1 2 31 3 11 "(c) Type of facility?" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 0 No 42 1 Yes 20 Sysmiss 438 "(c) Type of facility?" Private for profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 0 No 31 1 Yes 31 Sysmiss 438 "(c) Type of facility?" NGO/ Faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 0 No 50 1 Yes 12 Sysmiss 438 "(c) Type of facility?" (d)Indicate reasons: Diabetes-related tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 0 The question was asked to patients with type 2 diabetes to indicate if their reason for hospital admission was for diabetes-related tests and medications in the 6 months after COVID. 1 2 3 1 1 2 3 4 5 6 7 8 9 2 1 2 3 4 5 6 7 9 2 1 2 3 4 5 7 9 1 1 2 3 4 6 1 1 2 3 4 6 7 9 1 1 2 3 4 7 9 1 1 2 4 5 6 7 8 9 2 1 2 4 6 7 9 2 1 2 4 7 1 1 2 8 9 1 1 2 9 1 1 2 9 96 1 1 3 1 1 3 4 5 6 7 8 9 1 1 3 4 9 2 2 15 2 3 1 2 3 4 1 2 3 4 6 1 2 3 4 6 7 8 9 2 2 3 4 6 8 9 1 2 3 4 6 9 1 2 3 4 7 8 1 2 3 4 9 2 2 3 7 9 1 2 3 8 9 96 1 2 3 9 1 2 4 7 9 1 3 1 3 4 6 7 8 9 1 3 4 9 1 3 5 9 1 4 1 5 1 9 2 96 4 "(d)Indicate reasons: Diabetes-related tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a urine test related to their diabetes care in the 6 months after COVID 0 No 41 1 Yes 21 Sysmiss 438 "(d)Indicate reasons: Diabetes-related tests and medications:" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a blood test by needle related to their diabetes care in the 6 months after COVID. 0 No 16 1 Yes 46 Sysmiss 438 "(d)Indicate reasons: Diabetes-related tests and medications:" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a finger prick blood test related to their diabetes care in the 6 months after COVID. 0 No 32 1 Yes 30 Sysmiss 438 "(d)Indicate reasons: Diabetes-related tests and medications:" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their blood pressure measured related to their diabetes care in the 6 months after COVID. 0 No 33 1 Yes 29 Sysmiss 438 "(d)Indicate reasons: Diabetes-related tests and medications:" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo an eye exam related to their diabetes care in the 6 months after COVID. 0 No 52 1 Yes 10 Sysmiss 438 "(d)Indicate reasons: Diabetes-related tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their feet tested for feeling related to their diabetes care in the 6 months after COVID. 0 No 45 1 Yes 17 Sysmiss 438 "(d)Indicate reasons: Diabetes-related tests and medications:" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their weight taken on scale related to their diabetes care in the 6 months after COVID. 0 No 43 1 Yes 19 Sysmiss 438 "(d)Indicate reasons: Diabetes-related tests and medications:" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their weight measured with a tape related to their diabetes care in the 6 months after COVID. 0 No 50 1 Yes 12 Sysmiss 438 "(d)Indicate reasons: Diabetes-related tests and medications:" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their medication collected as part of their diabetes care in the 6 months after COVID. 0 No 30 1 Yes 32 Sysmiss 438 "(d)Indicate reasons: Diabetes-related tests and medications:" Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months after COVID. 0 No 56 1 Yes 6 Sysmiss 438 "(d)Indicate reasons: Diabetes-related tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 6 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months after COVID. Covid 2 Covid 19 illeness 1 Getting drips 1 1 She had an accident and due to that her sugars went up and needed to be controlled she also had a minor stroke 1 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 0 The question was asked to patients with type 2 diabetes to indicate how they covered the cost of their diabetes care, specifying the most frequently used or relevant payment option in the 6 months after COVID. 1 1 1 2 3 9 1 2 18 2 3 2 2 3 5 1 2 5 9 1 2 96 1 3 23 3 4 1 3 5 6 3 5 7 9 1 3 9 1 5 4 7 9 96 1 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through free treatment in the 6 months after COVID. 0 No 60 1 Yes 2 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through health insurance in the 6 months after COVID. 0 No 38 1 Yes 24 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through their own cash in the 6 months after COVID. 0 No 26 1 Yes 36 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through parental support in the 6 months after COVID. 0 No 61 1 Yes 1 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through other family support in the 6 months after COVID. 0 No 49 1 Yes 13 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by working for a provider in the 6 months after COVID. 0 No 62 1 Yes 0 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by selling an asset in the 6 months after COVID. 0 No 60 1 Yes 2 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by taking a loan in the 6 months after COVID. 0 No 62 1 Yes 0 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by getting assistance in the 6 months after COVID. 0 No 57 1 Yes 5 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 0 No 62 1 Yes 0 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months after COVID. 0 No 60 1 Yes 2 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 62 438 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months after COVID. 0 No 62 1 Yes 0 Sysmiss 438 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 2 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months after COVID. Harambee 1 Mtiba 1 a. Indicate number of times Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 373 127 0 9998 27.657 517.637 The question was asked to patients with type 2 diabetes to indicate the number of times he/she was admitted to the hospital in the 6 months after COVID "a. Indicate number of times" (b). Number of nights in total (summing up all admissions Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 0 9998 102.418 1009.911 The question was asked to patients with type 2 diabetes to indicate the number of nights in total he/she was admitted to the hospital in the 6 months after COVID. "(b). Number of nights in total (summing up all admissions" (c) Type of facility? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 0 The question was asked to patients with type 2 diabetes to indicate the type of facility he/she was admitted to the hospital in the 6 months after COVID. 1 38 1 2 2 1 3 1 2 42 2 3 3 3 12 "(c) Type of facility?" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 0 No 57 1 Yes 41 Sysmiss 402 "(c) Type of facility?" Private for profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 0 No 51 1 Yes 47 Sysmiss 402 "(c) Type of facility?" NGO/ Faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 0 No 82 1 Yes 16 Sysmiss 402 "(c) Type of facility?" (d)Indicate reasons: Diabetes-related tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 0 The question was asked to patients with type 2 diabetes to indicate if their reason for hospital admission was for diabetes-related tests and medications in the 6 months after COVID. 1 2 3 4 5 7 9 1 1 2 3 4 6 7 1 1 2 3 4 7 1 1 2 3 4 9 3 1 2 3 9 1 1 2 4 1 1 2 4 9 1 1 2 4 9 96 1 1 2 6 9 96 1 1 2 9 1 1 3 1 1 3 4 2 1 3 4 6 8 1 1 3 4 7 1 1 3 4 7 9 1 1 4 9 1 2 16 2 3 4 2 2 3 4 5 7 2 2 3 4 6 7 1 2 3 4 7 8 9 1 2 3 4 7 9 3 2 3 4 9 1 2 3 6 9 1 2 4 6 7 9 1 2 4 7 9 1 2 7 8 1 2 9 96 1 3 4 3 4 6 3 4 5 7 1 3 4 6 7 9 1 3 4 6 9 1 3 4 7 1 3 4 7 9 6 3 4 8 9 1 3 4 9 10 3 5 7 8 1 3 7 9 1 3 9 3 4 1 4 5 9 1 4 9 2 9 5 9 96 1 96 2 "(d)Indicate reasons: Diabetes-related tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a urine test related to their diabetes care in the 6 months after COVID 0 No 79 1 Yes 19 Sysmiss 402 "(d)Indicate reasons: Diabetes-related tests and medications:" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a blood test by needle related to their diabetes care in the 6 months after COVID. 0 No 55 1 Yes 43 Sysmiss 402 "(d)Indicate reasons: Diabetes-related tests and medications:" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a finger prick blood test related to their diabetes care in the 6 months after COVID. 0 No 38 1 Yes 60 Sysmiss 402 "(d)Indicate reasons: Diabetes-related tests and medications:" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their blood pressure measured related to their diabetes care in the 6 months after COVID. 0 No 40 1 Yes 58 Sysmiss 402 "(d)Indicate reasons: Diabetes-related tests and medications:" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo an eye exam related to their diabetes care in the 6 months after COVID. 0 No 92 1 Yes 6 Sysmiss 402 "(d)Indicate reasons: Diabetes-related tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their feet tested for feeling related to their diabetes care in the 6 months after COVID. 0 No 90 1 Yes 8 Sysmiss 402 "(d)Indicate reasons: Diabetes-related tests and medications:" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their weight taken on scale related to their diabetes care in the 6 months after COVID. 0 No 72 1 Yes 26 Sysmiss 402 "(d)Indicate reasons: Diabetes-related tests and medications:" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their weight measured with a tape related to their diabetes care in the 6 months after COVID. 0 No 93 1 Yes 5 Sysmiss 402 "(d)Indicate reasons: Diabetes-related tests and medications:" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their medication collected as part of their diabetes care in the 6 months after COVID. 0 No 46 1 Yes 52 Sysmiss 402 "(d)Indicate reasons: Diabetes-related tests and medications:" Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months after COVID. 0 No 92 1 Yes 6 Sysmiss 402 "(d)Indicate reasons: Diabetes-related tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 6 0 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months after COVID. Getting drips 1 Getting some drips 3 Kidney tests 1 Malaria and pneumonia 1 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 0 The question was asked to patients with type 2 diabetes to indicate how they covered the cost of their diabetes care, specifying the most frequently used or relevant payment option in the 6 months after COVID. 1 10 2 25 2 3 2 2 3 5 2 2 96 1 3 43 3 5 11 3 7 1 3 9 2 5 1 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through free treatment in the 6 months after COVID. 0 No 88 1 Yes 10 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through health insurance in the 6 months after COVID. 0 No 68 1 Yes 30 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through their own cash in the 6 months after COVID. 0 No 37 1 Yes 61 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through parental support in the 6 months after COVID. 0 No 98 1 Yes 0 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through other family support in the 6 months after COVID. 0 No 84 1 Yes 14 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by working for a provider in the 6 months after COVID. 0 No 98 1 Yes 0 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by selling an asset in the 6 months after COVID. 0 No 97 1 Yes 1 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by taking a loan in the 6 months after COVID. 0 No 98 1 Yes 0 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by getting assistance in the 6 months after COVID. 0 No 96 1 Yes 2 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 0 No 98 1 Yes 0 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months after COVID. 0 No 97 1 Yes 1 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 98 402 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months after COVID. 0 No 98 1 Yes 0 Sysmiss 402 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 1 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months after COVID. UHC 1 a. Indicate number of times Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 373 127 0 9998 109.627 1030.921 The question was asked to patients with type 2 diabetes to indicate the number of times he/she was admitted to the hospital in the 6 months after COVID "a. Indicate number of times" (b). Number of nights in total (summing up all admissions Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 319 181 0 9998 31.759 559.78 The question was asked to patients with type 2 diabetes to indicate the number of nights in total he/she was admitted to the hospital in the 6 months after COVID. "(b). Number of nights in total (summing up all admissions" (c) Type of facility? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 0 The question was asked to patients with type 2 diabetes to indicate the type of facility he/she was admitted to the hospital in the 6 months after COVID. 1 115 1 2 11 1 3 4 2 145 2 3 6 3 42 "(c) Type of facility?" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 0 No 193 1 Yes 130 Sysmiss 177 "(c) Type of facility?" Private for profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 0 No 161 1 Yes 162 Sysmiss 177 "(c) Type of facility?" NGO/ Faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 0 No 271 1 Yes 52 Sysmiss 177 "(c) Type of facility?" (d)Indicate reasons: Diabetes-related tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 0 The question was asked to patients with type 2 diabetes to indicate if their reason for hospital admission was for diabetes-related tests and medications in the 6 months after COVID. 1 5 1 2 3 1 2 3 1 1 2 3 4 1 1 2 3 4 5 6 7 8 9 5 1 2 3 4 5 6 7 9 2 1 2 3 4 5 7 9 2 1 2 3 4 6 7 8 9 1 1 2 3 4 7 1 1 2 3 4 7 9 3 1 2 3 4 9 2 1 2 3 5 6 7 9 1 1 2 3 5 7 1 1 2 3 6 8 9 1 1 2 3 9 1 1 2 4 5 6 7 8 9 14 1 2 4 5 7 9 2 1 2 4 6 96 1 1 2 4 7 8 9 1 1 2 5 8 9 1 1 2 6 7 8 9 1 1 2 7 9 1 1 2 9 3 1 3 2 1 3 4 1 1 3 4 5 6 7 8 9 1 1 3 4 5 7 9 96 1 1 3 4 6 7 8 9 1 1 3 4 7 9 2 1 3 4 9 2 1 3 7 1 1 3 9 3 2 36 2 3 2 2 3 4 3 2 3 4 5 2 2 3 4 5 6 7 8 9 1 2 3 4 5 6 8 9 96 1 2 3 4 5 7 8 9 2 2 3 4 5 8 1 2 3 4 5 9 1 2 3 4 6 7 8 9 2 2 3 4 6 7 9 2 2 3 4 6 9 2 2 3 4 7 1 2 3 4 7 8 9 1 2 3 4 7 9 5 2 3 4 8 9 2 2 3 4 9 13 2 3 5 1 2 3 5 6 7 8 9 1 2 3 7 2 2 3 9 1 2 4 1 2 4 6 7 1 2 4 7 9 1 2 4 9 1 2 8 9 1 2 9 8 3 18 3 4 12 3 4 5 6 7 9 1 3 4 5 7 2 3 4 5 7 9 1 3 4 5 8 9 1 3 4 5 9 1 3 4 6 7 1 3 4 6 7 8 2 3 4 6 7 9 1 3 4 6 9 1 3 4 7 4 3 4 7 8 9 2 3 4 7 9 12 3 4 8 9 1 3 4 9 19 3 5 2 3 5 7 1 3 7 1 3 7 9 4 3 8 1 3 9 14 4 2 4 7 1 4 7 9 1 5 2 9 43 9 96 3 96 6 "(d)Indicate reasons: Diabetes-related tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a urine test related to their diabetes care in the 6 months after COVID 0 No 255 1 Yes 68 Sysmiss 177 "(d)Indicate reasons: Diabetes-related tests and medications:" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a blood test by needle related to their diabetes care in the 6 months after COVID. 0 No 179 1 Yes 144 Sysmiss 177 "(d)Indicate reasons: Diabetes-related tests and medications:" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo a finger prick blood test related to their diabetes care in the 6 months after COVID. 0 No 139 1 Yes 184 Sysmiss 177 "(d)Indicate reasons: Diabetes-related tests and medications:" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their blood pressure measured related to their diabetes care in the 6 months after COVID. 0 No 172 1 Yes 151 Sysmiss 177 "(d)Indicate reasons: Diabetes-related tests and medications:" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to undergo an eye exam related to their diabetes care in the 6 months after COVID. 0 No 272 1 Yes 51 Sysmiss 177 "(d)Indicate reasons: Diabetes-related tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their feet tested for feeling related to their diabetes care in the 6 months after COVID. 0 No 279 1 Yes 44 Sysmiss 177 "(d)Indicate reasons: Diabetes-related tests and medications:" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their weight taken on scale related to their diabetes care in the 6 months after COVID. 0 No 229 1 Yes 94 Sysmiss 177 "(d)Indicate reasons: Diabetes-related tests and medications:" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their weight measured with a tape related to their diabetes care in the 6 months after COVID. 0 No 278 1 Yes 45 Sysmiss 177 "(d)Indicate reasons: Diabetes-related tests and medications:" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if one reason for their hospital admission was to have their medication collected as part of their diabetes care in the 6 months after COVID. 0 No 122 1 Yes 201 Sysmiss 177 "(d)Indicate reasons: Diabetes-related tests and medications:" Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months after COVID. 0 No 311 1 Yes 12 Sysmiss 177 "(d)Indicate reasons: Diabetes-related tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 12 0 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months after COVID. Advise on how to eat a balanced diet and take care of oneself 1 Chest pains and back pains 1 For consultation about my rising blood sugar readings 1 HB1C, liver tests and kidney tests 1 He had cut himself with a panga and had an infection 1 Kidney tests 2 1 She was going for checkup and treatment for her back because it keeps paining her from time to time 1 She was recieving treatment for chest pains complications 1 Stool test 1 Went for chest check up treatment 1 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 0 The question was asked to patients with type 2 diabetes to indicate how they covered the cost of their diabetes care, specifying the most frequently used or relevant payment option in the 6 months after COVID. 0 1 1 22 1 3 2 1 3 5 2 2 75 2 10 1 2 3 25 2 3 5 2 2 3 9 1 3 144 3 4 3 3 5 21 3 5 8 1 3 5 9 1 3 9 3 3 9 96 1 4 1 5 14 5 7 9 1 9 1 96 1 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through free treatment in the 6 months after COVID. 0 No 297 1 Yes 26 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through health insurance in the 6 months after COVID. 0 No 219 1 Yes 104 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through their own cash in the 6 months after COVID. 0 No 117 1 Yes 206 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through parental support in the 6 months after COVID. 0 No 319 1 Yes 4 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care through other family support in the 6 months after COVID. 0 No 281 1 Yes 42 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by working for a provider in the 6 months after COVID. 0 No 323 1 Yes 0 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by selling an asset in the 6 months after COVID. 0 No 322 1 Yes 1 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by taking a loan in the 6 months after COVID. 0 No 322 1 Yes 1 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if they covered the cost of their diabetes care by getting assistance in the 6 months after COVID. 0 No 315 1 Yes 8 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 0 No 322 1 Yes 1 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months after COVID. 0 No 321 1 Yes 2 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 323 177 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the 6 months after COVID. 0 No 322 1 Yes 1 Sysmiss 177 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 2 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the 6 months after COVID. 1 Mtiba 1 3.20: Think about the health care you received at places other than a health fac Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about whether, in the three months before the COVID-19 pandemic (before March 2020), they received healthcare from providers outside of a hospital, such as a specialist doctor or surgeon, primary care doctor, nurse, pharmacist or dispensary, health educator, medical assistant/clinical officer, or community health worker. 1 Yes 292 2 No 208 "3.20: Think about the health care you received at places other than a health facility in the [pre-COVID]. Have you ever received in the 3 months before COVID healthcare from one of the following: specialist doctor or surgeon, primary care doctor, nurse, pharmacist or dispensary, health educator, medical assistant/clinical officer, community health worker?" a ) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 292 208 The question was asked to patients with type 2 diabetes to indicate the number of non-hospital healthcare visits to special doctor or surgon they had during the three months after the start of COVID-19. 0 231 1 32 2 15 3 8 5 2 6 2 14 1 17 1 Sysmiss 208 "a ) Indicate number of visits" (b) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 0 82000 9706.148 17001.711 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for their non-hospital healthcare visits to the special doctor or surgon during the three months after the start of COVID-19. "(b) Total fees and charges" (c) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 0 The question was asked to patients with type 2 diabetes to specify the type of facility they visited a specialist doctor or surgeon in a non-hospital healthcare during the three months after the start of COVID-19. 1 16 1 2 1 2 39 3 5 "(c) Type" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a public facility. 0 No 44 1 Yes 17 Sysmiss 439 "(c) Type" Private for Profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a private for-profit facility. 0 No 21 1 Yes 40 Sysmiss 439 "(c) Type" Private-NGO/faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a privat NGO or faith-based facility. 0 No 56 1 Yes 5 Sysmiss 439 "(c) Type" None Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 61 1 Yes 0 Sysmiss 439 "(c) Type" None/na Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 61 1 Yes 0 Sysmiss 439 "(c) Type" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 0 The question was asked to patients with type 2 diabetes to indicate if their reason for visiting the specialist doctor or surgeon in a non-hospital facility during the three months after the start of COVID-19 was for diabetes-specific tests and medications. 0 2 1 2 3 4 5 6 7 8 9 2 1 2 3 4 5 7 1 1 2 3 4 6 7 8 9 1 1 2 3 4 6 9 1 1 2 3 4 8 9 1 1 2 3 6 7 8 9 1 1 2 4 5 6 7 8 9 4 1 2 4 5 9 1 1 2 4 6 1 1 2 4 7 8 1 1 2 6 7 8 9 1 1 3 4 5 6 7 8 9 2 1 3 4 9 1 1 4 2 2 3 1 2 3 4 1 2 3 4 5 6 7 8 9 2 2 3 4 5 6 8 9 1 2 3 4 5 9 2 2 3 4 6 7 1 2 3 4 9 1 2 3 5 7 1 2 3 96 1 2 4 4 2 4 5 1 2 4 5 6 7 9 1 2 4 9 96 1 2 8 9 1 3 1 3 4 7 1 3 5 0 1 3 5 96 1 3 9 1 5 3 5 9 1 5 96 1 96 10 "d ) Indicate reasons: Diabetes-related tests and medications" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the specialist doctor or surgeon in a non-hospital facility during the three months after the start of COVID-19 was to undergo a urine test related to their diabetes care. 0 No 41 1 Yes 20 Sysmiss 439 "d ) Indicate reasons: Diabetes-related tests and medications" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the specialist doctor or surgeon in a non-hospital facility during the three months after the start of COVID-19 was to have a blood test taken by needle related to their diabetes care. 0 No 27 1 Yes 34 Sysmiss 439 "d ) Indicate reasons: Diabetes-related tests and medications" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the specialist doctor or surgeon in a non-hospital facility during the three months after the start of COVID-19 was to have a finger-prick test for blood sugar. 0 No 35 1 Yes 26 Sysmiss 439 "d ) Indicate reasons: Diabetes-related tests and medications" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the specialist doctor or surgeon in a non-hospital facility during the three months after the start of COVID-19 was to have their blood pressure measured. 0 No 27 1 Yes 34 Sysmiss 439 "d ) Indicate reasons: Diabetes-related tests and medications" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the specialist doctor or surgeon in a non-hospital facility during the three months after the start of COVID-19 was to have an eye exam. 0 No 36 1 Yes 25 Sysmiss 439 "d ) Indicate reasons: Diabetes-related tests and medications" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the specialist doctor or surgeon in a non-hospital facility during the three months after the start of COVID-19 was to have their feet tested for sensation. 0 No 43 1 Yes 18 Sysmiss 439 "d ) Indicate reasons: Diabetes-related tests and medications" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the specialist doctor or surgeon in a non-hospital facility during the three months after the start of COVID-19 was to have their weight measured on a scale. 0 No 42 1 Yes 19 Sysmiss 439 "d ) Indicate reasons: Diabetes-related tests and medications" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a specialist doctor or surgeon in a non-hospital facility during the three months after the start of COVID-19 was to have their waist measured with a tape. 0 No 44 1 Yes 17 Sysmiss 439 "d ) Indicate reasons: Diabetes-related tests and medications" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a specialist doctor or surgeon in a non-hospital facility during the three months after the start of COVID-19 was to collect medication. 0 No 35 1 Yes 26 Sysmiss 439 "d ) Indicate reasons: Diabetes-related tests and medications" Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a non-hospital facility during the three months after the start of COVID-19. 0 No 47 1 Yes 14 Sysmiss 439 "d ) Indicate reasons: Diabetes-related tests and medications" None Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 N/A 0 No 58 1 Yes 3 Sysmiss 439 "d ) Indicate reasons: Diabetes-related tests and medications" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 0 N/A 0 61 "d ) Indicate reasons: Diabetes-related tests and medications" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 10 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a non-hospital facility during the three months after the start of COVID-19. Cardiologist 1 For surgery 1 He had to have the Chuma removed from his leg 1 I called the doctor when my blood sugar levels were high and he would advice me on what to do. 1 I had a phone consultation with the doctor when my sugar levels stayed constantly high throughout the week 1 MRI 1 Operation for hernia 1 Surgery 1 Talked to the doctor whenever I had raised blood sugar levels while testing at home 1 Ultrasound 1 e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 0 The question was asked to patients with type 2 diabetes to indicate how they covered the costs of their non-hospital healthcare visits to the specialist doctor or surgeon during the three months after the start of COVID-19, choosing the most used or relevant option. 1 2 1 2 3 1 2 10 2 3 6 3 29 3 4 3 3 5 3 4 1 5 5 9 1 "e ) Covered by: (please choose the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the specialist doctor or surgeon during the three months after the start of COVID-19 through free treatment. 0 No 58 1 Yes 3 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the specialist doctor or surgeon during the three months after the start of COVID-19 through health insurance. 0 No 44 1 Yes 17 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the specialist doctor or surgeon during the three months after the start of COVID-19 through own cash. 0 No 19 1 Yes 42 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the specialist doctor or surgeon during the three months after the start of COVID-19 through parent's support. 0 No 57 1 Yes 4 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the specialist doctor or surgeon during the three months after the start of COVID-19 through other family support. 0 No 53 1 Yes 8 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the specialist doctor or surgeon during the three months after the start of COVID-19 by working for the provider. 0 No 61 1 Yes 0 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the specialist doctor or surgeon during the three months after the start of COVID-19 by selling an asset. 0 No 61 1 Yes 0 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the specialist doctor or surgeon during the three months after the start of COVID-19 by taking a loan. 0 No 61 1 Yes 0 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the specialist doctor or surgeon during the three months after the start of COVID-19 by getting assistance. 0 No 60 1 Yes 1 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the specialist doctor or surgeon during the three months after the start of COVID-19 through deferred payment arranged by the provider. 0 No 61 1 Yes 0 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. 0 No 61 1 Yes 0 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 439 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the three months after COVID. 0 No 61 1 Yes 0 Sysmiss 439 "e ) Covered by: (please choose the most used/relevant option)" e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 61 0 N/A 0 61 "e ) Covered by: (please choose the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 0 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. a ) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 292 208 0 9998 68.997 825.976 The question was asked to patients with type 2 diabetes to indicate the number of non-hospital healthcare visits to the primary care doctor they had during the three months after the start of COVID-19. "a ) Indicate number of visits" (b) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 0 10000 1852.727 2813.744 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19. "(b) Total fees and charges" (c) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 0 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for non-hospital healthcare during the three months after the start of COVID-19. 1 23 1 2 5 1 3 1 2 28 2 3 1 3 8 "(c) Type" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a public facility. 0 No 37 1 Yes 29 Sysmiss 434 "(c) Type" Private for profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a private for-profit facility. 0 No 32 1 Yes 34 Sysmiss 434 "(c) Type" NGO/ Faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a privat NGO or faith-based facility. 0 No 56 1 Yes 10 Sysmiss 434 "(c) Type" (c) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 0 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 66 "(c) Type" (c) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 0 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 66 "(c) Type" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 0 The question was asked to patients with type 2 diabetes to indicate if their reason for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19 was for diabetes-specific tests and medications. 1 2 2 1 2 3 4 6 7 9 1 1 2 4 2 1 4 9 96 1 1 9 1 2 3 4 2 3 4 3 2 3 4 5 6 9 1 2 3 4 5 7 1 2 3 4 5 8 9 1 2 3 4 6 7 8 9 2 2 3 4 6 7 9 1 2 3 4 8 9 1 2 3 4 9 6 2 3 4 9 96 1 2 3 9 2 2 4 1 2 4 5 6 7 8 9 1 3 8 3 4 1 3 4 5 1 3 4 6 7 9 1 3 4 6 9 1 3 4 9 3 3 9 1 4 2 4 6 7 9 1 5 4 9 5 9 96 1 96 5 "d ) Indicate reasons: Diabetes-related tests and medications" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19 was to undergo a urine test related to their diabetes care. 0 No 59 1 Yes 7 Sysmiss 434 "d ) Indicate reasons: Diabetes-related tests and medications" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19 was to have a blood test taken by needle related to their diabetes care. 0 No 36 1 Yes 30 Sysmiss 434 "d ) Indicate reasons: Diabetes-related tests and medications" Finger Prick Blood test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19 was to have a finger-prick test for blood sugar. 0 No 26 1 Yes 40 Sysmiss 434 "d ) Indicate reasons: Diabetes-related tests and medications" Blood Pressure Measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19 was to have their blood pressure measured. 0 No 33 1 Yes 33 Sysmiss 434 "d ) Indicate reasons: Diabetes-related tests and medications" Eye Exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19 was to have an eye exam. 0 No 57 1 Yes 9 Sysmiss 434 "d ) Indicate reasons: Diabetes-related tests and medications" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19 was to have their feet tested for sensation. 0 No 57 1 Yes 9 Sysmiss 434 "d ) Indicate reasons: Diabetes-related tests and medications" Taking your weight on your scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19 was to have their weight measured on a scale. 0 No 58 1 Yes 8 Sysmiss 434 "d ) Indicate reasons: Diabetes-related tests and medications" Measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19 was to have their waist measured with a tape. 0 No 61 1 Yes 5 Sysmiss 434 "d ) Indicate reasons: Diabetes-related tests and medications" collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19 was to collect medication. 0 No 34 1 Yes 32 Sysmiss 434 "d ) Indicate reasons: Diabetes-related tests and medications" Others, specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19. 0 No 58 1 Yes 8 Sysmiss 434 "d ) Indicate reasons: Diabetes-related tests and medications" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 0 N/A 0 66 "d ) Indicate reasons: Diabetes-related tests and medications" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 0 N/A 0 66 "d ) Indicate reasons: Diabetes-related tests and medications" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 5 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting the primary care doctor in a non-hospital facility during the three months after the start of COVID-19. 1 HB1C, liver and kidney tests 1 Pancreatitis checkup 1 She was being taken through her diet and what to eat and also seeked advise on the medications she was given by her doctor 1 Supplements 1 e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 0 The question was asked to patients with type 2 diabetes to indicate how they covered the costs of their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19, choosing the most used or relevant option. 1 9 1 2 1 1 3 1 1 3 5 1 2 7 2 3 2 2 3 4 1 2 3 5 1 2 3 5 9 1 3 28 3 4 1 3 5 3 3 9 1 5 6 9 1 96 2 "e ) Covered by: (please choose the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19 through free treatment. 0 No 54 1 Yes 12 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19 through health insurance. 0 No 53 1 Yes 13 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19 through own cash. 0 No 26 1 Yes 40 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19 through parent's support. 0 No 64 1 Yes 2 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19 through other family support. 0 No 54 1 Yes 12 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19 by working for the provider. 0 No 66 1 Yes 0 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19 by selling an asset. 0 No 66 1 Yes 0 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19 by taking a loan. 0 No 66 1 Yes 0 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19 by getting assistance. 0 No 63 1 Yes 3 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the primary care doctor during the three months after the start of COVID-19 through deferred payment arranged by the provider. 0 No 66 1 Yes 0 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. 0 No 64 1 Yes 2 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 434 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the three months after COVID. 0 No 66 1 Yes 0 Sysmiss 434 "e ) Covered by: (please choose the most used/relevant option)" e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 66 0 N/A 0 66 "e ) Covered by: (please choose the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 2 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. Free service 1 Mtiba 1 a ) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 292 208 0 9998 34.36 585.082 The question was asked to patients with type 2 diabetes to indicate the number of non-hospital healthcare visits to the nurse they had during the three months after the start of COVID-19. "a ) Indicate number of visits" (b) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 0 9998 1156.533 2614.642 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19. "(b) Total fees and charges" (c) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 0 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for non-hospital healthcare during the three months after the start of COVID-19. 1 4 1 2 1 2 9 3 1 "(c) Type" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a public facility. 0 No 10 1 Yes 5 Sysmiss 485 "(c) Type" Private for Profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a private for-profit facility. 0 No 5 1 Yes 10 Sysmiss 485 "(c) Type" Private-NGO/faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a privat NGO or faith-based facility. 0 No 14 1 Yes 1 Sysmiss 485 "(c) Type" None Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 15 1 Yes 0 Sysmiss 485 "(c) Type" None/na Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 15 1 Yes 0 Sysmiss 485 "(c) Type" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 0 The question was asked to patients with type 2 diabetes to indicate if their reason for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19 was for diabetes-specific tests and medications. 1 1 1 2 3 1 2 3 2 2 3 4 5 6 7 8 9 1 2 5 9 1 2 7 1 3 1 3 4 1 3 9 1 4 1 9 2 96 2 "d ) Indicate reasons: Diabetes-related tests and medications" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19 was to undergo a urine test related to their diabetes care. 0 No 13 1 Yes 2 Sysmiss 485 "d ) Indicate reasons: Diabetes-related tests and medications" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19 was to have a blood test taken by needle related to their diabetes care. 0 No 9 1 Yes 6 Sysmiss 485 "d ) Indicate reasons: Diabetes-related tests and medications" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19 was to have a finger-prick test for blood sugar. 0 No 8 1 Yes 7 Sysmiss 485 "d ) Indicate reasons: Diabetes-related tests and medications" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19 was to have their blood pressure measured. 0 No 12 1 Yes 3 Sysmiss 485 "d ) Indicate reasons: Diabetes-related tests and medications" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19 was to have an eye exam. 0 No 13 1 Yes 2 Sysmiss 485 "d ) Indicate reasons: Diabetes-related tests and medications" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19 was to have their feet tested for sensation. 0 No 14 1 Yes 1 Sysmiss 485 "d ) Indicate reasons: Diabetes-related tests and medications" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19 was to have their weight measured on a scale. 0 No 13 1 Yes 2 Sysmiss 485 "d ) Indicate reasons: Diabetes-related tests and medications" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19 was to have their waist measured with a tape. 0 No 14 1 Yes 1 Sysmiss 485 "d ) Indicate reasons: Diabetes-related tests and medications" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19 was to collect medication. 0 No 10 1 Yes 5 Sysmiss 485 "d ) Indicate reasons: Diabetes-related tests and medications" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19. 0 No 13 1 Yes 2 Sysmiss 485 "d ) Indicate reasons: Diabetes-related tests and medications" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 N/A 0 No 15 1 Yes 0 Sysmiss 485 "d ) Indicate reasons: Diabetes-related tests and medications" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 0 N/A 0 15 "d ) Indicate reasons: Diabetes-related tests and medications" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 2 0 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a nurse in a non-hospital facility during the three months after the start of COVID-19. General checkup on health 1 She had an infection inside her nail. 1 e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 0 The question was asked to patients with type 2 diabetes to indicate how they covered the costs of their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19, choosing the most used or relevant option. 0 1 1 3 2 2 2 3 1 3 7 5 1 "e ) Covered by: (please choose the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19 through free treatment. 0 No 12 1 Yes 3 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19 through health insurance. 0 No 12 1 Yes 3 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19 through own cash. 0 No 7 1 Yes 8 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19 through parent's support. 0 No 15 1 Yes 0 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19 through other family support. 0 No 14 1 Yes 1 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19 by working for the provider. 0 No 15 1 Yes 0 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19 by selling an asset. 0 No 15 1 Yes 0 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19 by taking a loan. 0 No 15 1 Yes 0 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19 by getting assistance. 0 No 15 1 Yes 0 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the nurse during the three months after the start of COVID-19 through deferred payment arranged by the provider. 0 No 15 1 Yes 0 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. 0 No 15 1 Yes 0 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 485 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the three months after COVID. 0 No 14 1 Yes 1 Sysmiss 485 "e ) Covered by: (please choose the most used/relevant option)" e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 15 0 N/A 0 15 "e ) Covered by: (please choose the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 0 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. a ) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 292 208 0 9998 138.651 1163.933 The question was asked to patients with type 2 diabetes to indicate the number of non-hospital healthcare visits to a pharmacist or dispensary they had during the three months after the start of COVID-19. "a ) Indicate number of visits" (b) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 0 99998 2664.089 8196.124 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19. "(b) Total fees and charges" (c) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 0 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for non-hospital healthcare during the three months after the start of COVID-19. 1 9 1 3 2 2 157 3 11 "(c) Type" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a public facility. 0 No 168 1 Yes 11 Sysmiss 321 "(c) Type" Private for Profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a private for-profit facility. 0 No 22 1 Yes 157 Sysmiss 321 "(c) Type" Private-NGO/faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a privat NGO or faith-based facility. 0 No 166 1 Yes 13 Sysmiss 321 "(c) Type" None Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 179 1 Yes 0 Sysmiss 321 "(c) Type" None/na Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 179 1 Yes 0 Sysmiss 321 "(c) Type" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 0 The question was asked to patients with type 2 diabetes to indicate if their reason for visiting a pharmacist or dispensary during the three months after the start of COVID-19 was for diabetes-specific tests and medications. 1 2 1 1 2 3 4 5 6 7 9 1 1 2 9 1 1 3 4 9 1 1 3 5 9 1 1 4 5 1 1 4 9 1 2 3 4 1 2 3 4 9 1 2 4 6 7 8 9 1 2 4 6 9 1 2 4 8 1 2 4 9 2 2 5 7 9 1 2 9 1 3 4 3 3 4 9 4 3 9 9 4 9 3 5 9 1 6 7 9 1 7 9 1 9 140 96 1 "d ) Indicate reasons: Diabetes-related tests and medications" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a a pharmacist or dispensary during the three months after the start of COVID-19 was to undergo a urine test related to their diabetes care. 0 No 172 1 Yes 7 Sysmiss 321 "d ) Indicate reasons: Diabetes-related tests and medications" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a pharmacist or dispensary during the three months after the start of COVID-19 was to have a blood test taken by needle related to their diabetes care. 0 No 167 1 Yes 12 Sysmiss 321 "d ) Indicate reasons: Diabetes-related tests and medications" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a pharmacist or dispensary during the three months after the start of COVID-19 was to have a finger-prick test for blood sugar. 0 No 158 1 Yes 21 Sysmiss 321 "d ) Indicate reasons: Diabetes-related tests and medications" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a pharmacist or dispensary during the three months after the start of COVID-19 was to have their blood pressure measured. 0 No 158 1 Yes 21 Sysmiss 321 "d ) Indicate reasons: Diabetes-related tests and medications" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a pharmacist or dispensary during the three months after the start of COVID-19 was to have an eye exam. 0 No 174 1 Yes 5 Sysmiss 321 "d ) Indicate reasons: Diabetes-related tests and medications" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a pharmacist or dispensary during the three months after the start of COVID-19 was to have their feet tested for sensation. 0 No 175 1 Yes 4 Sysmiss 321 "d ) Indicate reasons: Diabetes-related tests and medications" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a pharmacist or dispensary during the three months after the start of COVID-19 was to have their weight measured on a scale. 0 No 174 1 Yes 5 Sysmiss 321 "d ) Indicate reasons: Diabetes-related tests and medications" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a pharmacist or dispensary during the three months after the start of COVID-19 was to have their waist measured with a tape. 0 No 177 1 Yes 2 Sysmiss 321 "d ) Indicate reasons: Diabetes-related tests and medications" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a pharmacist or dispensary during the three months after the start of COVID-19 was to collect medication. 0 No 8 1 Yes 171 Sysmiss 321 "d ) Indicate reasons: Diabetes-related tests and medications" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a pharmacist or dispensary during the three months after the start of COVID-19. 0 No 178 1 Yes 1 Sysmiss 321 "d ) Indicate reasons: Diabetes-related tests and medications" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 N/A 0 No 179 1 Yes 0 Sysmiss 321 "d ) Indicate reasons: Diabetes-related tests and medications" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 0 N/A 0 179 "d ) Indicate reasons: Diabetes-related tests and medications" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 1 0 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a pharmacist or dispensary during the three months after the start of COVID-19. Stomach gases 1 e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 0 The question was asked to patients with type 2 diabetes to indicate how they covered the costs of their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19, choosing the most used or relevant option. 1 2 1 3 1 2 6 2 3 2 2 5 1 3 144 3 5 8 3 96 1 5 13 9 1 "e ) Covered by: (please choose the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19 through free treatment. 0 No 176 1 Yes 3 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19 through health insurance. 0 No 170 1 Yes 9 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19 through own cash. 0 No 23 1 Yes 156 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19 through parent's support. 0 No 179 1 Yes 0 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19 through other family support. 0 No 157 1 Yes 22 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19 by working for the provider. 0 No 179 1 Yes 0 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19 by selling an asset. 0 No 179 1 Yes 0 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19 by taking a loan. 0 No 179 1 Yes 0 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19 by getting assistance. 0 No 178 1 Yes 1 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a pharmacist or dispensary during the three months after the start of COVID-19 through deferred payment arranged by the provider. 0 No 179 1 Yes 0 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. 0 No 178 1 Yes 1 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 321 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the three months after COVID. 0 No 179 1 Yes 0 Sysmiss 321 "e ) Covered by: (please choose the most used/relevant option)" e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 179 0 N/A 0 179 "e ) Covered by: (please choose the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 1 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. Mtiba 1 a ) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 292 208 The question was asked to patients with type 2 diabetes to indicate the number of non-hospital healthcare visits to the health educator they had during the three months after the start of COVID-19. 0 238 1 15 2 7 3 20 4 3 6 6 10 1 12 2 Sysmiss 208 "a ) Indicate number of visits" (b) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 0 2000 162.963 470.767 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19. "(b) Total fees and charges" (c) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 0 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for non-hospital healthcare during the three months after the start of COVID-19. 0 1 1 20 1 2 1 2 26 3 6 "(c) Type" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a public facility. 0 No 33 1 Yes 21 Sysmiss 446 "(c) Type" Private for Profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a private for-profit facility. 0 No 27 1 Yes 27 Sysmiss 446 "(c) Type" Private-NGO/faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a privat NGO or faith-based facility. 0 No 48 1 Yes 6 Sysmiss 446 "(c) Type" None Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 53 1 Yes 1 Sysmiss 446 "(c) Type" None/na Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 54 1 Yes 0 Sysmiss 446 "(c) Type" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 0 The question was asked to patients with type 2 diabetes to indicate if their reason for visiting a health educator in a non-hospital facility during the three months after the start of COVID-19 was for diabetes-specific tests and medications. 0 18 1 2 4 5 6 7 8 9 2 3 1 3 4 5 3 4 7 1 3 4 7 8 1 3 5 1 3 9 1 4 7 1 5 1 6 9 1 7 1 96 20 "d ) Indicate reasons: Diabetes-related tests and medications" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a health educator in a non-hospital facility during the three months after the start of COVID-19 was to undergo a urine test related to their diabetes care. 0 No 52 1 Yes 2 Sysmiss 446 "d ) Indicate reasons: Diabetes-related tests and medications" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a a health educator in non-hospital facility during the three months after the start of COVID-19 was to have a blood test taken by needle related to their diabetes care. 0 No 52 1 Yes 2 Sysmiss 446 "d ) Indicate reasons: Diabetes-related tests and medications" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a health educator in a non-hospital facility during the three months after the start of COVID-19 was to have a finger-prick test for blood sugar. 0 No 44 1 Yes 10 Sysmiss 446 "d ) Indicate reasons: Diabetes-related tests and medications" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a health educator in a non-hospital facility during the three months after the start of COVID-19 was to have their blood pressure measured. 0 No 44 1 Yes 10 Sysmiss 446 "d ) Indicate reasons: Diabetes-related tests and medications" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a health educator in a non-hospital facility during the three months after the start of COVID-19 was to have an eye exam. 0 No 50 1 Yes 4 Sysmiss 446 "d ) Indicate reasons: Diabetes-related tests and medications" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a health educator in a non-hospital facility during the three months after the start of COVID-19 was to have their feet tested for sensation. 0 No 51 1 Yes 3 Sysmiss 446 "d ) Indicate reasons: Diabetes-related tests and medications" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a health educator in a non-hospital facility during the three months after the start of COVID-19 was to have their weight measured on a scale. 0 No 48 1 Yes 6 Sysmiss 446 "d ) Indicate reasons: Diabetes-related tests and medications" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a health educator in a non-hospital facility during the three months after the start of COVID-19 was to have their waist measured with a tape. 0 No 51 1 Yes 3 Sysmiss 446 "d ) Indicate reasons: Diabetes-related tests and medications" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a health educator in a non-hospital facility during the three months after the start of COVID-19 was to collect medication. 0 No 50 1 Yes 4 Sysmiss 446 "d ) Indicate reasons: Diabetes-related tests and medications" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a health educator in a non-hospital facility during the three months after the start of COVID-19. 0 No 34 1 Yes 20 Sysmiss 446 "d ) Indicate reasons: Diabetes-related tests and medications" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 N/A 0 No 36 1 Yes 18 Sysmiss 446 "d ) Indicate reasons: Diabetes-related tests and medications" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 0 N/A 0 54 "d ) Indicate reasons: Diabetes-related tests and medications" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 0 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a health educator in a non-hospital facility during the three months after the start of COVID-19. Advise on Diabetes health and management 1 Advise on health related issues of diabetes 1 Diabetes education 1 Diabetes education and nutrition 1 Diabetes management Education 1 Diabetes management and education 1 Diabetes management and education seminars 1 Diabetes management and nutrition 1 Diabetes management education 1 Education on Diabetes management 4 Nutritional assessment 1 Nutritionist 2 She was being educated on Diabetes and also did exercises 1 She was going for diabetes education management teachings 1 Talk and Education on Diabetes management 1 They were being educated on Diabetes 1 e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 0 The question was asked to patients with type 2 diabetes to indicate how they covered the costs of their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19, choosing the most used or relevant option. 0 15 1 29 2 2 3 7 3 96 1 "e ) Covered by: (please choose the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19 through free treatment. 0 No 25 1 Yes 29 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19 through health insurance. 0 No 52 1 Yes 2 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19 through own cash. 0 No 46 1 Yes 8 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19 through parent's support. 0 No 54 1 Yes 0 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19 through other family support. 0 No 54 1 Yes 0 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19 by working for the provider. 0 No 54 1 Yes 0 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19 by selling an asset. 0 No 54 1 Yes 0 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19 by taking a loan. 0 No 54 1 Yes 0 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19 by getting assistance. 0 No 54 1 Yes 0 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to the health educator during the three months after the start of COVID-19 through deferred payment arranged by the provider. 0 No 54 1 Yes 0 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. 0 No 53 1 Yes 1 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 446 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the three months after COVID. 0 No 39 1 Yes 15 Sysmiss 446 "e ) Covered by: (please choose the most used/relevant option)" e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 54 0 N/A 0 54 "e ) Covered by: (please choose the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 1 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. Nutritionist 1 a ) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 292 208 0 9998 34.517 585.073 The question was asked to patients with type 2 diabetes to indicate the number of non-hospital healthcare visits to a medical assistant/clinical officer they had during the three months after the start of COVID-19. "a ) Indicate number of visits" (b) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 0 9998 3024.2 3861.844 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19. "(b) Total fees and charges" (c) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 0 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for non-hospital healthcare during the three months after the start of COVID-19. 1 8 1 2 2 2 19 3 1 "(c) Type" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a public facility. 0 No 20 1 Yes 10 Sysmiss 470 "(c) Type" Private for Profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a private for-profit facility. 0 No 9 1 Yes 21 Sysmiss 470 "(c) Type" Private-NGO/faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a privat NGO or faith-based facility. 0 No 29 1 Yes 1 Sysmiss 470 "(c) Type" None Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 30 1 Yes 0 Sysmiss 470 "(c) Type" None/na Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 30 1 Yes 0 Sysmiss 470 "(c) Type" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 0 The question was asked to patients with type 2 diabetes to indicate if their reason for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19 was for diabetes-specific tests and medications. 0 1 1 1 1 2 3 4 5 6 7 8 9 2 1 2 3 4 5 7 8 1 1 2 4 5 6 7 8 9 6 1 3 1 1 3 4 5 6 7 8 1 1 3 4 5 6 7 8 9 2 2 2 2 3 1 2 3 4 9 1 3 3 3 9 1 9 3 96 4 "d ) Indicate reasons: Diabetes-related tests and medications" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19 was to undergo a urine test related to their diabetes care. 0 No 16 1 Yes 14 Sysmiss 470 "d ) Indicate reasons: Diabetes-related tests and medications" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19 was to have a blood test taken by needle related to their diabetes care. 0 No 17 1 Yes 13 Sysmiss 470 "d ) Indicate reasons: Diabetes-related tests and medications" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19 was to have a finger-prick test for blood sugar. 0 No 17 1 Yes 13 Sysmiss 470 "d ) Indicate reasons: Diabetes-related tests and medications" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19 was to have their blood pressure measured. 0 No 17 1 Yes 13 Sysmiss 470 "d ) Indicate reasons: Diabetes-related tests and medications" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19 was to have an eye exam. 0 No 18 1 Yes 12 Sysmiss 470 "d ) Indicate reasons: Diabetes-related tests and medications" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19 was to have their feet tested for sensation. 0 No 19 1 Yes 11 Sysmiss 470 "d ) Indicate reasons: Diabetes-related tests and medications" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19 was to have their weight measured on a scale. 0 No 18 1 Yes 12 Sysmiss 470 "d ) Indicate reasons: Diabetes-related tests and medications" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19 was to have their waist measured with a tape. 0 No 18 1 Yes 12 Sysmiss 470 "d ) Indicate reasons: Diabetes-related tests and medications" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19 was to collect medication. 0 No 15 1 Yes 15 Sysmiss 470 "d ) Indicate reasons: Diabetes-related tests and medications" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19. 0 No 26 1 Yes 4 Sysmiss 470 "d ) Indicate reasons: Diabetes-related tests and medications" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 N/A 0 No 29 1 Yes 1 Sysmiss 470 "d ) Indicate reasons: Diabetes-related tests and medications" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 0 N/A 0 30 "d ) Indicate reasons: Diabetes-related tests and medications" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 4 0 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a medical assistant/clinical officer in a non-hospital facility during the three months after the start of COVID-19. Counseling sessions and nutrition 1 He went to seek advise on how to maintain his health. 1 Sugar was high and had to be put under drip to maintain the sugar levels 1 Xray 1 e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 0 The question was asked to patients with type 2 diabetes to indicate how they covered the costs of their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19, choosing the most used or relevant option. 0 2 1 3 2 9 3 14 3 5 1 5 1 "e ) Covered by: (please choose the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19 through free treatment. 0 No 27 1 Yes 3 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19 through health insurance. 0 No 21 1 Yes 9 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19 through own cash. 0 No 15 1 Yes 15 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19 through parent's support. 0 No 30 1 Yes 0 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19 through other family support. 0 No 28 1 Yes 2 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19 by working for the provider. 0 No 30 1 Yes 0 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19 by selling an asset. 0 No 30 1 Yes 0 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19 by taking a loan. 0 No 30 1 Yes 0 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19 by getting assistance. 0 No 30 1 Yes 0 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a medical assistant/clinical officer during the three months after the start of COVID-19 through deferred payment arranged by the provider. 0 No 30 1 Yes 0 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. 0 No 30 1 Yes 0 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 470 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the three months after COVID. 0 No 28 1 Yes 2 Sysmiss 470 "e ) Covered by: (please choose the most used/relevant option)" e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 30 0 N/A 0 30 "e ) Covered by: (please choose the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 0 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. a ) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 292 208 0 9998 34.366 585.082 "a ) Indicate number of visits" (b) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19. 0 11 Sysmiss 489 "(b) Total fees and charges" (c) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 0 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for non-hospital healthcare during the three months after the start of COVID-19. 0 1 1 6 2 4 "(c) Type" Public Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a public facility. 0 No 5 1 Yes 6 Sysmiss 489 "(c) Type" Private for Profit Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a private for-profit facility. 0 No 7 1 Yes 4 Sysmiss 489 "(c) Type" Private-NGO/faith based Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if the type of non-hospital facility they visited during the three months after the start of COVID-19 was a privat NGO or faith-based facility. 0 No 11 1 Yes 0 Sysmiss 489 "(c) Type" None Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 10 1 Yes 1 Sysmiss 489 "(c) Type" None/na Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they did not visit any non-hospital facility during the three months after the start of COVID-19. 0 No 11 1 Yes 0 Sysmiss 489 "(c) Type" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 0 The question was asked to patients with type 2 diabetes to indicate if their reason for visiting a community health worker in a non-hospital facility during the three months after the start of COVID-19 was for diabetes-specific tests and medications. 0 1 2 3 4 1 5 6 7 1 9 1 96 7 "d ) Indicate reasons: Diabetes-related tests and medications" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a community health worker in a non-hospital facility during the three months after the start of COVID-19 was to undergo a urine test related to their diabetes care. 0 No 11 1 Yes 0 Sysmiss 489 "d ) Indicate reasons: Diabetes-related tests and medications" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a community health worker in a non-hospital facility during the three months after the start of COVID-19 was to have a blood test taken by needle related to their diabetes care. 0 No 10 1 Yes 1 Sysmiss 489 "d ) Indicate reasons: Diabetes-related tests and medications" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a community health worker in a non-hospital facility during the three months after the start of COVID-19 was to have a finger-prick test for blood sugar. 0 No 10 1 Yes 1 Sysmiss 489 "d ) Indicate reasons: Diabetes-related tests and medications" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a community health worker in a non-hospital facility during the three months after the start of COVID-19 was to have their blood pressure measured. 0 No 10 1 Yes 1 Sysmiss 489 "d ) Indicate reasons: Diabetes-related tests and medications" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a community health worker in a non-hospital facility during the three months after the start of COVID-19 was to have an eye exam. 0 No 10 1 Yes 1 Sysmiss 489 "d ) Indicate reasons: Diabetes-related tests and medications" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a community health worker in a non-hospital facility during the three months after the start of COVID-19 was to have their feet tested for sensation. 0 No 10 1 Yes 1 Sysmiss 489 "d ) Indicate reasons: Diabetes-related tests and medications" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a community health worker in a non-hospital facility during the three months after the start of COVID-19 was to have their weight measured on a scale. 0 No 10 1 Yes 1 Sysmiss 489 "d ) Indicate reasons: Diabetes-related tests and medications" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a community health worker in a non-hospital facility during the three months after the start of COVID-19 was to have their waist measured with a tape. 0 No 11 1 Yes 0 Sysmiss 489 "d ) Indicate reasons: Diabetes-related tests and medications" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if one reason for visiting a community health worker in a non-hospital facility during the three months after the start of COVID-19 was to collect medication. 0 No 10 1 Yes 1 Sysmiss 489 "d ) Indicate reasons: Diabetes-related tests and medications" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a non-hospital facility during the three months after the start of COVID-19. 0 No 4 1 Yes 7 Sysmiss 489 "d ) Indicate reasons: Diabetes-related tests and medications" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 N/A 0 No 10 1 Yes 1 Sysmiss 489 "d ) Indicate reasons: Diabetes-related tests and medications" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 0 N/A 0 11 "d ) Indicate reasons: Diabetes-related tests and medications" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a non-hospital facility during the three months after the start of COVID-19. Advise on Diabetes health and management and giving assistance to Diabetic patients 1 Advise on Diabetes management and self care 1 Advise on health related issues on Diabetes 1 Diabetes education and management 1 Education on Diabetes management 1 He was approached by a community health worker and he told him the benefits of joining accessafya health care center and the treatment offered at the facility. 1 To know how she's doing in terms of health 1 e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 0 The question was asked to patients with type 2 diabetes to indicate how they covered the costs of their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19, choosing the most used or relevant option. 0 8 1 2 1 3 1 "e ) Covered by: (please choose the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19 through free treatment. 0 No 8 1 Yes 3 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19 through health insurance. 0 No 11 1 Yes 0 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19 through own cash. 0 No 10 1 Yes 1 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19 through parent's support. 0 No 11 1 Yes 0 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19 through other family support. 0 No 11 1 Yes 0 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19 by working for the provider. 0 No 11 1 Yes 0 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19 by selling an asset. 0 No 11 1 Yes 0 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19 by taking a loan. 0 No 11 1 Yes 0 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19 by getting assistance. 0 No 11 1 Yes 0 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if they covered the costs of their non-hospital healthcare visits to a community health worker during the three months after the start of COVID-19 through deferred payment arranged by the provider. 0 No 11 1 Yes 0 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. 0 No 11 1 Yes 0 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 489 The question was asked to patients with type 2 diabetes to indicate if cost coverage options were not applicable to their situation in the three months after COVID. 0 No 3 1 Yes 8 Sysmiss 489 "e ) Covered by: (please choose the most used/relevant option)" e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 11 0 N/A 0 11 "e ) Covered by: (please choose the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 0 0 The question was asked to patients with type 2 diabetes to specify any other methods they used to cover the cost of their diabetes care in the three months after COVID. During the 3 months in the [PRE–COVID] period did you visit a traditional h Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about whether they or someone on their behalf visited a traditional healer or faith dwelling for care during the three months in the pre-COVID period (before March 2020). 1 Yes 19 2 No 481 "3.30 During the 3 months in the [PRE–COVID] period did you visit a traditional healer or faith healer?" Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 19 481 0 9998 2107.105 4186.502 The question was asked to patients with type 2 diabetes to indicate the number of visits they or someone on their behalf made to a traditional healer, faith dweller, or herbalist during the three months in the pre-COVID period. "Indicate number of visits" Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 19 481 0 17000 2434.211 4772.434 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for visits to a traditional healer, faith dweller, or herbalist during the three months in the pre-COVID period. "Total fees and charges" d ) Indicate reasons: Diabetes-related tests and medications Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 19 0 The question was asked to patients with type 2 diabetes to specify the reason for visiting a traditional healer, faith dweller, or herbalist during the three months in the pre-COVID period. 1 2 1 2 1 1 3 2 2 8 3 5 96 1 "d ) Indicate reasons: Diabetes-related tests and medications" Treatment Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 19 481 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a traditional healer, faith dweller, or herbalist during the three months in the pre-COVID period was for treatment. 0 No 14 1 Yes 5 Sysmiss 481 Collect Medications Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 19 481 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a traditional healer, faith dweller, or herbalist during the three months in the pre-COVID period was to collect medication. 0 No 10 1 Yes 9 Sysmiss 481 Spiritual Healing Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 19 481 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a traditional healer, faith dweller, or herbalist during the three months in the pre-COVID period was for spiritual healing. 0 No 12 1 Yes 7 Sysmiss 481 Other (Please Specify) Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 19 481 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a traditional healer, faith dweller, or herbalist during the three months in the pre-COVID period. 0 No 18 1 Yes 1 Sysmiss 481 Other Specify Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 1 0 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a traditional healer, faith dweller, or herbalist during the three months in the pre-COVID period. None 1 "Other Specify" e ) Covered by: (please choose the most used/relevant option) Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 19 481 The question was asked to patients with type 2 diabetes to indicate how the costs of visits to a traditional healer, faith dweller, or herbalist were covered during the three months in the pre-COVID period. 0 n/a 2 1 (1) Free treatment 6 2 (2) Health insurance 0 3 (3) Own cash 10 4 (4) Parents support 0 5 (5) Other family support 0 6 (6) Had to work for provider 0 7 (7) Selling an asset 0 8 (8) Took loan 0 9 (9) Got assistance 0 10 (10) Deferred by provider 0 96 (96) Other (please specify) 1 Sysmiss 481 "e ) Covered by: (please choose the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 1 0 The question was asked to patients with type 2 diabetes to specify the method used to cover the costs of visits to a traditional healer, faith dweller, or herbalist during the three months in the pre-COVID period. Own money 1 "Other Specify" 3.32 Think about the health care you received at places other than a hospital In Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question was asked to patients with type 2 diabetes about whether, during the three most challenging months of the COVID-19 period, they received healthcare outside of a hospital from one of the following: a specialist doctor or surgeon, primary care doctor, nurse, traditional healer, pharmacist or dispensary, health educator, medical assistant/clinical officer, or community health worker. 1 Yes 283 2 No 217 a) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 283 217 The question was asked to patients with type 2 diabetes to indicate the number of visits they made to a specialist doctor or surgeon during the three worst months of the COVID-19 period. 0 247 1 16 2 8 3 7 4 2 6 2 9 1 Sysmiss 217 "a) Indicate number of visits" b) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for healthcare during the three worst months of the COVID-19 period, such as a public or private facility, or NGO. 0 4 None/na 0 1 1 Public 9 2 2 Private for profit 26 3 3 Private-NGO/faith based 1 Sysmiss 464 "b) Type" c) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 0 150000 21245.167 35430.788 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for healthcare received from a specialist doctor or surgeon during the three worst months of the COVID-19 period. "c) Total fees and charges" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 0 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period was for diabetes-specific tests and medications. 1 2 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 96 1 1 2 4 5 6 7 8 9 2 1 2 4 6 7 8 1 1 2 9 1 1 3 4 5 7 9 1 1 3 7 9 1 1 4 1 1 4 7 1 2 1 2 3 4 5 6 7 8 9 1 2 3 4 5 7 1 2 3 4 5 8 9 1 2 3 4 6 7 1 2 3 4 9 1 2 4 1 2 4 5 7 8 9 1 2 4 6 96 1 3 4 5 1 3 4 9 2 3 4 96 1 5 2 5 96 1 6 7 9 1 6 8 1 9 96 1 96 5 "d) Please indicate reason: Diabetes-specific tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period was for a urine test related to their diabetes care. 0 No 24 1 Yes 12 Sysmiss 464 "d) Please indicate reason: Diabetes-specific tests and medications:" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period was for a blood test taken by needle or a finger-stick blood test related to their diabetes care. 0 No 21 1 Yes 15 Sysmiss 464 "d) Please indicate reason: Diabetes-specific tests and medications:" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period was for a finger-prick test for blood sugar related to their diabetes care. 0 No 23 1 Yes 13 Sysmiss 464 "d) Please indicate reason: Diabetes-specific tests and medications:" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period was for blood pressure measurement related to their diabetes care. 0 No 16 1 Yes 20 Sysmiss 464 "d) Please indicate reason: Diabetes-specific tests and medications:" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period was for an eye exam related to their diabetes care. 0 No 23 1 Yes 13 Sysmiss 464 "d) Please indicate reason: Diabetes-specific tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period was for a test of their feet for sensation (feeling) related to their diabetes care. 0 No 26 1 Yes 10 Sysmiss 464 "d) Please indicate reason: Diabetes-specific tests and medications:" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period was for having their weight measured on a scale as part of their diabetes care. 0 No 23 1 Yes 13 Sysmiss 464 "d) Please indicate reason: Diabetes-specific tests and medications:" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period was for having their waist measured with a tape as part of their diabetes care. 0 No 27 1 Yes 9 Sysmiss 464 "d) Please indicate reason: Diabetes-specific tests and medications:" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period was to collect medication related to their diabetes care. 0 No 21 1 Yes 15 Sysmiss 464 "d) Please indicate reason: Diabetes-specific tests and medications:" Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period. 0 No 26 1 Yes 10 Sysmiss 464 "d) Please indicate reason: Diabetes-specific tests and medications:" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period. 0 No 36 1 Yes 0 Sysmiss 464 "d) Please indicate reason: Diabetes-specific tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 10 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a specialist doctor or surgeon during the three worst months of the COVID-19 period. Consulted the doctor over my blood sugar levels which were a bit high during covid and also to ask if we could do alternative drug because the one he just prescribed was very expensive 1 Dialysis 1 Examination of stroke 1 Eye operation 1 Her leg was amputated due to diabetes 1 I called the doctor whenever I had raised blood sugar levels while testing at home 1 Leg surgery (loosed his leg) 1 Surgery 1 Upper endoscopy 1 Xrays and ct scan 1 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 0 The question was asked to patients with type 2 diabetes to indicate how the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period were covered, choosing the most used or relevant option. 1 2 1 2 6 2 3 5 1 2 3 9 1 2 5 1 3 20 3 4 1 3 5 1 3 8 9 1 3 9 1 4 1 5 1 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period were covered through free treatment. 0 No 35 1 Yes 1 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period were covered through health insurance. 0 No 26 1 Yes 10 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period were covered through own cash. 0 No 10 1 Yes 26 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period were covered through parent's support. 0 No 34 1 Yes 2 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period were covered through other family support. 0 No 32 1 Yes 4 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period were covered by working for the provider. 0 No 36 1 Yes 0 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period were covered through selling an asset. 0 No 36 1 Yes 0 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period were covered by taking a loan. 0 No 35 1 Yes 1 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period were covered by getting assistance. 0 No 33 1 Yes 3 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period were covered through deferred payment by the provider. 0 No 36 1 Yes 0 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period. 0 No 36 1 Yes 0 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 36 464 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period. 0 No 36 1 Yes 0 Sysmiss 464 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 0 0 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a specialist doctor or surgeon during the three worst months of the COVID-19 period. a) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 283 217 0 9998 35.862 594.291 The question was asked to patients with type 2 diabetes to indicate the number of visits they made to a primary care doctor during the three worst months of the COVID-19 period. "a) Indicate number of visits" b) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for healthcare during the three worst months of the COVID-19 period, such as a public or private facility, or NGO. 0 4 None/na 0 1 1 Public 20 2 2 Private for profit 30 3 3 Private-NGO/faith based 3 Sysmiss 447 "b) Type" c) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 0 10000 2338.604 2986.16 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for healthcare received from a primary care doctor during the three worst months of the COVID-19 period. "c) Total fees and charges" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 0 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a primary care doctor during the three worst months of the COVID-19 period was for diabetes-specific tests and medications. 1 1 1 2 1 1 2 3 1 1 2 3 4 6 7 8 9 1 1 2 3 4 7 1 1 2 3 9 1 1 2 4 9 1 1 2 7 9 1 1 3 4 9 1 1 3 9 1 1 4 5 9 1 2 2 2 3 4 2 3 4 2 2 3 4 5 6 8 9 1 2 3 4 5 6 9 1 2 3 4 6 7 8 9 2 2 3 4 6 7 9 1 2 3 4 7 8 9 1 2 3 4 9 2 2 4 9 3 3 3 3 4 1 3 4 9 3 3 6 9 1 3 9 3 3 96 1 4 1 5 96 1 9 5 96 4 "d) Please indicate reason: Diabetes-specific tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a primary care doctor during the three worst months of the COVID-19 period was for a urine test for blood sugar related to their diabetes care. 0 No 42 1 Yes 11 Sysmiss 447 "d) Please indicate reason: Diabetes-specific tests and medications:" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a primary care doctor during the three worst months of the COVID-19 period was for a blood test for blood sugar related to their diabetes care. 0 No 27 1 Yes 26 Sysmiss 447 "d) Please indicate reason: Diabetes-specific tests and medications:" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a primary care doctor during the three worst months of the COVID-19 period was for a finger-prick test for blood sugar related to their diabetes care. 0 No 21 1 Yes 32 Sysmiss 447 "d) Please indicate reason: Diabetes-specific tests and medications:" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a primary care doctor during the three worst months of the COVID-19 period was for blood pressure measurement related to their diabetes care. 0 No 30 1 Yes 23 Sysmiss 447 "d) Please indicate reason: Diabetes-specific tests and medications:" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a primary care doctor during the three worst months of the COVID-19 period was for an eye exam related to their diabetes care. 0 No 49 1 Yes 4 Sysmiss 447 "d) Please indicate reason: Diabetes-specific tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a primary care doctor during the three worst months of the COVID-19 period was for a test of their feet for sensation (feeling) related to their diabetes care. 0 No 46 1 Yes 7 Sysmiss 447 "d) Please indicate reason: Diabetes-specific tests and medications:" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a primary care doctor during the three worst months of the COVID-19 period was for having their weight measured on a scale as part of their diabetes care. 0 No 46 1 Yes 7 Sysmiss 447 "d) Please indicate reason: Diabetes-specific tests and medications:" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a primary care doctor during the three worst months of the COVID-19 period was for having their waist measured with a tape as part of their diabetes care. 0 No 48 1 Yes 5 Sysmiss 447 "d) Please indicate reason: Diabetes-specific tests and medications:" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a primary care doctor during the three worst months of the COVID-19 period was to collect medication related to their diabetes care. 0 No 23 1 Yes 30 Sysmiss 447 "d) Please indicate reason: Diabetes-specific tests and medications:" Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a primary care doctor during the three worst months of the COVID-19 period. 0 No 47 1 Yes 6 Sysmiss 447 "d) Please indicate reason: Diabetes-specific tests and medications:" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 0 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a primary care doctor during the three worst months of the COVID-19 period. 0 53 "d) Please indicate reason: Diabetes-specific tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 6 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a primary care doctor during the three worst months of the COVID-19 period. Checkups 1 Chest examination 1 Cholesterol 1 HB1, liver and kidney tests 1 Physiotherapy because movement was hard after the accident it damaged one of her hipbones 1 She was being taken through her diet and what to eat and also seemed advise on the medications she was given by her doctor 1 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 0 The question was asked to patients with type 2 diabetes to indicate how the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period were covered, choosing the most used or relevant option. 1 2 1 3 1 2 5 2 3 2 2 5 1 3 28 3 5 5 5 6 9 1 96 2 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period were covered through free treatment. 0 No 50 1 Yes 3 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period were covered through health insurance. 0 No 45 1 Yes 8 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period were covered through own cash. 0 No 17 1 Yes 36 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period were covered through parent's support. 0 No 53 1 Yes 0 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period were covered through other family support. 0 No 41 1 Yes 12 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period were covered by working for the provider. 0 No 53 1 Yes 0 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period were covered through selling an asset. 0 No 53 1 Yes 0 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period were covered by taking a loan. 0 No 53 1 Yes 0 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period were covered by getting assistance. 0 No 52 1 Yes 1 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period were covered through deferred payment by the provider. 0 No 53 1 Yes 0 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period. 0 No 51 1 Yes 2 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 53 447 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period. 0 No 53 1 Yes 0 Sysmiss 447 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 2 0 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a primary care doctor during the three worst months of the COVID-19 period. Free 1 Mtiba 1 a) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 283 217 0 270 1 8 2 2 3 1 4 1 7 1 Sysmiss 217 "a) Indicate number of visits" b) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for healthcare during the three worst months of the COVID-19 period, such as a public or private facility, or NGO. 0 4 None/na 1 1 1 Public 5 2 2 Private for profit 6 3 3 Private-NGO/faith based 1 Sysmiss 487 "b) Type" c) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 9998 1149.077 2734.573 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for healthcare received from a nurse during the three worst months of the COVID-19 period. "c) Total fees and charges" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 0 1 1 1 2 3 1 1 3 2 1 3 4 7 8 1 2 2 2 3 1 3 2 3 9 1 9 2 "d) Please indicate reason: Diabetes-specific tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a nurse during the three worst months of the COVID-19 period was for a urine test for blood sugar related to their diabetes care. 0 No 8 1 Yes 5 Sysmiss 487 "d) Please indicate reason: Diabetes-specific tests and medications:" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a nurse during the three worst months of the COVID-19 period was for a blood test for blood sugar related to their diabetes care. 0 No 9 1 Yes 4 Sysmiss 487 "d) Please indicate reason: Diabetes-specific tests and medications:" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 5 1 Yes 8 Sysmiss 487 "d) Please indicate reason: Diabetes-specific tests and medications:" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 12 1 Yes 1 Sysmiss 487 "d) Please indicate reason: Diabetes-specific tests and medications:" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 13 1 Yes 0 Sysmiss 487 "d) Please indicate reason: Diabetes-specific tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 13 1 Yes 0 Sysmiss 487 "d) Please indicate reason: Diabetes-specific tests and medications:" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 12 1 Yes 1 Sysmiss 487 "d) Please indicate reason: Diabetes-specific tests and medications:" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 12 1 Yes 1 Sysmiss 487 "d) Please indicate reason: Diabetes-specific tests and medications:" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 10 1 Yes 3 Sysmiss 487 "d) Please indicate reason: Diabetes-specific tests and medications:" Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 13 1 Yes 0 Sysmiss 487 "d) Please indicate reason: Diabetes-specific tests and medications:" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 0 0 13 "d) Please indicate reason: Diabetes-specific tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 0 0 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 0 1 1 2 1 2 3 1 3 7 3 9 1 5 1 9 1 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 12 1 Yes 1 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 11 1 Yes 2 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 4 1 Yes 9 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 13 1 Yes 0 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 12 1 Yes 1 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 13 1 Yes 0 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 13 1 Yes 0 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 13 1 Yes 0 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 11 1 Yes 2 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 0 No 13 1 Yes 0 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a nurse during the three worst months of the COVID-19 period. 0 No 13 1 Yes 0 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 13 487 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a nurse during the three worst months of the COVID-19 period. 0 No 13 1 Yes 0 Sysmiss 487 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 0 0 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a nurse during the three worst months of the COVID-19 period. a) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 283 217 0 9998 178.855 1319.186 The question was asked to patients with type 2 diabetes to indicate the number of visits they made to a pharmacist or dispensary during the three worst months of the COVID-19 period. "a) Indicate number of visits" b) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for healthcare during the three worst months of the COVID-19 period, such as a public or private facility, or NGO. 0 4 None/na 0 1 1 Public 7 2 2 Private for profit 192 3 3 Private-NGO/faith based 12 Sysmiss 289 "b) Type" c) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 0 48000 2338.223 4617.272 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for healthcare received from a pharmacist or dispensary during the three worst months of the COVID-19 period. "c) Total fees and charges" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 0 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period was for diabetes-specific tests and medications. 1 1 1 2 1 1 2 3 4 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 9 1 1 2 3 9 1 1 2 4 9 1 1 2 7 9 1 1 3 9 1 2 1 2 3 4 1 2 3 4 6 7 9 1 2 3 4 9 3 2 4 5 6 8 9 1 2 4 6 9 1 2 4 9 3 2 9 1 3 1 3 4 1 3 4 7 9 1 3 4 9 5 3 5 6 9 1 3 6 9 1 3 9 10 4 1 4 5 9 1 4 6 1 4 9 1 9 164 9 96 1 96 1 "d) Please indicate reason: Diabetes-specific tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period was for a urine test for blood sugar related to their diabetes care. 0 No 202 1 Yes 9 Sysmiss 289 "d) Please indicate reason: Diabetes-specific tests and medications:" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period was for a blood test taken by needle for blood sugar related to their diabetes care. 0 No 192 1 Yes 19 Sysmiss 289 "d) Please indicate reason: Diabetes-specific tests and medications:" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period was for a finger-prick test for blood sugar related to their diabetes care. 0 No 181 1 Yes 30 Sysmiss 289 "d) Please indicate reason: Diabetes-specific tests and medications:" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period was for blood pressure measurement related to their diabetes care. 0 No 186 1 Yes 25 Sysmiss 289 "d) Please indicate reason: Diabetes-specific tests and medications:" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period was for an eye exam related to their diabetes care. 0 No 206 1 Yes 5 Sysmiss 289 "d) Please indicate reason: Diabetes-specific tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period was for a test of their feet for sensation (feeling) related to their diabetes care. 0 No 203 1 Yes 8 Sysmiss 289 "d) Please indicate reason: Diabetes-specific tests and medications:" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period was for having their weight measured on a scale as part of their diabetes care. 0 No 206 1 Yes 5 Sysmiss 289 "d) Please indicate reason: Diabetes-specific tests and medications:" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period was for having their waist measured with a tape as part of their diabetes care. 0 No 209 1 Yes 2 Sysmiss 289 "d) Please indicate reason: Diabetes-specific tests and medications:" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period was to collect medication related to their diabetes care. 0 No 10 1 Yes 201 Sysmiss 289 "d) Please indicate reason: Diabetes-specific tests and medications:" Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period. 0 No 209 1 Yes 2 Sysmiss 289 "d) Please indicate reason: Diabetes-specific tests and medications:" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period. 0 No 211 1 Yes 0 Sysmiss 289 "d) Please indicate reason: Diabetes-specific tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 2 0 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a pharmacist or dispensary during the three worst months of the COVID-19 period. Pneumonia 1 Stomach gases 1 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 0 The question was asked to patients with type 2 diabetes to indicate how the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period were covered, choosing the most used or relevant option. 1 1 1 3 2 2 7 2 3 1 2 5 1 3 162 3 5 12 3 5 7 9 1 3 5 9 1 3 7 1 3 9 2 5 16 5 9 1 8 9 1 9 2 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period were covered through free treatment. 0 No 208 1 Yes 3 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period were covered through health insurance. 0 No 202 1 Yes 9 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period were covered through own cash. 0 No 29 1 Yes 182 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period were covered through parent's support. 0 No 211 1 Yes 0 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period were covered through other family support. 0 No 179 1 Yes 32 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period were covered by working for the provider. 0 No 211 1 Yes 0 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period were covered through selling an asset. 0 No 209 1 Yes 2 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period were covered by taking a loan. 0 No 210 1 Yes 1 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period were covered by getting assistance. 0 No 203 1 Yes 8 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period were covered through deferred payment by the provider. 0 No 211 1 Yes 0 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period. 0 No 211 1 Yes 0 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 211 289 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period. 0 No 211 1 Yes 0 Sysmiss 289 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 0 0 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a pharmacist or dispensary during the three worst months of the COVID-19 period. a) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 283 217 The question was asked to patients with type 2 diabetes to indicate the number of visits they made to a health educator during the three worst months of the COVID-19 period. 0 255 1 6 2 7 3 7 4 2 6 5 12 1 Sysmiss 217 "a) Indicate number of visits" b) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for healthcare during the three worst months of the COVID-19 period, such as a public or private facility, or NGO. 0 4 None/na 0 1 1 Public 9 2 2 Private for profit 15 3 3 Private-NGO/faith based 4 Sysmiss 472 "b) Type" c) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 0 1500 78.571 296.095 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for healthcare received from a health educator during the three worst months of the COVID-19 period. "c) Total fees and charges" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 0 0 8 1 1 1 2 4 5 6 7 8 9 1 3 4 2 3 4 9 1 4 7 1 4 7 8 1 4 8 1 5 1 9 2 96 9 "d) Please indicate reason: Diabetes-specific tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 0 No 26 1 Yes 2 Sysmiss 472 "d) Please indicate reason: Diabetes-specific tests and medications:" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 0 No 27 1 Yes 1 Sysmiss 472 "d) Please indicate reason: Diabetes-specific tests and medications:" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 0 No 25 1 Yes 3 Sysmiss 472 "d) Please indicate reason: Diabetes-specific tests and medications:" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 0 No 21 1 Yes 7 Sysmiss 472 "d) Please indicate reason: Diabetes-specific tests and medications:" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 0 No 26 1 Yes 2 Sysmiss 472 "d) Please indicate reason: Diabetes-specific tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 0 No 27 1 Yes 1 Sysmiss 472 "d) Please indicate reason: Diabetes-specific tests and medications:" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 0 No 25 1 Yes 3 Sysmiss 472 "d) Please indicate reason: Diabetes-specific tests and medications:" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 0 No 25 1 Yes 3 Sysmiss 472 "d) Please indicate reason: Diabetes-specific tests and medications:" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 0 No 24 1 Yes 4 Sysmiss 472 "d) Please indicate reason: Diabetes-specific tests and medications:" Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a health educator during the three worst months of the COVID-19 period. 0 No 19 1 Yes 9 Sysmiss 472 "d) Please indicate reason: Diabetes-specific tests and medications:" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a health educator during the three worst months of the COVID-19 period. 0 No 20 1 Yes 8 Sysmiss 472 "d) Please indicate reason: Diabetes-specific tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 9 0 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a health educator during the three worst months of the COVID-19 period. Advise on Diabetes health and management 1 Advise on Diabetes management and seminar on Diabetes education 1 Advise on maintaining a healthy lifestyle and changing diet and watching what one eats 1 Diabetes education 1 Education on Diabetes management 1 Education on Diabetes management and nutrition 1 Education on diabetes nutrition 1 She was being educated on Diabetes and also did exercises 1 She was being educated on Diabetes management 1 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 0 The question was asked to patients with type 2 diabetes to indicate how the costs of their visits to a health educator during the three worst months of the COVID-19 period were covered, choosing the most used or relevant option. 0 7 1 16 3 4 9 1 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a health educator during the three worst months of the COVID-19 period were covered through free treatment. 0 No 12 1 Yes 16 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a health educator during the three worst months of the COVID-19 period were covered through health insurance. 0 No 28 1 Yes 0 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a health educator during the three worst months of the COVID-19 period were covered through own cash. 0 No 24 1 Yes 4 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a health educator during the three worst months of the COVID-19 period were covered through parent's support. 0 No 28 1 Yes 0 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a health educator during the three worst months of the COVID-19 period were covered through other family support. 0 No 28 1 Yes 0 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a health educator during the three worst months of the COVID-19 period were covered by working for the provider. 0 No 28 1 Yes 0 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a health educator during the three worst months of the COVID-19 period were covered through selling an asset. 0 No 28 1 Yes 0 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a health educator during the three worst months of the COVID-19 period were covered by taking a loan. 0 No 28 1 Yes 0 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a health educator during the three worst months of the COVID-19 period were covered by getting assistance. 0 No 27 1 Yes 1 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a health educator during the three worst months of the COVID-19 period were covered through deferred payment by the provider. 0 No 28 1 Yes 0 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a health educator during the three worst months of the COVID-19 period. 0 No 28 1 Yes 0 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 28 472 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a health educator during the three worst months of the COVID-19 period. 0 No 21 1 Yes 7 Sysmiss 472 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 0 0 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a health educator during the three worst months of the COVID-19 period. a) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 283 217 The question was asked to patients with type 2 diabetes to indicate the number of visits they made to a medical assistant/clinical officer during the three worst months of the COVID-19 period. 0 263 1 7 2 2 3 6 4 1 6 3 10 1 Sysmiss 217 "a) Indicate number of visits" b) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for healthcare during the three worst months of the COVID-19 period, such as a public or private facility, or NGO. 0 4 None/na 0 1 1 Public 5 2 2 Private for profit 14 3 3 Private-NGO/faith based 1 Sysmiss 480 "b) Type" c) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 0 8888 2702 3726.34 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for healthcare received from a medical assistant/clinical officer during the three worst months of the COVID-19 period. "c) Total fees and charges" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 0 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period was for diabetes-specific tests and medications. 0 1 1 2 1 2 3 1 1 2 3 4 5 6 7 8 9 2 1 2 4 5 6 7 8 9 5 1 3 4 5 6 7 8 9 1 2 3 4 1 2 4 6 9 1 3 9 1 5 96 1 96 4 "d) Please indicate reason: Diabetes-specific tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period was for a urine test for blood sugar related to their diabetes care. 0 No 9 1 Yes 11 Sysmiss 480 "d) Please indicate reason: Diabetes-specific tests and medications:" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period was for a blood test taken by needle for blood sugar related to their diabetes care. 0 No 10 1 Yes 10 Sysmiss 480 "d) Please indicate reason: Diabetes-specific tests and medications:" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period was for a finger-prick test for blood sugar related to their diabetes care. 0 No 14 1 Yes 6 Sysmiss 480 "d) Please indicate reason: Diabetes-specific tests and medications:" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period was for blood pressure measurement related to their diabetes care. 0 No 10 1 Yes 10 Sysmiss 480 "d) Please indicate reason: Diabetes-specific tests and medications:" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period was for an eye exam related to their diabetes care. 0 No 11 1 Yes 9 Sysmiss 480 "d) Please indicate reason: Diabetes-specific tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period was for a test of their feet for sensation (feeling) related to their diabetes care. 0 No 11 1 Yes 9 Sysmiss 480 "d) Please indicate reason: Diabetes-specific tests and medications:" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period was for having their weight measured on a scale as part of their diabetes care. 0 No 12 1 Yes 8 Sysmiss 480 "d) Please indicate reason: Diabetes-specific tests and medications:" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period was for having their waist measured with a tape as part of their diabetes care. 0 No 12 1 Yes 8 Sysmiss 480 "d) Please indicate reason: Diabetes-specific tests and medications:" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period was to collect medication related to their diabetes care. 0 No 10 1 Yes 10 Sysmiss 480 "d) Please indicate reason: Diabetes-specific tests and medications:" Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period. 0 No 15 1 Yes 5 Sysmiss 480 "d) Please indicate reason: Diabetes-specific tests and medications:" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 N/A 0 No 19 1 Yes 1 Sysmiss 480 "d) Please indicate reason: Diabetes-specific tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 5 0 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a medical assistant/clinical officer during the three worst months of the COVID-19 period. Advise on health related issues on Diabetes 1 Cholesterol 1 Counseling sessions and nutrition 1 He went to seek advise on how to maintain his health 1 She was done for Liver and heart tests 1 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 0 The question was asked to patients with type 2 diabetes to indicate how the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period were covered, choosing the most used or relevant option. 0 3 1 1 2 6 2 3 1 2 5 1 3 5 5 1 9 1 96 1 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period were covered through free treatment. 0 No 19 1 Yes 1 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period were covered through health insurance. 0 No 12 1 Yes 8 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period were covered through own cash. 0 No 14 1 Yes 6 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period were covered through parent's support. 0 No 20 1 Yes 0 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period were covered through other family support. 0 No 18 1 Yes 2 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period were covered by working for the provider. 0 No 20 1 Yes 0 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period were covered through selling an asset. 0 No 20 1 Yes 0 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period were covered by taking a loan. 0 No 20 1 Yes 0 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period were covered by getting assistance. 0 No 19 1 Yes 1 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period were covered through deferred payment by the provider. 0 No 20 1 Yes 0 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period. 0 No 19 1 Yes 1 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 20 480 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period. 0 No 17 1 Yes 3 Sysmiss 480 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 1 0 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a medical assistant/clinical officer during the three worst months of the COVID-19 period. Mtiba 1 a) Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 283 217 0 1500 5.353 89.164 The question was asked to patients with type 2 diabetes to indicate the number of visits they made to a community health worker during the three worst months of the COVID-19 period. "a) Indicate number of visits" b) Type Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to specify the type of facility they visited for healthcare during the three worst months of the COVID-19 period, such as a public or private facility, or NGO. 0 4 None/na 1 1 1 Public 4 2 2 Private for profit 2 3 3 Private-NGO/faith based 0 Sysmiss 493 "b) Type" c) Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 0 9998 1642.571 3726.565 The question was asked to patients with type 2 diabetes to indicate the total fees and charges for healthcare received from a community health worker during the three worst months of the COVID-19 period. "c) Total fees and charges" d) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 0 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a community health worker during the three worst months of the COVID-19 period was for diabetes-specific tests and medications. 1 1 3 1 96 5 "d) Please indicate reason: Diabetes-specific tests and medications:" Urine test Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a community health worker during the three worst months of the COVID-19 period was for a urine test for blood sugar related to their diabetes care. 0 No 6 1 Yes 1 Sysmiss 493 "d) Please indicate reason: Diabetes-specific tests and medications:" Test on your blood taken by needle Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a community health worker during the three worst months of the COVID-19 period was for a blood test taken by needle for blood sugar related to their diabetes care. 0 No 7 1 Yes 0 Sysmiss 493 "d) Please indicate reason: Diabetes-specific tests and medications:" finger-prick test for blood sugar Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a community health worker during the three worst months of the COVID-19 period was for a finger-prick test for blood sugar related to their diabetes care. 0 No 6 1 Yes 1 Sysmiss 493 "d) Please indicate reason: Diabetes-specific tests and medications:" Blood pressure measurement Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a community health worker during the three worst months of the COVID-19 period was for blood pressure measurement related to their diabetes care. 0 No 7 1 Yes 0 Sysmiss 493 "d) Please indicate reason: Diabetes-specific tests and medications:" eye exam Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a community health worker during the three worst months of the COVID-19 period was for an eye exam related to their diabetes care. 0 No 7 1 Yes 0 Sysmiss 493 "d) Please indicate reason: Diabetes-specific tests and medications:" test of your feet for feeling Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a community health worker during the three worst months of the COVID-19 period was for a test of their feet for sensation (feeling) related to their diabetes care. 0 No 7 1 Yes 0 Sysmiss 493 "d) Please indicate reason: Diabetes-specific tests and medications:" taking your weight on a scale Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a community health worker during the three worst months of the COVID-19 period was for having their weight measured on a scale as part of their diabetes care. 0 No 7 1 Yes 0 Sysmiss 493 "d) Please indicate reason: Diabetes-specific tests and medications:" measuring your waist with a tape Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a community health worker during the three worst months of the COVID-19 period was for having their waist measured with a tape as part of their diabetes care. 0 No 7 1 Yes 0 Sysmiss 493 "d) Please indicate reason: Diabetes-specific tests and medications:" Collect medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the reason for visiting a community health worker during the three worst months of the COVID-19 period was to collect medication related to their diabetes care. 0 No 7 1 Yes 0 Sysmiss 493 "d) Please indicate reason: Diabetes-specific tests and medications:" Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a community health worker during the three worst months of the COVID-19 period. 0 No 2 1 Yes 5 Sysmiss 493 "d) Please indicate reason: Diabetes-specific tests and medications:" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 N/A 0 No 7 1 Yes 0 Sysmiss 493 "d) Please indicate reason: Diabetes-specific tests and medications:" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 5 0 The question was asked to patients with type 2 diabetes to specify any other reasons for visiting a community health worker during the three worst months of the COVID-19 period. Advise on Diabetes health management 1 Advise on health related issues on Diabetes 1 Diet management 1 Education on Diabetes and nutrition 1 To know how she's doing in terms of health 1 (e) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 0 The question was asked to patients with type 2 diabetes to indicate how the costs of their visits to a community health worker during the three worst months of the COVID-19 period were covered, choosing the most used or relevant option. 0 5 3 1 5 1 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a community health worker during the three worst months of the COVID-19 period were covered through free treatment. 0 No 7 1 Yes 0 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a community health worker during the three worst months of the COVID-19 period were covered through health insurance. 0 No 7 1 Yes 0 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a community health worker during the three worst months of the COVID-19 period were covered through own cash. 0 No 6 1 Yes 1 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a community health worker during the three worst months of the COVID-19 period were covered through parent's support. 0 No 7 1 Yes 0 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a community health worker during the three worst months of the COVID-19 period were covered through other family support. 0 No 6 1 Yes 1 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a community health worker during the three worst months of the COVID-19 period were covered by working for the provider. 0 No 7 1 Yes 0 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a community health worker during the three worst months of the COVID-19 period were covered through selling an asset. 0 No 7 1 Yes 0 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a community health worker during the three worst months of the COVID-19 period were covered by taking a loan. 0 No 7 1 Yes 0 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a community health worker during the three worst months of the COVID-19 period were covered by getting assistance. 0 No 7 1 Yes 0 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to indicate if the costs of their visits to a community health worker during the three worst months of the COVID-19 period were covered through deferred payment by the provider. 0 No 7 1 Yes 0 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a community health worker during the three worst months of the COVID-19 period. 0 No 7 1 Yes 0 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a community health worker during the three worst months of the COVID-19 period. 0 No 2 1 Yes 5 Sysmiss 493 "(e) Indicate how you covered the cost: Please mention the most used/relevant option)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 0 0 The question was asked to patients with type 2 diabetes to specify any other method they used to cover the costs of their visits to a community health worker during the three worst months of the COVID-19 period. 3.40 In the months during the [COVID period] ${FromMonth} to ${ToMonth} , did Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine whether patients with type 2 diabetes, or someone on their behalf, visited a traditional healer or faith dwelling for care during a specified three-month period within the COVID. 1 Yes 14 2 No 486 a. Indicate number of visits Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 1 9998 2858.643 4685.775 The question sought to determine the number of visits made by patients with type 2 diabetes, or someone on their behalf, to a traditional healer or faith dwelling during a specified three-month period within the COVID timeframe. "a. Indicate number of visits" b. Total fees and charges Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 0 83000 6567.857 22034.48 The question sought to determine the total fees and charges incurred by patients with type 2 diabetes, or someone on their behalf, for visits to a traditional healer or faith dwelling during a specified three-month period within the COVID timeframe. "b. Total fees and charges" c) Please indicate reason: Diabetes-specific tests and medications: Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 0 The question sought to determine the reasons why patients with type 2 diabetes, or someone on their behalf, visited a traditional healer or faith dwelling during a specified three-month period within the COVID timeframe. 1 1 1 2 2 1 3 2 2 3 3 6 "c) Please indicate reason: Diabetes-specific tests and medications:" Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if one reason for visiting a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was for treatment related to diabetes care. 0 9 1 5 Sysmiss 486 Collect Medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if one reason for visiting a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was to collect medication related to diabetes care. 0 9 1 5 Sysmiss 486 Spiritual Healing Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if one reason for visiting a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was for spiritual healing related to diabetes care. 0 6 1 8 Sysmiss 486 Other (please specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if there were any other reasons for visiting a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe, with an option to specify. 0 14 Sysmiss 486 Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 0 0 The question sought to determine if there were any other reasons for visiting a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe, with an option to specify. "Other Specify" (d) Indicate how you covered the cost: Please mention the most used/relevant opt Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 0 The question sought to determine how patients with type 2 diabetes covered the costs of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe. 0 2 1 5 3 6 96 1 "(d) Indicate how you covered the cost: Please mention the most used/relevant option)" Free Treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was covered through free treatment. 0 No 9 1 Yes 5 Sysmiss 486 Health Insurance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was covered through health insurance. 0 No 14 1 Yes 0 Sysmiss 486 Own Cash Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was covered by using their own cash. 0 No 8 1 Yes 6 Sysmiss 486 Parent's Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was covered through support from their parents. 0 No 14 1 Yes 0 Sysmiss 486 Other family Support Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was covered by getting support from other family. 0 No 14 1 Yes 0 Sysmiss 486 Had to work for provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was covered by working for provider. 0 No 14 1 Yes 0 Sysmiss 486 Selling an asset Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was covered through selling an asset. 0 No 14 1 Yes 0 Sysmiss 486 Took loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was covered by taking a loan. 0 No 14 1 Yes 0 Sysmiss 486 Got assistance Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was covered by getting assistance. 0 No 14 1 Yes 0 Sysmiss 486 Deferred by Provider Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe was deferred by the provider. 0 No 14 1 Yes 0 Sysmiss 486 Other, Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 The question sought to determine if there were any other methods used to cover the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe, with an option to specify. 0 No 13 1 Yes 1 Sysmiss 486 Not Applicable Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 14 486 N/A 0 No 12 1 Yes 2 Sysmiss 486 Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 1 0 The question sought to determine if there were any other methods used to cover the cost of visits to a traditional healer or faith dwelling during the specified three-month period within the COVID timeframe, with an option to specify. No payment done 1 "Other Specify" 3.42 Since COVID-19 cases were identified in [Country], which of the following h Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine which factors affected the diabetes self-care of patients with type 2 diabetes since COVID-19 cases were identified in their country, with options to tick all that apply. 1 4 1 2 4 1 2 3 4 1 1 2 3 4 5 1 1 2 3 4 5 6 22 1 2 3 4 5 6 7 8 1 2 3 4 6 9 1 2 3 5 1 1 2 3 5 6 25 1 2 3 5 6 7 6 1 2 3 6 9 1 2 3 6 7 1 1 2 4 5 1 1 2 4 5 6 4 1 2 4 5 6 7 2 1 2 4 6 10 1 2 5 4 1 2 5 6 7 1 2 5 6 7 4 1 2 6 16 1 2 6 96 1 1 2 96 1 1 3 4 1 1 3 4 5 6 4 1 3 4 5 6 7 3 1 3 4 6 1 1 3 5 1 1 3 5 6 3 1 3 6 2 1 4 5 6 1 1 4 6 1 1 5 1 1 5 6 2 1 6 8 1 96 1 2 15 2 3 4 1 2 3 4 5 1 2 3 4 5 6 27 2 3 4 5 6 7 5 2 3 4 6 8 2 3 5 1 2 3 5 6 15 2 3 5 6 7 2 2 3 5 7 1 2 3 6 7 2 4 8 2 4 5 6 12 2 4 5 6 7 3 2 4 5 7 1 2 4 6 13 2 4 6 96 1 2 4 7 1 2 5 3 2 5 6 14 2 6 25 2 6 96 3 2 96 1 3 4 1 3 4 5 3 3 4 5 6 8 3 4 5 6 96 1 3 4 6 3 3 5 1 3 5 6 10 3 5 6 96 1 3 6 5 4 5 1 4 5 6 6 4 6 6 4 96 1 5 1 5 6 24 5 6 7 2 6 56 6 7 1 6 96 6 7 2 96 23 "3.42 Since COVID-19 cases were identified in [Country], which of the following have affected your diabetes self-care? (Tick all that apply)" Difficulty in securing appointments with a doctor Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if difficulty securing an appointment with a doctor affected the diabetes self-care of patients with type 2 diabetes since COVID-19 cases were identified in their country. 0 330 1 170 Hesitation leaving home due to risk of COVID-19 infaection Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if hesitation leaving home due to risk of COVID-19 infaection affected the diabetes self-care of patients with type 2 diabetes since COVID-19 cases were identified in their country. 0 195 1 305 Difficulty in buying infection control supplies such as sanitizer, masks Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if difficulty in buying infection control supplies such as sanitizer, masks affected the diabetes self-care of patients with type 2 diabetes since COVID-19 cases were identified in their country. 0 301 1 199 Difficulty seeking community and social services Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if difficulty seeking community and social services affected the diabetes self-care of patients with type 2 diabetes since COVID-19 cases were identified in their country. 0 320 1 180 Transport cost too high Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if the high cost of transport affected the diabetes self-care of patients with type 2 diabetes since COVID-19 cases were identified in their country. 0 257 1 243 Lack of money to buy medications Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if lack of money to buy medicine affected the diabetes self-care of patients with type 2 diabetes since COVID-19 cases were identified in their country. 0 87 1 413 Lack of COVID 19 vaccination Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if lack of COVID 19 vaccine affected the diabetes self-care of patients with type 2 diabetes since COVID-19 cases were identified in their country. 0 458 1 42 Other Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if any other factors, not listed, have affected the diabetes self-care of patients with type 2 diabetes since COVID-19 cases were identified in their country. 0 460 1 40 Other Specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 40 The question sought to determine if any other factors, not listed, have affected the diabetes self-care of patients with type 2 diabetes since COVID-19 cases were identified in their country, with an option to specify. 9999 2 Difficult in seeing a doctor due to the high population 1 Fear of covid infection 1 He doesn't use medication he stopped and manages through his diet and nutrition he stopped taking medication in 2009 1 He has no challenge 1 He said he did not have any difficulties 1 I'm a truck driver so most of the time I only buy drugs since i don't have time to go to hospital for proper check up. The long truck queues at the border during covid made me anxious so my sugar levels were always high during that time. 1 Inactive NHIF card made it impossible to access medication 1 Lack of drugs in chemists 1 Lack of food 2 Lack of medication from the facility 1 Lack of medication stock 1 1 Lateness because they mostly miss their appointment and usually the doctor leaves to attend to others because they miss their appointment and so they have to see another one 1 Lost his job 1 Lost job 2 Missing drugs at the hospital and told to go and buy 1 None 11 1 She was afraid to be vaccinated because it would affect her because of the conditions such as T2D and HIV/AIDS. 1 She was not affected because she is managing herself through her diet and lifestyle 1 1 The participant did not have any challenges 1 The participant has no challenges because she gets support from her children 1 Was not affected 1 Was very sick in bedridden 1 When she relocated to Machakos it was difficult to get an appointment because she had to settle and adjust 1 "Other Specify" 3.43. What is the name of the main healthcare facility you used [before COVID] t Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 492 0 The question sought to determine the main healthcare facility that patients with type 2 diabetes used before COVID-19 to receive care related to their diabetes. .Access Afya Tasia 1 Acces Afya Kwa Ruben 1 1 1 Access Afya 11 1 1 Access Afya (Kwa Njega) 1 Access Afya (Mukuru) 1 Access Afya (Tasia) 1 Access Afya Baba ndogo 1 Access Afya Mukuru 8 Access Afya Mukuru kwa Njenga 1 Access Afya Tasia 3 Access Afya Tassia 4 Access Afya kwa Njenga 1 Access Afya mukuru 1 Access afya 3 Access afya Mukuru 1 Access afya kwa njenga 1 Access afya mukuru 3 1 Access afya mukuru kwa njenga 3 Access afya mukuru njenga 3 Access afya njenga 3 Access afya tassia 6 Access mukuru 1 Accessafya 2 Accessafya but then it was closed 1 Acess Afya 2 1 Acess Afya Tasia 1 Afya center 1 Avenue moi airbase clinic forces memorial 1 Baraka German Doctors 1 Baraka dispensary 1 1 Charles lwanga,langata hospital 1 Coast General hospital 1 Copit nursing home 1 Copit nursing hospital 2 Coptic Hospital 3 Coptic Mission Hospital 1 Coptic Nursing Home 1 Coptic Nursing home 3 Coptic hospital 2 Coptic mission 1 Coptic nursing home 1 Cresent 1 Doesn't know 1 Emmanuel hospital 1 Gatundu 1 He says he goes to any healthcare facility he doesn't have a specific one 1 Immaculate Hospital 1 1 Itando Mission Health Centre 1 Itando Mission of hope and health center 1 Itando mission of hope and health Centre 2 Jamie nursing hospital 1 Jamii 1 Jamii Misson hospital 1 Jamii hospital 3 1 Jamii nursing home 6 Jamii nursing hospital 10 Jumuia health Centre and Private hospital in town 1 Kahawa Barrack Health Centre 1 Kapsabet health Centre 1 1 1 Karatina District hospital and karatina nursing hospital 1 Karatina Nursing Home 1 Karatina Nursing home 1 2 Karatina nursing home 2 Karatina nursing hospital 6 Karuri level 4 hospital 1 1 Kasarani at D.O's office (Kwa Kanjo) 1 Kasarani health Centre 2 Kasarani health center 1 Kenol hospital 1 1 Kenyatta Dr plaza 1 Kenyatta hospital 1 Kenyatta national 2 Kenyatta national hospital 1 Kiambu 1 Kiambu Sub-County 1 Kiambu county referral hospital 1 Kiambu level 4 1 Kibera South health center 1 Kieni mission 1 Kikuyu PCEA and Melchizedek hospital 1 Kikuyu hospital 1 Kikuyu mission hospital 1 Kikuyu pcea hospital 1 Kimbo Health care 1 6 Langata Hospital 1 Langata health Centre 2 Langata health center 1 Langata health centre 2 Langata health centre,kenyatta national hospital 1 Langata hospital 22 Langata hospital (Githurai) 1 Langata hostial 1 Lethood private hospital 1 Limuru 1 1 2 3 Limuru Health Centre 1 1 Limuru Hospital 1 1 Limuru Nursing Home 8 Limuru Nursing home 7 1 Limuru nursing home 10 Limuru nursing hospital 2 Limuru nusing home 1 Lions Hospital 1 Lunga lunga 1 Lunga lunga health center 1 Lungalunga health centre 2 Lungalunga health centre,mukuru access afya 1 MELCHIZEDEK 1 Makadara health center 1 Male hospital 1 Maleba hospital 1 Mama lucy kibaki hospital and access afya mukutu kwa njenga 1 Mamalucy 1 Matayos hospital in Busia 1 Mater Hospital 1 Maximum centre 1 Mbagathi Hospital 2 Mbale Rural Hospital 1 Medihill hospital 1 Medwin health centre 1 Melchezedek 1 1 Melchezedek Hospital 4 Melchezedek hospital 1 Melchezedick 1 Melchizedeck hospitals 1 Melchizedek 5 1 Melchizedek Hospital 3 Melchizedek hospital 5 Melchizedek hospital,dream centre 1 Melchizedick 1 Melkizedek hospital 1 Mewa Hospital 1 Mugoma 1 Mukurweini District hospital 1 1 Mun'goma hospital 5 Mung'oma 4 Mungoma 5 Mungoma Hospital 13 Mungoma health center 2 Mungoma hospital 6 Nairobi West hospital 1 Nazareth 2 1 Patel Hospital 1 Patel Nursing Home 1 Private doctor clinic Dr Eva 1 Provide international korogocho 1 Reina rosary utawala 1 Riavai dispensary 1 1 Riruta health Centre 1 Riruta health centre,melchizedek 1 Saitoti Health Centre, st. John 1 Saitoti hospital 1 Sega Mission Hospital 1 Shalom hospital 1 St Francis Community hospital 1 St John 2 St John Hospital 5 St John hospital 8 St John's 1 1 St John's Hospital 1 St John's hospital 1 St Joseph 1 1 St Mary's hospital and access afya mukuru kwa njenga 1 St Mary's mission hospital 1 St Monica 1 St Patrick 1 St Teresa hospital 1 St Teresa hospital Kiambu 1 St john 10 2 St john hospital 8 St john hospital and lifeline hospital 1 St johns 7 St. Francis Kasarani 1 St. John 1 St. John Hospital 1 St. John's Hospital 3 St. Johns Hospital 6 St.Francis Community Hospital 1 St.John hospital 1 St.John's Hospital 3 St.Johns Hospital 1 St.john githurai 1 St.john hospital 1 St.john hospital and kahawa West hospital 1 St.johns 1 Strathmore 4 Strathmore Hospital 1 Strathmore University Clinic 2 Strathmore University Hospital 1 Strathmore University medical Centre 1 Strathmore University medical centre 1 Strathmore clinic 1 Strathmore health centre 1 Strathmore medical center 2 The Bliss hospital 1 Tianganga Catholic dispensary 1 Tiganga Catholic dispensary 1 1 Tigoni District Hospital 1 Tigoni Hospital 1 Tigoni district hospital 2 Tigoni health center 1 Tin'ganga Catholic Dispensary 3 Tin'ganga Dispensary 1 Ting'ang'a Catholic dispensary 4 Ting'ang'a catholic dispensary 1 1 Ting'anga Catholic Dispensary 4 Tinganga Catholic Dispensary 1 Tinganga Catholic dispensary 6 Tinganga catholic 1 Tinganga dispensary 1 Tumutumu Hospital 1 Upperhill medical Centre 1 Uthiru Health Centre 1 Vihiga County Referral Hospital 5 Vihiga District hospital 1 Vihiga Referral 1 Vihiga Referral Hospital 1 Vihiga county referral hospital 1 Vihiga hospital 1 Wangige health Centre 1 Westland health centre 1 Westlands/meridian medical centre 1 access afya 1 access afya njenga 2 "3.43. What is the name of the main healthcare facility you used [before COVID] to get TD2-related care?" 3.44 Were you usually successful in seeing this healthcare provider before COVID Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 500 0 The question sought to determine whether patients with type 2 diabetes were usually successful in seeing their healthcare provider before COVID March 2020. 1 Yes 494 2 No 6 "3.44 Were you usually successful in seeing this healthcare provider before COVID ?" 3.45 Did you usually have a phone consultation or in person consultation [before Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 494 6 The question sought to determine whether patients with type 2 diabetes typically had a phone consultation or an in-person consultation with their healthcare provider before COVID March 2020. 1 (a) phone consultation 5 2 (b) In-person 488 96 (c) Other (e.g. whatsapp) 1 Sysmiss 6 "3.45 Did you usually have a phone consultation or in person consultation [before COVID-19]?" 3.45 Other specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 1 0 The question sought to determine whether patients with type 2 diabetes typically had any other consultation with their healthcare provider before COVID March 2020. I had both in-person and phone consultation 1 "3.45 Other specify" 3.46 If you were unable to see a healthcare provider [before COVID-19], please t Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 0 The question sought to determine the reasons why patients with type 2 diabetes were unable to see a healthcare provider before March 2020, prior to the COVID-19 pandemic. 1 1 1 2 1 2 3 1 3 1 96 3 "3.46 If you were unable to see a healthcare provider [before COVID-19], please tell us what are the reasons why you were not able to see a healthcare provider at the facility you visited? [tick all that apply]" Unable to go out Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question sought to determine if one reason patients with type 2 diabetes were unable to see a healthcare provider before March 2020 was due to being unable to go out. 0 No 5 1 Yes 2 Sysmiss 493 Unable to afford Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question sought to determine if one reason patients with type 2 diabetes were unable to see a healthcare provider before March 2020 was due to being unable to aaford. 0 No 5 1 Yes 2 Sysmiss 493 clinic closed Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question sought to determine if one reason patients with type 2 diabetes were unable to see a healthcare provider before March 2020 was due to the clinic being closed. 0 No 5 1 Yes 2 Sysmiss 493 Other reason (Specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 7 493 The question sought to determine if there were other reasons, aside from being unable to go out, that prevented patients with type 2 diabetes from seeing a healthcare provider before March 2020, with an option to specify. 0 No 4 1 Yes 3 Sysmiss 493 3.46 Other specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 3 0 The question sought to determine if there were other reasons, aside from being unable to go out, that prevented patients with type 2 diabetes from seeing a healthcare provider before March 2020, with an option to specify. Doctors went on strike 1 Doctors' strike 1 One on one 1 "3.46 Other specify" 3.47 What is the name of the main healthcare facility you used [during COVID] to Patients with type 2 diabetes being interviewed. What is the main healthcare facility you used [during COVID] to get TD2-related care? N/A N/A Patients with type 2 diabetes 492 The question sought to determine the main healthcare facility that patients with type 2 diabetes used during the COVID-19 period to receive care related to their diabetes. 0 1 9998 1 Access Afya 6 1 Access Afya (Mukuru) 2 Access Afya Mukuru 7 Access Afya Tasia 1 Access Afya kwa Njenga 1 Access Afya kwa njenga 1 Access Mukuru 1 Access afya 3 Access afya (Mukuru) 1 1 Access afya kwa njenga 1 Access afya mukuru 2 1 Access afya mukuru kwa njenga 1 Access afya mukuru njenga 2 Access afya njega 1 Access afya njenga 1 Accessafya 1 Acess Afya 3 AcessAfya njenga 1 Aghakan hospital 1 Ambira Hospital 1 Athi-river level 4 1 Avenue moi air base Forces memorial 1 BMMC Hospital 1 Bahati health centre 1 Baraka German Doctors 1 Baraka dispensary 1 1 1 Brought medication mostly from chemistry 1 Cannot remember the name (my personal doctor's clinic) 1 Chemist 1 Coast General hospital 1 1 Copit nursing hospital 3 Coptic Hospital 2 Coptic Nursing home 3 Coptic hospital 2 Coptic hospital and strathmore clinic 1 Crescent medical clinic 1 Cresent 1 Dhc welfare family hospital 1 1 1 1 1 Different Pharmacy 1 Dmrc hospital ngara 1 Doctors plaza 1 Doesn't go to any health facility he self manages at home through his diet and lifestyle and checks his blood sugars using his machine 1 Dolphin nursing home 1 Dream centre 1 Eagle and salama hospital 1 Embakasi health center 1 Embakasi health centre 1 Embu level 5 Hospital 1 1 Fort Florence hospital kisumu 1 GSU Juja 1 Gatundu hospital 2 Gatundu level 5 1 Gatundu level 6 1 Gikuyani 1 Githurai chemist 1 He did not go to any health facility 1 He says he goes to any health facility he doesn't have a specific one 1 I don't go to hospital nowadays I just test for blood sugar levels three times a day at home and buy drugs which were prescribed before covid 1 Igo, Kangemi 1 Immaculate Hospital 1 Itando Mission Health Centre 2 Itando Mission Health centre 1 Itando Mission of hope and health center 1 Itando mission of hope and health Centre 2 Itando missions 1 Iyabe level 4 1 Jamie nursing hospital 1 Jamii 1 1 Jamii hospital 5 1 Jamii nursing home 7 Jamii nursing hospital 6 Jericho health center 1 1 Kabaa hospital 1 1 Kahawa west hospital 1 Kakamega private clinic 1 Kalama level 4 1 Kangema Sub-County Hospital 1 Kapsabet hospital,mbagathi 1 Kapsara subcounty 1 Karasani dispensary 1 1 1 Karatina District hospital 1 Karatina Nursing home 1 Karatina nursing home 3 Karatina nursing hospital 3 Karatina sub County hospital 1 Kasarani Health Centre 1 Kasarani health Centre 1 Kasarani health centre 1 Kawangware 1 Kayole dispensary 1 Kenol hospital 1 1 2 1 Kenyatta National Hospital 4 Kenyatta University 1 Kenyatta University Hospital 1 Kenyatta hospital 3 Kenyatta national 3 1 Kenyatta national Hospital 1 Kenyatta national hospital 2 Kenyatta national hospital othaya 1 Kesusu hospital in kisii 1 Kiambu Referral Hospital 1 Kiambu county referral hospital 1 Kiandutu Dispensary 1 Kihara level 4 hospital 1 Kikuyu Hospital 1 Kikuyu PCEA Hospital 1 Kikuyu pcea hospital and professor awour plaza (private) 1 Kimbo Health care 1 Kindubay hospital 1 Kitunduni dispensary 1 Kuraamu health Centre 1 Kwa DO the participant doesn't know the name of the health facility she attends she only knows that it is next to the DO's office 1 1 Lang'ata Health centre 1 1 1 Langata Hospital 2 Langata Hospital kiu 1 Langata health Centre 1 Langata health center 4 Langata health centre 5 Langata hospital 10 Langata hospital and Langata health center 1 Life maker wendani 1 Lifeline clinic 1 1 1 1 Limuru Health Centre 1 Limuru Hospital 1 Limuru Nursing Home 3 Limuru Nursing home 5 Limuru cottage hospital 1 Limuru health center 1 1 Limuru nursing Home 1 Limuru nursing home 6 Lion's first eye sight hospital 1 Lions Hospital 1 Longonot dispensary 1 Lunga Lunga Health Centre 2 Lunga lunga heath Centre 1 Lungalunga Health Centre 1 Lungalunga health centre 4 Lussigetti health center 1 MUGUNDA HEALTH FACILITIES 1 1 Madantare diagnosis centre 1 1 Makadara health Centre 1 Mama Lucy hospital 1 Mama Lucy kibaki 1 Mama Lucy kibaki hospital 1 Mama Lucy, Umoja 1 Mama lucy health Centre 1 Mama lucy kibaki,lungalunga health centre 1 Manguo Hospital 1 Mareba health Centre 1 Marera Hospital 1 1 Marira dispensary,ndeiya health centre 1 Massage health centre 1 2 Mathare Refereral Hospital 1 Mathare hospital 1 Mathari 1 Matibabu Hospital 1 Maximum centre 1 Maya clinic 1 Mbaale refusal hospital 1 Mbagathi 1 Mbagathi Hospital 1 Mbale Rural Dispensary 1 Mbale hospitals 1 Mbangathi hospital 1 Mbooni health Centre 1 Melchezedek 1 Melchezedek Hospital 1 Melchizedek 2 Melchizedek Hospital 3 Melchizedek hospital 2 Meoni Centre hospital 1 Mercy medical clinic 1 Moi referral hospital 1 Momandu Level 4 1 Mother mercy clinic 1 Mradi hospital 1 Mugumuini dispensary 1 Mukangu 1 Mukuru Mm Clinic 1 Mukurweni District hospital 1 1 Mun'goma Hospital 1 Mun'goma hospital 2 Mung'oma 5 Mungama hospital 1 Mungoma 8 Mungoma Hospital 16 Mungoma Medical Clinic 1 Mungoma health center 2 Mungoma hospital 4 Nairobi hospital 1 Naivasha nursing home 1 Nazareth 1 Nazareth Hospital 1 Nazareth hospital 2 Neema Hospital 1 Neema Uhai Hospital 1 1 Never went to a health facility during Covid period. I used to buy my drugs from the pharmacy 1 Ngaira Rhodes dispensary 1 Ngenda health center 1 Ngong dispensary 1 None doesn't go anywhere 1 Nyathuna level 4 hospital 1 Nyeri pgh 1 Ogangata rongai health Centre 1 Otiende health centre 2 1 Patel Hospital 1 Pharmacy 3 Private doctor Dr Eva 1 Reina rosary utawala 1 Reuben Mukuru health centre 1 Riabai 1 Riabai dispensary 1 Riruta health Centre 1 Riruta health center 1 Rongai health centre 1 1 Royal rider 1 Ruiru Referral Hospital 1 Ruiru Sub-County 1 Ruiru dispensary 1 Rukuma County hospital 1 Rukuma health center 1 Ruthigiti level 4 subcounty hospital 1 1 1 Sereni hospitals and rehabilitation centres 1 1 She just bought medication from chemist 1 1 She was doing self management at home she was not going to any health facility 1 She was not going to any health facility 1 Sikwenda hospital kwa sababu ya ukosefu wa fedha 1 St Francis Community hospital kasarani 1 St Francis Kasarani 1 St James clinic kiambu 1 1 1 St John Hospital 1 St John hospital 4 St Joseph 1 St Mary's hospital 1 St Mary's mission hospital 2 St Patrick hospital kayole 1 St Patrick nursing hospital 1 St Teresa hospital 1 St Teresa hospital Kiambu 1 St francis hospital 1 St john 2 2 St john and langata 1 St john hospital 5 St marys 1 St marys hospital 1 St. John 2 St. Johns Hospital 1 St.John's Dispensary Westland 1 St.John's Hospital 3 St.Marry's Hospital 1 St.Mary's Hospital 1 St.Odila Clinic 1 St.john 1 St.john hospital 1 Strathmore University Clinic 1 Strathmore University medical Centre 2 Strathmore medical center 2 Thika level 5 1 Thika level 5 hospital 1 1 Tigoni District Hospital 1 Tigoni Hospital 1 Tigoni district hospital 1 Tin'ganga Catholic Dispensary 2 Tin'ganga Dispensary 1 Ting'ang'a Catholic dispensary 3 Ting'ang'a catholic 1 Ting'ang'a catholic dispensary 1 Ting'ang'a dispensary 1 1 Ting'anga Catholic Dispensary 2 Ting'anga Dispensary 1 Tinganga Catholic Dispensary 1 Tinganga Catholic dispensary 8 Tinganga dispensary 1 Tumutumu District hospital 1 Tumutumu Hospital 1 Tumutumu pcea hospital 1 Upperhill medical Centre 1 Uthiru Health Centre 1 Vateli hospital 1 1 Vihiga County Hospital 1 Vihiga County Referral Hospital 2 Vihiga County referral hospital 1 Vineyard Hospital-Thika 1 Vision Health centre 1 Wagige level 4 1 Waithaka Dispensary 1 Wama hospital 1 Westland health centre 1 Yala Sub-County Hospital 1 nakuru general hospital 1 "3.47 What is the name of the main healthcare facility you used [during COVID] to get TD2-related car" 3.48: Were you successful in seeing this healthcare provider during the [COVID] Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 500 0 The question sought to determine whether patients with type 2 diabetes were successful in seeing their healthcare provider during the COVID-19 period. 1 Yes 464 2 No 36 "3.48: Were you successful in seeing this healthcare provider during the [COVID] period?" 3.49: Did you usually have a phone consultation or in-person consultation during Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 464 36 The question sought to determine whether patients with type 2 diabetes had a phone or in-person consultation with their healthcare provider during the COVID-19 period. 1 (a) phone consultation 16 2 (b) In-person 447 96 (c) Other (e.g. whatsapp) 1 Sysmiss 36 "3.49: Did you usually have a phone consultation or in-person consultation during the [COVID] period?" 3.49 Other specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 1 0 The question sought to determine whether patients with type 2 diabetes had any other form of consultation with their healthcare provider during the COVID-19 period. The doctor dealt with emergency cases first 1 "3.49 Other specify" 3.50: If you were unable to see a healthcare provider during the [COVID] period, Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 36 0 The question sought to determine the reasons why patients with type 2 diabetes were unable to see a healthcare provider during the COVID-19 period. 1 2 1 2 3 1 2 3 1 1 2 4 2 1 2 4 96 1 1 2 5 1 1 3 1 1 3 96 1 1 4 3 1 5 2 1 96 2 2 1 3 3 3 4 5 1 3 96 1 4 2 4 5 1 4 96 1 5 2 96 5 "3.50: If you were unable to see a healthcare provider during the [COVID] period, please tell us what caused this? [tick all that apply]" Afraid to go out due to fear of COVID-19 infection Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 36 464 The question sought to determine the reasons why patients with type 2 diabetes were unable to see a healthcare provider during the COVID-19 period was due to being afraid of being infected by going out. 0 No 17 1 Yes 19 Sysmiss 464 Lockdown restricted me from going out Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 36 464 The question sought to determine if one reason patients with type 2 diabetes were unable to see a healthcare provider during the COVID-19 period was due to restrictions on going out related to COVID-19. 0 No 27 1 Yes 9 Sysmiss 464 Unable to go out for other reason Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 36 464 The question sought to determine if one reason patients with type 2 diabetes were unable to see a healthcare provider during the COVID-19 period was due to other reason for not going out. 0 No 28 1 Yes 8 Sysmiss 464 Unable to afford Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 36 464 The question sought to determine if one reason patients with type 2 diabetes were unable to see a healthcare provider during the COVID-19 period was due to being unable to afford. 0 No 25 1 Yes 11 Sysmiss 464 Clinic closed Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 36 464 The question sought to determine if one reason patients with type 2 diabetes were unable to see a healthcare provider during the COVID-19 period was due to the clinic being closed. 0 No 29 1 Yes 7 Sysmiss 464 Other reason (Specify) Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 36 464 The question sought to determine if there were other reasons, aside from COVID-19 restrictions, that prevented patients with type 2 diabetes from seeing a healthcare provider during the COVID-19 period. 0 No 25 1 Yes 11 Sysmiss 464 3.50: Other specify Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 11 The question sought to determine if there were other reasons, aside from COVID-19 restrictions, that prevented patients with type 2 diabetes from seeing a healthcare provider during the COVID-19 period. 1 1 He manages his diabetes through his diet and nutrition 1 I didn't go to the hospital 1 1 Lack of funds 1 1 1 She was doing self management at home she was not going to any health facility 1 She was not going to any health facility because she has the machine at home she checks her own blood sugars once in a while at home 1 The participant self manages through his diet and lifestyle he doesn't go to a health facility he checks his blood sugars using his machine 1 "3.50: Other specify" 3.51 Considering that during the [COVID] period you were not successful in seein Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 36 464 The question sought to determine if patients with type 2 diabetes sought healthcare at an alternative facility when they were not successful in seeing their usual healthcare provider during the COVID-19 period. 1 Yes 13 2 No 23 Sysmiss 464 "3.51 Considering that during the [COVID] period you were not successful in seeing your usual healthcare provider, did you seek healthcare in another facility?" 3.52a How long did the journey to the healthcare facility take? Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 494 6 0 9998 35.346 449.568 The question sought to determine the length of time it typically took patients with type 2 diabetes to travel to their healthcare facility in the pre-COVID period. "3.52a How long did the journey to the healthcare facility take?" Minutes or hours Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 494 6 N/A 1 Minutes 247 2 Hours 247 Sysmiss 6 "Minutes or hours" 3.53a How did you usually travel to the hospital/health facility? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 494 6 The question sought to determine the mode of transport the patients with type 2 diabetes used to travel to the hospital or the health facility in the pre-COVID period. 1 (1) Walk 126 2 (2) Bicycle 0 3 (3) Motorcycle 72 4 (4) Tricycle (tuktuk) 1 5 (5) Private car 27 6 (6) Public taxi/bus/matatu 266 96 96 Other (specify) 2 Sysmiss 6 "3.53a How did you usually travel to the hospital/health facility?" 3.53a Other specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 2 The question sought to determine the other mode of transport not listed that patients with type 2 diabetes used to travel to the hospital or the health facility in the pre-COVID period. Did not go to a health facility during covid he self manages at home through his diet and lifestyle and monitors his blood sugar with his machine 1 In 2009 he was hospitalised only for 2 weeks and given medication for only a short time and afterwards he doesn't take any medication 1 "3.53a Other specify" 3.54a Did you pay for the journey to the health facility? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 494 6 The question sought to determine if the patients with type two diabetes paid for transport or not when they travelled to the hospital or health facility in the pre-COVID period. 1 Yes 365 2 No 129 Sysmiss 6 "3.54a Did you pay for the journey to the health facility?" 3.54a If yes, how much in total did you pay for yourself for a round trip? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 365 135 0 5000 299.671 481.37 The question sought to determine the amont of money the patients with type two diabetes paid for transport when they travelled to the hospital or health facility in the pre-COVID period. "3.54a If yes, how much in total did you pay for yourself for a round trip?" 3.52b How long did the journey to the healthcare facility take? Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 465 35 0 10000 102.318 923.747 The question sought to determine the time patients with type two diabetes took when they travelled to the hospital or health facility in the pre-COVID period. "3.52b How long did the journey to the healthcare facility take?" Minutes or hours Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 465 35 The question sought to determine the specific time in minutes or hours patients with type two diabetes took when they travelled to the hospital or health facility in the pre-COVID period. 1 Minutes 230 2 Hours 235 Sysmiss 35 "Minutes or hours" 3.53b How did you usually travel to the hospital/health facility? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 465 35 The question sought to determine the mode of transport the patients with type 2 diabetes used to travel to the hospital or the health facility in the COVID period. 1 (1) Walk 109 2 (2) Bicycle 2 3 (3) Motorcycle 82 4 (4) Tricycle (tuktuk) 1 5 (5) Private car 31 6 (6) Public taxi/bus/matatu 237 96 96 Other (specify) 3 Sysmiss 35 "3.53b How did you usually travel to the hospital/health facility?" 3.53b Other specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 3 0 The question sought to determine the other mode of transport not listed that patients with type 2 diabetes used to travel to the hospital or the health facility in the COVID period. 1 Didn't go to see any doctor 1 None 1 "3.53b Other specify" 3.54b Did you pay for the journey to the health facility? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 465 35 The question sought to determine if the patients with type two diabetes paid for transport or not when they travelled to the hospital or health facility in the COVID period. 1 Yes 348 2 No 117 Sysmiss 35 "3.54b Did you pay for the journey to the health facility?" 3.54b If yes, how much in total did you pay for yourself for a round trip? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 348 152 0 10000 389.635 867.074 The question sought to determine the amont of money the patients with type two diabetes paid for transport when they travelled to the hospital or health facility in the COVID period. "3.54b If yes, how much in total did you pay for yourself for a round trip?" 4.1 Are you covered with any health insurance? Patients with type 2 diabetes being interviewed. Are you covered with any health insurance? N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if individuals are currently covered by any health insurance as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. 1 Yes 337 2 No 163 "4.1 Are you covered with any health insurance?" 4.2 If yes, which type of health insurance? Patients with type 2 diabetes being interviewed. If yes, which type of health insurance? N/A N/A Patients with type 2 diabetes 337 163 The question sought to determine the type of health insurance individuals have if they are covered, as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. 1 (a)NHIF 322 2 (b)private 11 96 Other 4 Sysmiss 163 "4.2 If yes, which type of health insurance?" Other specify Patients with type 2 diabetes being interviewed. If yes, which type of health insurance? N/A N/A Patients with type 2 diabetes 4 0 The question sought to determine if there were other types of health insurance coverage individuals have, with an option to specify, as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. 1 AON and Nhif 1 M-tiba 1 Mtiba 1 "Other specify" 4.3 When did you join the health insurance scheme? Patients with type 2 diabetes being interviewed. When did you join the health insurance scheme? N/A N/A Patients with type 2 diabetes 337 163 The question sought to determine when individuals joined their health insurance scheme as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. 1 (a) After being diagnosed with T2D 63 2 (b) Before being diagnosed with T2D 106 3 (c) Before COVID and before being diagnosed with T2D 160 4 (d) After COVID-19 8 Sysmiss 163 "4.3 When did you join the health insurance scheme?" 4.4 Please indicate your income [PRE-COVID] before March 2020 Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine individuals' income level before COVID-19 as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. 1 Monthly 212 2 Weekly 63 3 Daily 225 "4.4 Please indicate your income [PRE-COVID] before March 2020" Amount [IN LOCAL CURRENCY] Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 0 200000 8722.27 18264.61 The question sought to determine individuals' income level before COVID-19 as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. "Amount [IN LOCAL CURRENCY]" (a).Amount spent per month excluding transportin KSH [PRE–COVID] Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 0 200000 5305.828 10406.762 The question sought to determine the average monthly spending on general healthcare by individuals before COVID-19, including costs for medications, outpatient and inpatient services, out-of-pocket expenses, and transport, as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. "(a).Amount spent per month excluding transportin KSH [PRE–COVID]" (b).Amount spent per month excluding transportin KSH [ COVID] Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 0 200000 6175.17 12317.956 The question sought to determine the average monthly spending on general healthcare by individuals during COVID-19, including costs for medications, outpatient and inpatient services, out-of-pocket expenses, and transport, as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. "(b).Amount spent per month excluding transportin KSH [ COVID]" (c).Total transport cost per month [Pre- COVID-19] Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 0 24000 602.344 1777.331 The question sought to determine the total transport cost by individuals before COVID-19, including costs for medications, outpatient and inpatient services, out-of-pocket expenses, and transport, as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. "(c).Total transport cost per month [Pre- COVID-19]" (d).Total transport cost per month [COVID] Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 0 10000 607.304 1320.383 The question sought to determine the total transport cost by individuals during COVID-19, including costs for medications, outpatient and inpatient services, out-of-pocket expenses, and transport, as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. "(d).Total transport cost per month [COVID]" (a).Amount spent per month excluding transport in KSH [PRE–COVID] Patients with type 2 diabetes being interviewed. How much per month did you spend on average [PRE-COVID] to access to healthcare for T2D? N/A N/A Patients with type 2 diabetes 500 0 0 200000 4579.38 9902.441 The question sought to determine the average monthly amount spent by individuals on general healthcare, excluding transport costs, in Kenyan Shillings (KSH) before COVID-19 as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. "(a).Amount spent per month excluding transport in KSH [PRE–COVID]" (b).Amount spent per month excluding transport in KSH [COVID] Patients with type 2 diabetes being interviewed. How much per month did you spend on average [PRE-COVID] to access to healthcare for T2D? N/A N/A Patients with type 2 diabetes 500 0 0 55000 4676.524 6297.236 The question sought to determine the average monthly amount spent by individuals on general healthcare, excluding transport costs, in Kenyan Shillings (KSH) during COVID-19 as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. "(b).Amount spent per month excluding transport in KSH [COVID]" (c).Total transport cost per month [Pre- COVID-19] Patients with type 2 diabetes being interviewed. How much per month did you spend on average [PRE-COVID] to access to healthcare for T2D? N/A N/A Patients with type 2 diabetes 500 0 0 20000 538.988 1390.605 The question sought to determine the average monthly spending by individuals on healthcare specifically for type 2 diabetes (T2D) before COVID-19 as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. "(c).Total transport cost per month [Pre- COVID-19]" (d).Total transport cost per month [COVID] Patients with type 2 diabetes being interviewed. How much per month did you spend on average [PRE-COVID] to access to healthcare for T2D? N/A N/A Patients with type 2 diabetes 500 0 0 10000 591.188 1214.567 The question sought to determine the average monthly spending by individuals on healthcare specifically for type 2 diabetes (T2D) during COVID-19 as part of assessing the impact of COVID-19 on income, impoverishment, and availability of food. "(d).Total transport cost per month [COVID]" 4.7 Have COVID-19 laws/regulations/rules affected the ability of you or your hou Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if COVID-19 laws, regulations, or rules have impacted the ability of individuals or their households to earn money, with an option to select a response. 1 Yes 462 2 No 35 98 Don’t know 3 "4.7 Have COVID-19 laws/regulations/rules affected the ability of you or your household to earn money at any point?" 4.8 Which of the following statements are true regarding the ability of you or y Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to identify which statements accurately describe the impact of the COVID-19 period on the ability of individuals or their households to earn money over the past month, with an option to select all that apply. 1 326 1 2 42 1 96 11 2 19 96 102 "4.8 Which of the following statements are true regarding the ability of you or your household to earn money during the COVID period (Select all that apply) Choices:" Someone in the Household has lost a job Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if one of the impacts on household income during the COVID-19 period was that someone in the household lost a job. 0 No 121 1 Yes 379 Someone in the Household is on unpaid leave Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if one of the impacts on household income during the COVID-19 period was that someone in the household was on unpaid leave. 0 No 439 1 Yes 61 Other (specify) Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if there were other impacts on household income during the COVID-19 period, with an option to specify. 0 No 387 1 Yes 113 4.8 Other specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 113 The question sought to determine if there were other impacts on household income during the COVID-19 period, with an option to specify. 9999 1 1 1 1 1 1 1 Business collapsed 1 Business gone down 1 Business not performing good 1 Business stopped 1 Business was affected by the covid and it went down 1 Business was negatively affected 1 Business went down 22 Bussiness went down 1 Closed down his business 1 Closed his fruit shop 1 Closed his shop business 1 Closed sons business 1 1 Cost of living becomes expensive 1 1 Due to curfew it hindered earning of income for her husband 1 Family members died 1 He shut down his business 1 Her business was demolished she wants to restore it back 1 Her business went down 1 Her children don't have jobs they hustle here and there 1 Her customers said they didn't have money during the covid so she at times lacked jobs 1 Her husband is the breadwinner and so during covid he was laid off work for a couple of months and then he was called back to go and continue working. 1 Her husband was laid off work during covid 1 Jobs were down 1 Lack of enough money 1 Lack of job 1 Lack of job opportunities during the covid period 1 Lack of money 3 1 Life become expensive 1 Life has becomes expensive 1 1 Lost her poultry farming business 1 Lost his job as a truck driver 1 Low income 1 NA 1 1 No problem 1 None 14 1 1 Not accessing the market 2 Not affected 2 Not affected . 1 People were not paying rent for her rental houses 1 Relocated to rural home and churches were closed hence no source of income 1 Shut down her business 1 Shut down the business 1 1 Tenant not paying 1 1 The business was low 1 The business went down 1 The curfew was a hinderance because it gave her family members limited time to make ends meet 1 The husband couldn't sustain the family 1 The participant did not have any challenges 1 The participant had no challenges 1 The participant has no challenges 2 The participant said the economy has gone up and acquiring things has become a challenge 1 There are no job opportunities for her children to earn income in any way 1 There was no work to sell her fruits in the soko during covid 1 Things become expensive 1 Unable to sell goods from farm 1 Was not affected 1 Was not affected much 1 Work from home using her own resources without reimbursement 1 "4.8 Other specify" a) Where would you place yourself on this ladder [PRE-COVID before March 2020]? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 30 2 18 3 47 4 57 5 140 6 68 7 57 8 33 9 12 10 38 "a) Where would you place yourself on this ladder [PRE-COVID before March 2020]?" b) Where would you place yourself on this ladder in the [COVID] period? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 17 2 11 3 17 4 8 5 34 6 37 7 49 8 89 9 77 10 161 "b) Where would you place yourself on this ladder in the [COVID] period?" 4.10 a Is your family capable to get the standard three meals of food they need Patients with type 2 diabetes being interviewed. How much per month you do spend [during COVID] to access healthcare for T2D? On general healthcare resource use? N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine the average monthly spending by individuals on healthcare specifically for type 2 diabetes (T2D) and on general healthcare resource use during the COVID-19 period. 1 Yes 306 2 No 190 98 Don’t know 4 "4.10 a Is your family capable to get the standard three meals of food they need per day?" 4.11. What are your coping mechanisms in the case of financial hardship? Select Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to understand the actions individuals plan to take in response to financial hardship experienced during the COVID-19 period, with an option to select all applicable responses. 1 14 1 2 5 1 2 3 1 1 2 3 4 4 1 2 4 5 1 3 10 1 3 4 1 1 4 7 2 75 2 3 26 2 3 4 11 2 3 4 96 2 2 4 17 2 4 96 1 2 96 12 3 74 3 4 21 3 4 96 1 3 96 10 4 29 4 96 17 96 152 98 5 "4.11. What are your coping mechanisms in the case of financial hardship? Select all that apply." Not pay bills that are due (e.g., school fees, rent etc. Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if one response to financial hardship during the COVID-19 period was planning not to pay all bills that are due. 0 No 453 1 Yes 47 Take out a loan Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if one response to financial hardship during the COVID-19 period was planning to take out a loan. 0 No 341 1 Yes 159 Sell some assets/ animals/ Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if one response to financial hardship during the COVID-19 period was planning to sell some assets or animals. 0 No 339 1 Yes 161 Skip meals Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if one response to financial hardship during the COVID-19 period was planning to skip meals. 0 No 384 1 Yes 116 Other Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if there were other planned responses to financial hardship during the COVID-19 period, with an option to specify. 0 No 495 1 Yes 5 Other specify Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 195 The question sought to determine if there were other planned responses to financial hardship during the COVID-19 period, with an option to specify. 1 1 Ask for assistance 2 Ask for assistance from her children 1 Ask for assistance from my children 1 Ask from children 1 Ask help from people 1 Asking for assistance from family members 1 Asking for help from her children 1 Asking for support 1 Assist from the sons 1 Assistance from relatives 1 Assistance from well wishers 1 Assistant from family 2 1 Assistant from family members 2 Begging 3 Begging from close relatives 1 Begging from relatives 1 Begging from relatives and friends 1 1 2 1 1 Borrow from family 6 Borrow from friends 1 Borrow from neighbors 1 Borrow from neighbours 1 Borrow from people 1 Borrow money from family 1 1 Borrows from family 1 Calls for harambee, borrowing 1 Consumes what is available in his farm 1 1 Depend on children 2 Depend on children and God 1 Depending on children 1 1 Do farming 1 Do farming and sell farm product 1 Do farming for fruits and vegetables 1 Do nothing 1 Do some vegetables farming 1 1 Does crop farming to avoid buying food 1 Does laundry for other people 1 Does poultry farming so she can sell eggs when she is in financial constrains 1 Does side hustles 1 Does vegetables farming which she can sell 1 Doing business in order to sustain herself 1 Doing chicken business to sell eggs 1 Family assistance 1 Family donation 1 Family help 1 Family support 1 Farming 3 1 Farming for food animals 1 Find a job 1 Find money to buy a cow 1 From family 2 Get Help from children 1 Get a job 1 1 Get job 2 Getting Help from other people 1 1 Getting support for her business to boost her income in her business 1 God has been faithful I didn't have to do all that to survive 1 God has been faithful I still had my pension coming 1 1 Got assistance from a relative 1 He gets support from his children 1 He has rental houses that he rents out for 2000 per month 1 1 1 Help from family 3 Help from family members 1 Help from friends and family 2 Help from other people 3 Helping from neighbours 1 Her Kids are taking care of her 1 1 His children are supporting him 1 1 Husband took the role to cater 1 Hustling in order to get income 1 I still receive my pension and my children pays for my NHIF so I think I didn't find myself in serious in financial problems 1 I was helped by my children 1 I was not adversely affected by Covid 1 I was not very much affected by Covid so I could still manage somehow 1 I was oky with no issue 1 Invest in business of rearing chicken and selling their eggs 1 Is comfortable 1 Keeping goats 1 Kueka biashara 1 Kutafuta namna nyigine ya pesa 1 Looking for a small business to do to earn an income 1 1 Looking for work 1 Looking for work in order to get an income 1 1 Minimise budget 1 Moved to stay with her mother 1 N/a 1 Never missed 1 None 2 Not comfortable in answering the question 1 Nothing 2 Pension 1 Pray to God 1 Put more effort in the shamba 1 Reduce budget on junk food 1 Reduces her expenses 1 Reducing the expenditure 1 Relies on relatives 1 Relocated to cheaper house 1 1 Relocated to upcountry 1 Rely on family members 1 1 Rely on other relatives 1 Rely on well wishers and friends 1 Searches for work to do inorder to earn an income 1 Seek for assistance from my children 1 Seek help from her children 1 Seek support from others 1 Seeking help from relatives 1 Sell some farm products 1 1 1 Setting up a business 1 She is not doing anything 1 She is running a small business where she is selling fruits in order to make an income. 1 She looks for work to earn an income 1 She looks for work to make ends meet 1 1 She wants to go to upcountry to herd cows to sell their milk 1 She wants to revive her business of selling fruits and plastic items such as cups, plates 1 She will put up a business where she will be able to cope with the financial hardships. 1 Side hustles of doing other people laundry 1 2 1 Start a business 1 Start a bussiness 2 Start a small incoming generating activities 1 Start abussiness 1 Started Small business 1 Started a business 1 Started hawking 1 Started keeping chicken 1 Started sell uji,my son support 1 Started to keeping pigs and chicken 1 Stopped paying rent and moved to her own house Feeding on what is available not considering its balance food or not 1 1 Support from family members 1 Takes what is available not considering balance diet 1 Taking a loan 1 Tea plantation bonus 1 The participant has no challenges because her children support her 1 The participant plans to put chicken for laying eggs to sell and earn an income 1 To do business so as to have enough income to support her family as well as take care of her health 1 To have capital 1 Trim expenditure 1 Use what she has 1 Venturing into business to earn an income 1 Washing clothes for other people 1 Went upcontry to do farming 1 Went upcountry to do farming 1 "Other specify" 5.1 Think about BEFORE MARCH 2020 period. How many days in a week did you miss y Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 500 0 0 9999 141.91 1175.726 The question sought to determine the average number of days per week individuals missed their usual activities—such as work, work at home, or school—due to health reasons related to diabetes in the pre-COVID period. "5.1 Think about BEFORE MARCH 2020 period. How many days in a week did you miss your usual activities (work, work at home or school) because of health reasons related to diabetes?" 5.2 During the [COVID period] has the number of days you missed your usual activ Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 500 0 The question sought to determine the average number of days per week individuals missed their usual activities—such as work, work at home, or school—due to health reasons related to diabetes in the COVID period. 1 YES, increased 174 2 YES, decreased 40 3 NO, stayed the same 286 "5.2 During the [COVID period] has the number of days you missed your usual activities changed?" 5.3 Think about the [COVID] period. How many days in a week do you miss your usu Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 214 286 2 9999 102.084 963.909 The question sought to determine the average number of hours per day a hired caregiver spent providing care to the patient with type 2 diabetes in the pre-COVID period. "5.3 Think about the [COVID] period. How many days in a week do you miss your usual activities (work, work at home or school) because of health reasons related to diabetes?" 6.1a PRE COVID , did you or your family hire someone to take care of you because Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 1 Yes 30 2 No 470 "6.1a PRE COVID , did you or your family hire someone to take care of you because of your ill health?" 6.1b Has this changed in the [COVID] period? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if there were changes to the patients with type 2 diabetes after their families hired someone to provide care due to their ill healt in the COVID-19 period comapred to the pre-COVID period. 1 Yes 20 2 No 480 "6.1b Has this changed in the [COVID] period?" 6.2a Considering PRE COVID period, how much did you pay this person each month? Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 20 480 0 15000 3547.4 3938.217 The question sought to determine the amount paid to the hired caregiver by the type 2 diabetes patient's family in the pre-COVID period. "6.2a Considering PRE COVID period, how much did you pay this person each month?" 6.2b Has this amount changed in the [COVID] period? Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 20 480 The question sought to determine if the amount paid to the hired caregiver by the type 2 diabetes patient's family in the pre-COVID period changed. 1 Yes 8 2 No 12 Sysmiss 480 "6.2b Has this amount changed in the [COVID] period?" 6.2c Considering the [COVID] period, how much do you pay this person each month? Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 8 492 0 14000 3262.5 4765.632 The question sought to determine the amount paid to the hired caregiver by the type 2 diabetes patient's family in the COVID period. "6.2c Considering the [COVID] period, how much do you pay this person each month?" 6.3a PRE COVID, does someone from your family who is not paid usually take care Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if there was an unpaid caregiver in the patients famility who provided care. 1 Yes 47 2 No 453 "6.3a PRE COVID, does someone from your family who is not paid usually take care of you because of your ill health?" 6.3b Has this changed in the [COVID] period? Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 The question sought to determine if the amount paid to the hired caregiver by the type 2 diabetes patient's family in the COVID period changed. 1 Yes 29 2 No 471 "6.3b Has this changed in the [COVID] period?" 6.4a Considering the [PRE-COVID] period, how many hours per day did this person Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 47 453 0 9998 225.021 1456.571 The question sought to determine the average number of hours per day a hired caregiver spent providing care to the patient with type 2 diabetes in the pre-COVID period. "6.4a Considering the [PRE-COVID] period, how many hours per day did this person spend taking care of you?" 6.4b Has the number of hours per days this person spends taking care of you chan Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 75 425 The question sought to determine there was a change in average number of hours per day a hired caregiver spent providing care to the patient with type 2 diabetes in the pre-COVID period. 1 Yes 19 2 No 56 Sysmiss 425 "6.4b Has the number of hours per days this person spends taking care of you changed in the [COVID] period?" 6.4c Considering the [COVID] period, how many hours/day does this person spend t Patients with type 2 diabetes being interviewed. N/A Patients with type 2 diabetes 19 481 0 48 11.316 13.043 The question sought to determine the average number of hours per day a hired caregiver spent providing care to the patient with type 2 diabetes in the COVID period. "6.4c Considering the [COVID] period, how many hours/day does this person spend taking care of you?" K1. The main clinical symptoms of COVID-19 are fever, fatigue, dry cough, and ge Patients with type 2 diabetes being interviewed. K1. The main clinical symptoms of COVID-19 are fever, fatigue, dry cough, and general weakness N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 467 2 FALSE 13 8 I don't know 20 "K1. The main clinical symptoms of COVID-19 are fever, fatigue, dry cough, and general weakness" K2. Stuffy nose, runny nose, and sneezing are less common in persons infected wi Patients with type 2 diabetes being interviewed. K2. Stuffy nose, runny nose, and sneezing are less common in persons infected with the COVID-19 virus N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 292 2 FALSE 147 8 I don't know 61 "K2. Stuffy nose, runny nose, and sneezing are less common in persons infected with the COVID-19 virus" K3. There currently is no effective cure for COVID-2019, but early symptomatic a Patients with type 2 diabetes being interviewed. K3. There currently is no effective cure for COVID-2019, but early symptomatic and supportive treatment can help most patients recover from the infection. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 440 2 FALSE 24 8 I don't know 36 "K3. There currently is no effective cure for COVID-2019, but early symptomatic and supportive treatment can help most patients recover from the infection." K4. Only people who are elderly, those who have chronic illnesses, and obese are Patients with type 2 diabetes being interviewed. K4. Only people who are elderly, those who have chronic illnesses, and obese are more likely to be severe cases. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 322 2 FALSE 138 8 I don't know 40 "K4. Only people who are elderly, those who have chronic illnesses, and obese are more likely to be severe cases." K5. Eating or contacting wild animals might result in infection by the COVID-19 Patients with type 2 diabetes being interviewed. K5. Eating or contacting wild animals might result in infection by the COVID-19 virus. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 68 2 FALSE 325 8 I don't know 107 "K5. Eating or contacting wild animals might result in infection by the COVID-19 virus." K6. People with COVID-19 cannot infect others with the virus when a fever is not Patients with type 2 diabetes being interviewed. K6. People with COVID-2019 cannot infect others with the virus when a fever is not present. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 186 2 FALSE 242 8 I don't know 72 "K6. People with COVID-19 cannot infect others with the virus when a fever is not present." K7. The COVID-19 virus spreads via respiratory droplets of infected individuals. Patients with type 2 diabetes being interviewed. K7. The COVID-19 virus spreads via respiratory droplets of infected individuals. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 438 2 FALSE 28 8 I don't know 34 "K7. The COVID-19 virus spreads via respiratory droplets of infected individuals." K8. People can wear general medical masks to prevent the infection by the COVID- Patients with type 2 diabetes being interviewed. K8. People can wear general medical masks to prevent the infection by the COVID-19 virus. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 484 2 FALSE 9 8 I don't know 7 "K8. People can wear general medical masks to prevent the infection by the COVID-19 virus." K9. It is not necessary for children and young adults to take measures to preven Patients with type 2 diabetes being interviewed. K9. It is not necessary for children and young adults to take measures to prevent infection by the COVID-19 virus. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 171 2 FALSE 296 8 I don't know 33 "K9. It is not necessary for children and young adults to take measures to prevent infection by the COVID-19 virus." K10. To prevent infection by COVID-19, individuals should avoid going to crowded Patients with type 2 diabetes being interviewed. K10. To prevent infection by COVID-19, individuals should avoid going to crowded places such as train stations and avoid taking public transportation. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 464 2 FALSE 22 8 I don't know 14 "K10. To prevent infection by COVID-19, individuals should avoid going to crowded places such as train stations and avoid taking public transportation." K11. Isolation of people who are infected with the COVID-19 virus are effective Patients with type 2 diabetes being interviewed. K11. Isolation of people who are infected with the COVID-19 virus are effective ways to reduce the spread of the virus. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 465 2 FALSE 21 8 I don't know 14 "K11. Isolation of people who are infected with the COVID-19 virus are effective ways to reduce the spread of the virus." K12. People who have contact with someone infected with the COVID-19 virus shoul Patients with type 2 diabetes being interviewed. K12. People who have contact with someone infected with the COVID-19 virus should be immediately isolated from the public for 14 days. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 TRUE 478 2 FALSE 8 8 I don't know 14 "K12. People who have contact with someone infected with the COVID-19 virus should be immediately isolated from the public for 14 days." Attitudes 7.13 Do you think that COVID-19 will finally be successfully controlle Patients with type 2 diabetes being interviewed. A1. Do you think that COVID-19 will finally be successfully controlled? N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Agree 416 2 Disagree 32 8 I don't know 52 "Attitudes 7.13 Do you think that COVID-19 will finally be successfully controlled?" reserved_name_for_field_list_labels_624 Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 0 500 N/A Sysmiss 500 1. Avoided crowded areas; Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 414 2 No 86 "1. Avoided crowded areas;" 2. Avoided social events; Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 374 2 No 126 "2. Avoided social events;" 3. Avoided taking taxis (Matatus); Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 198 2 No 302 "3. Avoided taking taxis (Matatus);" 4. Avoided going out; Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 230 2 No 270 "4. Avoided going out;" 5. Avoided going to work Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 178 2 No 322 "5. Avoided going to work" 6. Avoided travelling long distances; Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 325 2 No 175 "6. Avoided travelling long distances;" 7. Used face masks when leaving home Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 482 2 No 18 "7. Used face masks when leaving home" 8. Worn glove Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 59 2 No 441 "8. Worn glove" 9. Used hand sanitizer; Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 438 2 No 62 "9. Used hand sanitizer;" 10. Taken ginger, lemon, to prevent COVID-19 Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 350 2 No 150 "10. Taken ginger, lemon, to prevent COVID-19" 11. Taken traditional herbs for COVID-19 treatment Patients with type 2 diabetes being interviewed. N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Yes 25 2 No 475 "11. Taken traditional herbs for COVID-19 treatment" reserved_name_for_field_list_labels_642 Patients with type 2 diabetes being interviewed. N/A N/A N/A Patients with type 2 diabetes 0 500 N/A Sysmiss 500 8.1 Feeling nervous, anxious or on edge Patients with type 2 diabetes being interviewed. Feeling nervous, anxious or on edge N/A N/A Patients with type 2 diabetes 500 0 N/A 0 Not At all 259 1 Several days 179 2 More than half the days 35 3 Nearly Every day 27 "8.1 Feeling nervous, anxious or on edge" 8.2 Not been able to stop or control worrying Patients with type 2 diabetes being interviewed. Not been able to stop or control worrying N/A N/A Patients with type 2 diabetes 500 0 N/A 0 Not At all 276 1 Several days 160 2 More than half the days 42 3 Nearly Every day 22 "8.2 Not been able to stop or control worrying" 8.3 Worrying too much about different things Patients with type 2 diabetes being interviewed. Worrying too much about different things N/A N/A Patients with type 2 diabetes 500 0 N/A 0 Not At all 223 1 Several days 164 2 More than half the days 74 3 Nearly Every day 39 "8.3 Worrying too much about different things" 8.4 Trouble relaxing Patients with type 2 diabetes being interviewed. Trouble relaxing N/A N/A Patients with type 2 diabetes 500 0 N/A 0 Not At all 316 1 Several days 135 2 More than half the days 33 3 Nearly Every day 16 "8.4 Trouble relaxing" 8.5 Being so restless that it is hard to sit still Patients with type 2 diabetes being interviewed. Being so restless that it is hard to sit still N/A N/A Patients with type 2 diabetes 500 0 N/A 0 Not At all 296 1 Several days 152 2 More than half the days 36 3 Nearly Every day 16 "8.5 Being so restless that it is hard to sit still" 8.6 Becoming easily annoyed or irritable Patients with type 2 diabetes being interviewed. Becoming easily annoyed or irritable N/A N/A Patients with type 2 diabetes 500 0 N/A 0 Not At all 171 1 Several days 206 2 More than half the days 64 3 Nearly Every day 59 "8.6 Becoming easily annoyed or irritable" 8.7 Feeling afraid as if something awful might happen Patients with type 2 diabetes being interviewed. Feeling afraid as if something awful might happen N/A N/A Patients with type 2 diabetes 500 0 N/A 0 Not At all 279 1 Several days 156 2 More than half the days 31 3 Nearly Every day 34 "8.7 Feeling afraid as if something awful might happen" Patients with type 2 diabetes being interviewed. Total score N/A N/A Patients with type 2 diabetes 500 0 N/A 0 83 1 44 10 11 11 19 12 12 13 12 14 3 15 4 16 3 17 1 18 2 2 55 20 1 3 37 4 43 5 41 6 33 7 47 8 31 9 18 8.8 MOBILITY Patients with type 2 diabetes being interviewed. MOBILITY N/A N/A Patients with type 2 diabetes 500 0 N/A 1 I have no problems in walking about 338 2 I have slight problems in walking about 94 3 I have moderate problems in walking about 44 4 I have severe problems in walking about 18 5 I am unable to walk about 6 "8.8 MOBILITY" 8.9 SELF-CARE Patients with type 2 diabetes being interviewed. SELF-CARE N/A N/A Patients with type 2 diabetes 500 0 N/A 1 I have no problems washing or dressing myself 441 2 I have slight problems washing or dressing myself 34 3 I have moderate problems washing or dressing myself 18 4 I have severe problems washing or dressing myself 5 5 I am unable to wash or dress myself 2 "8.9 SELF-CARE" 8.10 USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities Patients with type 2 diabetes being interviewed. USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities) N/A N/A Patients with type 2 diabetes 500 0 N/A 1 I have no problems doing my usual activities 385 2 I have slight problems doing my usual activities 62 3 I have moderate problems doing my usual activities 40 4 I have severe problems doing my usual activities 8 5 I am unable to do my usual activities 5 "8.10 USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities)" 8.11 PAIN / DISCOMFORT Patients with type 2 diabetes being interviewed. PAIN / DISCOMFORT N/A N/A Patients with type 2 diabetes 500 0 N/A 1 I have no pain or discomfort 206 2 I have slight pain or discomfort 192 3 I have moderate pain or discomfort 72 4 I have severe pain or discomfort 26 5 I have extreme pain or discomfort 4 "8.11 PAIN / DISCOMFORT" 8.12 ANXIETY / DEPRESSION Patients with type 2 diabetes being interviewed. ANXIETY / DEPRESSION N/A N/A Patients with type 2 diabetes 500 0 N/A 1 I am not anxious or depressed 291 2 I am slightly anxious or depressed 133 3 I am moderately anxious or depressed 52 4 I am severely anxious or depressed 20 5 I am extremely anxious or depressed 4 "8.12 ANXIETY / DEPRESSION" 813 We would like to know how good or bad your health is TODAY using a numbered Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 0 100 61.97 19.926 N/A "813 We would like to know how good or bad your health is TODAY using a numbered scale from 0 to 100. 100 means the best health you can imagine and 0 means the worst health you can imagine. Please tell me what number on the scale to indicate how your health is TODAY. YOUR HEALTH TODAY" 9.1 Have you ever suffered COVID-19 or contracted coronavirus? Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 499 1 N/A 1 1. Yes, based on my own experience/ knowledge 9 2 2. Yes, being told by a health providers/ medical personnel 9 3 3. Yes, confirmed test 22 4 No 459 Sysmiss 1 "9.1 Have you ever suffered COVID-19 or contracted coronavirus?" 9.2 Please specify the number of illness episodes Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 31 469 0 28 2.516 5.943 N/A "9.2 Please specify the number of illness episodes" 9.3 Did you visit a health facility to seek health care? Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 31 469 N/A 1 Yes 28 2 No 3 Sysmiss 469 "9.3 Did you visit a health facility to seek health care?" 9.4 How did you manage the illness? Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 3 497 N/A 1 1. Self treatment at home (using home/ tradional remedy, pharmacy drugs) 3 2 2. Visited traditional healer 0 3 3. Visited faith healer for prayers 0 4 4. Did nothing 0 Sysmiss 497 "9.4 How did you manage the illness?" 9.5 How much in total did you spent to treat the illness outside the health faci Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 3 497 7000 10000 9000 1732.051 N/A "9.5 How much in total did you spent to treat the illness outside the health facility?" 9.6 Which facility type you visited? (Think of a very costful episode) Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 28 472 N/A 1 1. Hospital -private 11 2 2. Hospital -public 10 3 3. Health centre -private 3 4 4. Health centre -public 2 5 5. Dispensary/ clinic -private 1 6 6. Dispensary -public 0 96 7. Other, specify 1 Sysmiss 472 "9.6 Which facility type you visited? (Think of a very costful episode)" Other Specify Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 1 0 N/A Kemri 1 "Other Specify" 9.7 Were you attended within 24 hours or admitted? (Think of a very costful epis Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 28 472 N/A 1 1. Attended within 24 hours (outpatient care) 12 2 2. Attended for more than 24 hours (inpatient care/ admission) 16 Sysmiss 472 "9.7 Were you attended within 24 hours or admitted? (Think of a very costful episode)" 9.8 How many nights you were admitted? _______Nights (Think of a very costful ep Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 16 484 1 90 19.188 21.473 N/A "9.8 How many nights you were admitted? _______Nights (Think of a very costful episode)" 9.9 How many visits did you make for the entire episode of illness? ______visits Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 28 472 1 60 6.571 13.335 N/A "9.9 How many visits did you make for the entire episode of illness? ______visits (Think of a very costful episode)" 9.10 How much in total did you spend to treat the illness episode at a health fa Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 28 472 0 750000 82739.143 159079.664 N/A "9.10 How much in total did you spend to treat the illness episode at a health facility? (Think of a very costful episode, if many episodes, and please include the cost related to consultation fees, medication, admission, gas, and transport)" Do you have any questions for me? Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 N/A 1 -Recomended Seminars/civic education about managing diabetes - Requested the access afya in mukuru interventions project to come back -Nhif to be made affordable to people who lives in urban poor 1 1 1 1 Aim of the study 1 Any direct benefit that leads to cost reduction will be much appreciated 1 1 1 Are we going to get help soon 1 Are you also going to give us free drugs and testing kits? 1 Are you bringing back M-tiba? 1 1 As you promised, I hope the information I've given will not be misused. 1 1 Can I be cured of diabetes and hypertension? 1 Can I get another glucometer? 1 1 Can the hospital or APHRC provide diabetic patients with things like porridge fluor? 1 Can this diabetes be treated completely? 1 1 1 Can you please help us with strips? sometimes I really want to test myself at home since my glucometer is still working but the strips are too expensive I can't afford at the moment 1 1 Commented on M-tiba or any program in the government that can help diabetic people access medication with ease to come to their aid. 1 1 Commented on the M-tiba that it was excellent and as the period that were using it they did not lack medication due to financial issues. Suggested the come back of the project 1 Commented on the come back of the M-tiba as it was very crusual to her in accessing medication 1 Commented on the government hospitals especially the dispensaries to stock enough diabetes medicines as well as enough health care workers to give satisfying services to the patients. 1 1 1 Commented on the stocks of medication is not enough in public hospital and the health are provider are not polite and dedicated 1 Comments on the cost of stripes if it could be adjusted 1 Cost of medication 1 Cost of medication and also most of his payments done through nhif 1 Cost of medication is high 2 Cost of medication was high 1 Currently he is admitted at coast General hospital for diabetes related issues and TB 1 Currently his health condition is oky 1 Currently stopped using medication just on diet 1 Currently the strips are too expensive please help us 1 1 Do you think my condition (diabetes & hypertension will be managed successfully? 1 During covid she she attended to mukuru kwa njenga not Ruben, 1 Education of diabetes care,currently she relocated to machakos County. 1 1 1 Getting access to medication is a challenge 1 Getting medication is a big challenge The organisation should come up with interventions that can empower diabetic patients 1 1 1 1 Grateful for being chosen to be interviewed 1 Grateful for being interviewed 1 Hakuna 1 He husband died through covid but she was never infected with it 1 1 How am I going to benefit directly as a participant? 1 1 How are you (APHRC) connected to M-tiba? 1 How are you planning to help us 1 1 1 How can APHRC help old people like me? 1 How can the organisation assist in reduction of medication costs 1 1 How do I know you will not misuse this information 1 How do you help me now that I have lost my job 1 How is this going to be of help to me again? 1 How much will you be sending me 1 How to get testing kits for free 1 How to replace expired m- tiba 1 How we directly help in medication 1 How we support diabetic patients 1 How will the organisation assist those who were affected by road construction in the slum area Cash transfer programs 1 1 1 I am always ready to participate in useful studies like this one and incase of any other, you can always count on me thank you 1 I appreciate your efforts to help us at least we now have testing machines both for hypertension and diabetes 1 I have no question 1 I hope this study will help improve services for us especially in the public hospitals. Some of us are forced to go to private hospitals not because we can afford but because at least we are assured of better services there 1 1 1 I'm very great full for having been chosen to participate in this one too hope it will be of great help as M-tiba 1 I've been having frequent urge to go for short-call lately. What could that be? 1 If aphrc can give him free machine 1 1 If machines Can be provided for self testing at homes 1 If mtiba services could continue 1 If there will be return of mtiba 1 1 Is M-tiba back? 1 1 1 Is it true that Covi-19 vaccine is not good for persons living with diabetes 1 Is it true that we are not supposed to use masks anymore? 1 1 1 Is there any help on drugs 1 1 1 Jane is currently ill and can't understand the questionnaire thus her daughter lucy assistanted since she takes care of her 1 Looking forward to the interventions that will aid diabetic patients 1 Looking forward to the new interventions 1 M-Tiba should be brought back 2 M-Tiba should be brought back How can we subsidise medication 1 M-Tiba was helpful 1 M-Tiba was of good help 1 M-Tiba was of great help 1 Mtiba return and currently uses drugs when she has cash 1 Mtiba services should be returned 1 Mtiba services to be returned 1 Mtiba services where good 1 1 Mtiba services where so helpful 3 Mtiba services where very helpful cost of medication is high 1 N9n3 1 1 Nhif cards 1 1 No 20 No question 12 No question raised by respondent 1 No question raised by the respondent 1 No questions but grateful 1 No questions raised by respondent 11 No questions raised by the respondent 2 No questions. 1 None 150 None . 1 None. 2 Now that you are doing research, are you going to bring drugs or call back teams that supported us like M-tiba? 1 1 Patient asked knowledge on diet 1 Please bring back M-tiba since it stopped we struggle to get enough money to buy strips and drug are very expensive too 1 Please don't take too long to send the money because last time I had an interview with you people it took three days 1 Provision of medication to patient with diabetes 1 Provision of testing machines 1 Q4.1.respondent has the card but it's paid for several months 1 Raised a concern on availability of diabetes medication in public hospital that the hospitals are not stocked which forces her to buy this drug at chemistry only when she has money 1 1 Recommended for free diabetes medication in government hospitals 1 Recommended for the affordable diabetes medication in public hospital 1 Recommended on M-tiba services as the best ever Requested government hospitals to stock enough diabetes medication as most patients cannot afford buying it. 1 1 1 1 Request for mtiba return 1 1 Requested M-tiba for to come back 1 Requested M-tiba to be restored because she could affords it unlike NHIF which she have it but inactive because it is expensive 1 Requested for M-tiba to be restored 2 Requested for M-tiba to be restored because it was easier and affordable to him to access his medication 1 Requested for assistance to top up his NHIF because it has been inactive for quite a while 1 Requested for m-tiba if it can restored 1 Requested if it is possible the M-tiba should be restored as it help her accessing medication as well as the testing kit Commented on lack of medication in public hospital that it is causing inconvenience in that some days she skips taking medi 1 Requested if possible the diabetic patients to be receiving drugs for free just like the HIV patients 1 Requested m- tiba to be restored as it was covering 80%0f the total cost of the medication 1 Requested sponsors who then collaborated with M-tiba to come back as by then she could afford getting her medication on time and in full dose. 1 Requested that m-tiba to be restore because it help her to acquire her medication without too much hustle 1 Requested the government to stock enough medication for diabetes patients and make it affordable 1 Requested the government to stock public hospital with quality diabetes medicines 1 Requested the project that was hosting M-tiba to come back as it was a great help to her in affording medication 1 Requested the public hospitals like otiende health centre to be stocked with medication 1 Requested the public hospitals to be stocked with enough diabetes medicines 1 Respondent asked if the will reopen Melchizedek clinic 1 Respondent asked where can she get free medication 1 Respondent is asking for any organization that help the physically challenged people because he is amputated on the leg and can't provide anymore for the family as he is the sole breadwinner. 1 Respondent raised no questions 1 Respondent was happy and would like to be contacted anytime 1 Return of mtiba 1 1 Return of mtiba services 1 Service used to be offered by mtiba will they return 1 1 1 She changed hospital during covid period 1 She didn't know how much was spent to pay for treatment on issue of covid 19 treatment 1 She normally controls her sugar through exercises and diet 1 She wanted to know what APHRC does. 1 She was asking if APHRC is a health centre and l answered by telling her we are a research center 1 1 1 1 1 1 1 Suggested the medication price to be reduced 1 Suggested-people with diabetes to access medication in public hospital for free just like the people living with HIV virus. -if maybe you are using the insurance card it should cater the medical expenses unlike now they buy medicines from their 1 1 Support for Mtiba should be continued 1 Support of medication to people with diabetes type 2 1 Support of medication to type 2 diabetes 1 Support on Medication 1 Support to diabetes patient and return 0f Mtiba services 1 Support to diabetes type 2 1 Support to diabetic patient 1 Support to patient with diabetes through mtiba 1 Support to people with diabetes and Return of mtiba 1 Support to vulnerable people with diabetes 1 Thank you for caring so much about us 1 1 Thank you for the great work you have been doing. Just requesting if you can bring back the M-tiba program please because it was of a great help to us. 1 Thank you for this interview and for being so patient 1 Thank you very much for calling 1 Thank you very much for calling to check on my health 1 Thank you very much for checking on me 1 The NGO that was collaborating with M-tiba did a helpful work and since their withdrawal she had never gotten herself medication as prescribed 1 The biggest challenge is medication 1 1 1 The idea of coming up with M-Tiba was good but the execution was wrong because the prices were inflated in some facilities 1 The organisation should come with measures that are attainable 1 1 The participant asked whether there is a cure for diabetes, l explained to her that unfortunately this is a chronic illness that she will have to be on medication management for the rest of her life. 1 The participant did not have a question 1 The participant did not have any questions 6 1 The participant had no question 1 The participant had no questions 16 The participant has no questions 10 The participant wanted assistance in seeking help for diabetes patients in accessing medicine and support her business. 1 The participant wanted to know what APHRC does and I explained to her that we are a health research facility and we are carrying out a research project on patients who are type 2 diabetes to know their experience during covid and before covid. 1 The participant wanted to know what APHRC does and what is it that she will gain from the interview/ research 1 The participant wanted to know what APHRC does and whether it is a health facililty and I was able to explain to him that APHRC is a health research center and that our main focus is doing research to people who have type 2 Diabetes and what th 1 The participant wanted to know what APHRC does and whether we are a health facility 1 The participant wanted to know whether APHRC can help in supporting Diabetic patients through the Mtiba, I explained to the participant that APHRC is a health research organisation that deals with research programs only and it is not a medical 1 The participant was asking for help for diabetes patients to have access to medications throughout because at times they do not get them easily. 1 The participant was asking if diabetes patients can get assistance in getting medication 1 The participant was asking if she could be contacted in the near future for any other project and l answered her yes because during consenting she agreed to be contacted again. 1 The participant was asking if she could be helped in getting support for medication 1 The participant was asking whether Diabetic patients would get access to free medications for diabetes 1 The participant was asking whether diabetes patients could get support in acquiring medication 1 1 There was change of hospital 1 There was change of hospital and medication 1 There was change of hospital to Mukunga health dispensary 1 There was no questions raised by respondent 1 1 Transport to kasarani hospital for medication is to high and cost of medication 1 Urged the government hospitals to be stocked with enough diabetes medication and make it affordable 1 Urged the government to give free drugs to diabetes patients just like the hip patients 1 Urged the government to stock free diabetes medicines 1 Wanted to know where he can service his machine for testing blood sugar level 1 We continue to support people with diabetes 1 1 We should come up with interventions that can help diabetes patients 1 1 What happened to mtiba services 1 What happened with M-tiba? 1 What is our upcoming project 1 1 1 When will M-tiba be back 1 When will get M-Tiba back It used to subsidise medical cost on 80 to 20 percent basis 1 1 Where can he get free medication 1 Where can she get free medication 1 Which interventions do have for those who have chronic illness 1 1 Why did M-tiba stop helping us? We really got quality healthcare services related to diabetes during that period 1 Why did you ask the last question if I have ever suffered covid? 1 1 Will appreciate any kind of assistance 1 Will mtiba be back? 1 Will the organisation help in subsidising medication 1 1 Will this study link us to health facilities where we will get subsidised health care services as did M-tiba? The prices for testing strips have been rising since onset of Covid-19 so much that even having glucometer does not help much because 1 Will you also give us drugs and strips? 1 1 You mentioned something about M-tiba sorry I've never heard of it 1 You need cheap in medication 1 medication should be subsidised 1 none 2 "Do you have any questions for me?" FW: RECORD COMMENTS/observations ABOUT THE INTERVIEW Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 499 N/A 0 1 1 1 100,000 thousands was the bill incurred in private hospital after being admitted for 7 days 1 1 3.8a and 3.8 the patients takes his drugs twice a day ie morning and evening 1 1 1 3.8c the respondent takes her medication thrice a day 1 3.9a I,80% was covered by 8888 and she paid 20% of total cost of 4500. She attended access afya tassie but it is missing in the hospitals listed in embarkation east 1 4.1 respondent said had NHIF but not active 1 4.1 the respondent has the NHIF card but not active 1 4.4 the respondent is currently unemployed so she doesn't have any income 1 5Successful interview 1 1 1 1 Asked if mtiba services are going to be returned 1 Asked if mtiba will be back 1 At the beginning of the interview the participant was tired because she is using one arm she lost one arm but we managed to finish the interview, she goes to see her private doctor Dr Eva since the Mtiba program finished and has been managing h 1 At the start of the interview there were afew network issues but we managed to do our interview and the participant was confident during the whole interview. The participant said that in the beginning she was using both oral and insulin and it 1 Bad network 1 1 1 Being a truck driver Respondent said that he is always on transit, therefore does not find time to go for clinics in hospital. Most of the time he tests at home and at the chemists at any stop over points either in Kenya or Uganda. 1 1 1 Charles had been admitted for some time 1 Complete 1 Cooperative 1 Coopreative 1 Cost of medication 1 Cost of medication is high 1 Cost of medication is higher 1 1 Currently he is buying medication from the chemist 1 Currently not taking medication controlling diabetes with diet 1 Currently not working depending on children support 1 1 1 1 1 1 1 1 1 Good 10 1 Greatful 1 H 1 Had a great time with the participant 1 Had a great time with the respondent 1 Had difficulty with transport to coptic Nursing home hence relocated to Ambira Hospital 1 Had to talk with the caregiver for her to participate in the interview 1 He currently seeks hospital care from two different hospitals 1 He had a challenge with his phone connection 1 1 1 1 He was so responsive 1 Her daughter Inlaw assistanted in giving responses 1 1 1 I responded to the participant and told her that APHRC is a health research center and we deal with research particularly wanting to know the experiences of T2D patients in relation to covid 19. We took a break and resumed at 2:55pm because the 1 I responded to the participant and told her that we as APHRC are a research center where we are carrying out a research to know and understand how their experience has been and how they have been managing TD2 during the covid peroid. Also durin 1 I was able to observe that the patient used to go to Kasarani health center before covid and during covid he goes to Kenyatta hospital for his clinic appointments. Also this participant is a type 1Diabetic patient because it came up during our 1 If the project can provide testing machines for diabetic patient 1 Informative 2 Insulin only used by participant 1 1 1 Interview took long as the respondent had other commitments to accomplish so we had a break of 1hr30min 1 Interview was done in bits 1 Interview was successful 2 Interview was very Good 1 Interview went on well 2 Interview went on well without any distractions. 1 Interview went on well without interruptions. Respondent understood all questions and answered as needed 1 1 It was difficult to get medication during covid 1 1 Medication price is so expensive 1 1 Monthly, weekly or daily Income estimates is hard for the respondent depends on handouts from relatives, 1 1 1 Mtiba services to be provided again 1 Mtiba services where so helpful 2 NHIF used for footing hospital bills in every visit. 1 Network issues 1 No option of access afya tassia in the list of embarkation East hospitals 3.8a and 3.8c the patient takes his drugs twice a day 1 None 80 Only NHIF used at hospital. 1 Partially blind 1 Participant had difficulty understanding the ladder and the scale of quality of life 1 1 1 Participant was very cooperative and understood all questions 1 Patient took long understanding the question due to age 1 1 Phone battery had an issue earlier 1 1 Provision of testing machines 1 Provision of testing strip 1 Q4.1 the respondent has the NHIF card but it is not active she has not paid the premiums since November last Yr. 1 1 1 1 1 1 1 1 Qtn 5.2 decreased. He never missed doing his duties during Covid period 1 1 1 Questions 1.7 the answer was don't know which was not in the list of choices. 1 Questions 3.8 (frequency)patient was taking insulin twice a day 1 Questions 3.8a the patient takes her medication twice a day;1glucoment and 1nogluc morning and evening 1 Questions 4.1 she has the card but not active 1 Questions on medication 3.6a-3.10c vales are missing because the respondent has not been in medication for T2D.She has been using diet(food) to control her diabetes 1 Referred to the nutritionist to the facility they go to 1 Relocated to rural home due to effects of corona virus 1 Requested for a night interview, using mixtard insulin only 1 Respondecould not remember the 3xact cost of healthcare related to diabetes pre-covid 1 Responded to all questions and requested to be provided with testing machines 1 1 1 1 1 1 Respondent also suffers from arthritis . Makumi is her third name ,also goes to Tinganga dispensary where testing blood glucose is free. Before covid her son gave him Ksh.500 a week and considered this as earning 1 Respondent cannot tell for how long he has lived with diabetes saying the records are at Tinganga Catholic dispensary but on probing further he states 7 years which he is not sure of. 1 Respondent did not know amount spent on diabetic drugs since she bought all her drugs monthly (for diabetes, hypertension and arthritis) 1 Respondent did not like being asked about her marital status otherwise the interview went on well 1 Respondent got insecure during interview when I asked about income and hung up. I called back and managed to convince him and completed the interview 1 Respondent had a difficult time understanding the read outs on knowledge about covid 19 1 Respondent had hearing problems therefore communication was not easy but I managed to control and complete the interview 1 Respondent is using NHIF to pay for testing and medication since he is a public servant, he attended to diabetes clinic once every month for testing and medication . 1 1 Respondent responds very well to research questions this was amazing, 1 1 1 1 1 Respondent said that she only buys her drugs when she gets some extra money after buying food and this rarely happens so she has to many days without medication especially since M-tiba stopped supporting them 1 Respondent said this year she has managed her glucose level and not in drugs because her recent reading are within normal range when tested. 1 1 Respondent stopped taking drugs in August 2021 and is currently on strict diet 1 1 Respondent understood all questions and answered well 1 Respondent understood all the questions and answered with ease The respondent was also aware of her condition and knew her drugs by name 1 Respondent understood all the questions except for the ladder I had to come up with much simpler illustration to make her understand 1 Respondent understood the questions and interview went on well 1 Respondent understood the questions therefore it was an enjoyable interview 1 1 1 Respondent used Ksh.1100 during Covid to buy strips to test at home hence decrease in the frequency of blood sugar testing, precovid test strips were given free and she didn't spend on testing at home. 1 Respondent used drugs only in precovid times and insulin only during covid times 1 Respondent uses insulin only but confirms he is having type 2 diabetes. He used Glucomet 10 years ago,based on his knowledge he said he suffered Covid 19 since he had a prolonged dry cough and flu. 1 1 1 Respondent was cooperative 2 Respondent was diagnosed with diabetes when she was a child 1 Respondent was greatful for the opportunity given to participate in the study 1 Respondent was happy with the interview 1 Respondent was happy with the work we are doing 1 Respondent was hesitant at the beginning but gained trust as we continued in the end it was a great one 1 1 Respondent was nice, understood all questions and answered with ease 1 Respondent was not able to give specific amount spent on diabetic drugs since she collects all her drugs monthly (including drugs for hypertension, cholesterol and diabetes) and paid a total amount of Ksh. 9000 (before Covid) and Kshs. 6500 (du 1 1 Respondent was not very clear due to poor network connection but I managed to get the needed information somehow 1 Respondent was old but knew her condition quite well including drugs and her clinics. Interview therefore went on well 1 1 Respondent was very cooperative 3 Respondent was very cooperative and gave all the information I needed 1 Respondent was very cooperative and had good knowledge of her condition 1 Respondent was very cooperative this made the interview easy 1 Respondent was very greatfulforthe opportunity 1 Respondent was very happy about the interview 1 Respondent was very happy at the end of interview though he didn't know anything about M-tiba so I had to give a brief background about the project 1 Respondent was very happy especially when I told her about reimbursement 1 Respondent was very happy for being contacted and engaged in the study 1 Respondent was very happy to be able to participate and agreed that her contact can be kept and be reached anytime 1 Respondent was very happy to have been chosen to participate in this study 1 Respondent was very happy to participate. We had a great interview 1 Respondent was very happy with the interview 2 Respondent was very positive 1 Respondent's wife suffered Covid 1 Return of mtiba and education about diabetes 1 Severe need Is being hosted by the daughter who is jobless 1 1 She couldn't access medication at somepoint during the covid period 1 She has been admitted in recent Days and the hospital she is attending is access afya kwa njenga not Ruben 1 She has been ill and admitted recently 1 She is a social worker. 1 She is attending to Nguluni Health Centre 1 1 She mostly does do payment through insurance cover 1 She really answered all questions well and engage me in questions to understand if the project will have a return 1 She really took time understanding why are we asking before and after covid 1 1 1 She was cooperative and on issues of giving out her id no was okay with her 1 She was happy and cooperative during the interview 1 1 She was more informed 1 1 Slight challenges in communication and network 1 Sometimes during covid she could not afford to buy medication and go out due to covid 1 Sought help from friends to take care of her because of ill health 1 Success interview 1 Successful completed 1 1 Successful interview 27 1 1 Supply of medication to patient with diabetics 1 Support of medication cost and she have been in stress due to death of her first born child 1 1 1 Thankful for the support mtiba offered before 1 1 1 The Participant before covid was testing at home and also during covid 1 1 1 1 1 1 The husband is the one who used to buy medication for diabetes at the pharmacy respondent doesn't know amount spent ,at times she used NHIF . 1 1 The interview started well and on time and the participant was active and towards the end she was a bit anxious because of disclosing the fact that she has HIV/AIDS though l assured her that her information is private and will not be disclosed 1 1 The interview took longer time because he has hearing problem. 1 The interview was a success. I noticed that the participant wanted medical assistant mostly for T2D she was asking for assistance because at times acquiring medication is a challenge for her 1 The interview was completed 1 The interview was good 2 1 1 The interview was good ,the respondent was very positive. 1 The interview was good I noticed that the participant was under Mtiba and it came to an end in 2020 while he was still receiving treatment in Nairobi, at the moment he has relocated to Machakos County though he still comes for treatment in Nair 1 The interview was good but conducted in native language 1 1 1 The interview was good though I noticed that the patient had really gone through a lot especially during the covid period. Where she said that 2020 was her worst year ever and she had so many underlying complications such as Hypertension, Amoeb 1 1 The interview was participanted by john and his wife 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 The participant before covid was going to Saitoti hospital and during the covid period she is currently seeking diabetes management at jamii hospital 1 The participant before covid was prescribed for Glucowell and Glucoment and afterwards during the covid period the doctor had to change it to Galpusmet. She was also under the Mtiba program and after it finished she moved to Langata health cent 1 The participant before covid was using oral drugs glucoment and Nogluc and during covid she is using insulin only. The doctor changed her medication because she had developed a wound on her leg due to diabetes that she still seeks treatment for 1 The participant comes from a family of Diabetic people she was first diagnosed with Diabetes in 2018 and has been receiving treatment for 6 months only, after the 6 months she stopped taking medication and so what she does is she monitors her b 1 The participant does not know the name of the facility she goes to currently she knows it is next to the DO's office and she is not employed and so in question 4.4 she is not earning any income because she's unemployed her husband is the one wh 1 The participant during covid was testing at home and before covid was going to a health care 1 The participant during the interview had mentioned that she was just from the hospital for her diabetes checkup. She was also under Mtiba but the program ended. 1 The participant first was attending Nairobi West hospital because this is where her diabetes was first discovered then later on during covid she was going to Langata health center upto date. The participant was prescribed for 3 drugs that is Gl 1 The participant goes to St Teresa hospital in Kiambu 1 1 The participant had an issue with her phone but we have managed to finish the interview today. Her phone had fallen and had issues 1 The participant had her leg amputated because of diabetes. 1 The participant had his drug Glucofej that he was using before covid changed in the covid period to galvasment 1 The participant has Nhif but is bring paid by the parents since she is unemployed. 1 The participant has another underlying condition that is HIV/AIDS.she also used to go to Melchizedek hospital and currently goes to lussigetti health centre. 1 The participant has constant headaches that usually disturb him alone I noticed this because he kept mentioning it during the interview 1 The participant has pancreatitis that she still seeking treatment for she also used to go to Melchizedek hospital but she no longer goes she instead goes to air base moi forces memorial an army based health facility. She also wasn't able during 1 The participant in the beginning before even covid was using insulin only and after 5 years she was stopped by her doctor and was put on glucoment and Nogluc. She is using glucoment and Nogluc to date after the change from insulin. Also the par 1 The participant is not on any medication especially during the covid period he is managing his diabetes through lifestyle and diet change he no longer takes medication for diabetes and he also has his machine that he monitors his blood sugar le 1 The participant is under insulin only and she goes to St Mary's mission hospital for treatment she also suffers from chest and back pains that at times hinder her to do her usual activities and she also tested positive for covid but received tr 1 The participant kept on requesting the services that were getting from St.johns concerning the t2d to be brought back because they were crucial to her health. 1 The participant says that before covid she used to go to Accessafya in Tassia for her diabetes management but it was closed and after it was closed she started managing it at home and started going toEmbakasi health centre and Makadara mercy of 1 The participant suffers from ulcers as well and before covid she was going to Langata hospital because they had the mtiba program and after it ended she moved to St Mary's mission hospital 1 The participant used to attend kibera South health center before coivd and during covid she attends langata health center. 1 The participant used to go langata hospital in Nairobi before covid but now relocated to kisii county and goes to kesusu hospital in kisii 1 The participant used to go to Accessafya but afterwards started going to Mukuru mm clinic. 1 The participant used to go to Kenyatta hospital for diabetes management before the covid period but during covid she goes to Langata health center. The participant was also involved in an accident that resulted in her having a minor stroke that 1 The participant used to go to Langata hospital before the covid period because they were getting support from the Mtiba program that was beneficial but after it ended she moved to upperhill medical Centre which is a facility owned and runned by 1 The participant used to go to Shalom hospital and now she goes to Mama Lucy hospital 1 The participant used to go to St John's hospital for diabetes management so she no longer goes instead she goes to Baraka dispensary for diabetes management. She also has a spine problem that she feels alot of pain in her back. 1 The participant used to go to Tinganga hospital and St Teresa hospital before covid and she is currently going to St Teresa hospital as her main facility, also before covid she used to take her blood sugars at home and during covid she was goin 1 1 The participant wanted the Mtiba services to be offered by APHRC but I explained and told him that we are not a health centre instead we are a health research centre and our main focus is to do research on patients with type 2 diabetes to hear 1 1 The participant was attending limuru Nursing home facility before covid and during covid she goes to limuru health center. Also before covid she was going to Limuru Nursing home for diabetes management and during the covid period since she has 1 The participant was diagnosed by TD2 in 2017 and after it was discovered that she has diabetes, she was put on medication that is triviamed and diamacron of which diamacron was later withdrawn by her doctor. She does self management of diabetes 1 1 The participant was diagnosed with Diabetes in January 2020 1 The participant was first diagnosed with Diabetes in 2009 at Medihill hospital in Eldoret where he was working and he was admitted for 2 weeks only and put under medication for only a short time afterwards he stopped taking medication and start 1 The participant was first discovered with Diabetes at Nazareth hospital in 2013, he has been going to Kiambu county referral hospital before covid and also during the covid peroid. He usually gets constant heaches as he says that this is someth 1 The participant was not comfortable in answering some of the questions like 4.9 and 4.11 and also he says that he goes to any healthcare facility for diabetes treatment and management he doesn't have a specific hospital where he goes for diabet 1 The participant was shy in the beginning to say that she has HIV/AIDS because she was in front of people but it later came out as we were winding up the interview, she also has a machine where she monitors her sugar levels and goes to hospital 1 The participant was under the Mtiba program that paid for her 80% for her to acquire medications for diabetes but when it ended she now uses NHIF as well as her own cash to purchase her medication because the Mtiba came to an end. 1 1 1 1 1 1 The patient really tired to give much despite interview to long 1 The patient used to go to two health facilities before pre -covid that is coptic hospital and strathmore clinic 1 1 1 1 1 1 1 1 The respondent can't remember the date ,month and the year she was born. 1 The respondent can't remember the date,the month and the year she was born. 1 The respondent could not remember the 3month that her health was affected most 1 The respondent did not have the specific month that her health was most affected . 1 The respondent gave me the names of medicine that he is taking but they are not diabetic related so I have not indicated . 1 1 1 1 1 1 1 The respondent is taking both insulin and drugs 1 1 The respondent requested if m- tiba could be restored as it was helping him access medication without delay. Question 3.8a and c,the patient takes his drugs twice a day 1 1 1 The respondent used to go dmrc hospital in ngara but strathmore is where the the m tiba project took place 1 1 1 1 1 This was a good interview 1 This was a great interview. 1 This was a great interview. Respondent was free and gave out so much information 1 This was a very easy one since respondent was old so I had to get some information from caretakers 1 This was a very nice interview though respondent did not disclose his monthly income 1 This was a very quick interview since the respondent was busy and I only had this opportunity- she has been postponing the interview for the last one week. 1 Tigoni district hospital closed the Diabetes clinic to care for only Covid 19 cases 1 1 1 Very greatful 1 Very informative 4 1 Very informative,6.4b still appearing even after correction 1 1 1 Was able to get all useful information from the respondent 1 Was successful 1 1 1 We will get back with more. 1 Welcoming 1 Welcoming and informative 1 Well informed 3 "FW: RECORD COMMENTS/observations ABOUT THE INTERVIEW" RESULT OF INTERVIEW Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Complete 500 "RESULT OF INTERVIEW" Unique submission ID Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A uuid:021e0059-8b96-4f8c-b6af-7372c81eeebc 1 uuid:02240c78-ae0a-4f97-9570-e202fd933d04 1 uuid:02eec64c-66b4-45c1-86fa-c6bcd17844a7 1 uuid:030dbd22-063d-41b1-9353-1929589d8ac5 1 uuid:033c5822-5a35-4503-ad43-11715137e684 1 uuid:037a3c51-2b48-4c1b-84e6-8399cd0b5fa9 1 uuid:03d77de5-8118-41f9-b594-51ef70a8b84b 1 uuid:049a0e77-08b2-4ea9-aa05-1194e3c29040 1 uuid:04e7765a-dd40-473e-8e4b-9c2824d72921 1 uuid:061679cb-844e-48e4-b04e-33f4a2b3f592 1 uuid:0699be2d-f1ea-4d77-ab70-13f31230159b 1 uuid:06f6cccd-38a8-43f5-ba5f-38f5755bb954 1 uuid:06faea53-e789-4a80-8b10-1cf06fefd0d3 1 uuid:070927ec-6575-4d3d-a30d-22d9376071fa 1 uuid:08830ed1-5365-4989-9fb7-625fab2e2640 1 uuid:089786e3-d4f8-423e-aff2-a678ce0c9f8b 1 uuid:0a1438e2-22bd-474b-b155-12df86a62bba 1 uuid:0bdc9fac-84c1-4711-9979-b666189a95fd 1 uuid:0bf29359-09f6-4639-a395-e9948e185924 1 uuid:0c1e07a6-b418-43e2-ae9a-a5da4d5ac616 1 uuid:0c5e1eac-31da-48de-9ed0-d2c3dd7d8510 1 uuid:0c90b1d6-deb8-4f52-9e83-3b3dc49741fa 1 uuid:0cafdd69-8876-4be5-ab90-02616d57ce54 1 uuid:0cfb87ee-8124-456c-b31d-7b175ac595de 1 uuid:0e9cf2f7-c932-465f-8d47-4d00d76be380 1 uuid:104aca5d-5917-48f3-b8b3-6973a1bb38a3 1 uuid:1117c51b-ef69-4575-8fed-813788ea3247 1 uuid:114a45a6-2ca5-4a2e-b094-52f6ff64799e 1 uuid:1219e739-d17b-4206-b597-5534070611c3 1 uuid:124bada2-6d99-41ab-b062-87b6f463e9b6 1 uuid:126bf26a-16a9-47de-879b-ceaabe05f2da 1 uuid:153555b7-551f-41ed-8dfd-bfeb995d2e67 1 uuid:15b27b05-fa2c-4000-850e-6bcf21f1a36b 1 uuid:15c31d66-4638-40ff-abef-cbbae4c0c7af 1 uuid:166615c2-8a14-4617-b07c-efa44e459c75 1 uuid:16b12df0-2727-4edd-8e32-c5c88fee7d4c 1 uuid:16e782aa-735c-481c-ae32-3e803a147329 1 uuid:1723d241-bd39-4ab6-a1c2-70359ac2b65d 1 uuid:189afee6-fc88-48a3-b78c-40185f958662 1 uuid:18b351d9-3107-4f31-9d9d-7cc0351501e3 1 uuid:18b7139d-8b05-4573-8117-f5c925e98b38 1 uuid:1900a097-9422-43bc-9158-261f8030f2c3 1 uuid:1940a849-07d1-4d91-be83-72cfe5145554 1 uuid:1af87d54-5bc2-47e0-b9e0-fcdd509f5265 1 uuid:1b03dce3-6f88-44d9-a4db-0a623fe46896 1 uuid:1b196d90-bf49-44e9-bdc2-50eae13786da 1 uuid:1bc7095c-2401-4882-975f-0eaffea19cb9 1 uuid:1be5992e-a5a0-4cd3-9952-fc33f2166756 1 uuid:1c5146cc-bcdc-41e2-9a4c-028927647e72 1 uuid:1c7c198e-d3fe-43d6-931d-e741ebaedae0 1 uuid:1d350d7c-d0c2-4300-ad5f-daebb05de9a3 1 uuid:1d577ae1-896d-410a-90d5-5968e1af0f10 1 uuid:1dec4b43-fa69-4ab8-b6b3-cd2deb915b65 1 uuid:1dfb0516-173a-4490-ac24-79420073362a 1 uuid:1f2cfadd-60ad-476a-b635-4dc18ac87582 1 uuid:1fcf6af1-7b33-4577-9d37-f72f5dd2c89a 1 uuid:204be100-d114-40ad-a09f-943d17367c79 1 uuid:205ad169-b8af-40c1-9409-df5df02e7b68 1 uuid:205dd88d-7649-4467-9d9b-e3a8f6b626e1 1 uuid:20c5a54a-1f1a-44d2-b754-ad2b8be5411c 1 uuid:2138910c-e5f6-4c59-835a-7e244cd49f5c 1 uuid:216e2190-2370-49a6-b548-86362bf18c14 1 uuid:21aa7a4e-d8a1-4fd4-8a3c-a8cb1cc6946d 1 uuid:24843be2-50a5-4423-b0cd-d44eda5f53c8 1 uuid:24aa0c65-a9df-4cff-9bcc-4e81ee5c855b 1 uuid:251ef535-db95-49cc-b87b-87003396e27d 1 uuid:252c65b1-90e2-4775-a4c2-50e6355a1921 1 uuid:255c59bd-4e30-4cc2-b2b3-9f224da6f6ca 1 uuid:2566a746-9f67-471e-88b8-c7e4dbaee533 1 uuid:2650d77b-0242-468e-a98b-9e38b4b5e941 1 uuid:26900ec5-706a-4f40-9c03-5df8a5e0c71d 1 uuid:285bcab0-2bfd-44ba-bed1-1bd1eac0724a 1 uuid:2935bb46-41fe-40f2-8ddc-a0ce20af8d02 1 uuid:29539ff7-9a6d-41c1-a177-94355cf30332 1 uuid:2a68d387-9f18-4677-8ec4-fec760a7853d 1 uuid:2ae650cf-e034-4d3b-9c82-97d31ea7ed2c 1 uuid:2bac7c50-e8f3-42fb-9dd9-56718f917956 1 uuid:2bbe497c-acdc-4107-b318-6d9e29ca34f2 1 uuid:2d2b7766-291d-465b-b83a-d5566582f48f 1 uuid:2d729296-ecb9-4820-aa2c-1879be330dd2 1 uuid:2dbaac1f-c45d-4015-b75a-553270884ca7 1 uuid:2e55a8c4-962b-4ae3-ac40-05625c584d95 1 uuid:2f145c53-a388-48c8-8ef2-66195e585363 1 uuid:312613e9-51bc-4afb-973d-0fd98577d774 1 uuid:312d314b-5dbf-4ad5-90c2-a5f7b87ce5f6 1 uuid:318bb232-ccfc-4161-8ac0-4027c598cd1b 1 uuid:32929a35-264a-4ace-ba14-3ccee5e77d76 1 uuid:33d00f79-e5c0-46fc-9a9f-10428c0746ff 1 uuid:33dd50e5-3697-4b79-a609-ee1c64af67ad 1 uuid:33f6f06f-4be4-4240-ba67-105cb18c3288 1 uuid:346c9476-ee65-4e22-83aa-21dd93cc3625 1 uuid:357875e5-ad7c-42b8-8535-1e7cdb8c6ccb 1 uuid:369a25e7-812f-44bc-b82a-dbd638b90335 1 uuid:37737905-a123-4283-b84d-524780f355c8 1 uuid:3791cc3b-54b3-4fd0-b6f9-32ae52d29bdb 1 uuid:37ee0719-b61e-4e45-ba7f-fa406f33e164 1 uuid:37f0fafe-b97d-4942-a461-17595bebee0b 1 uuid:38a82d4b-a0bf-4ccb-b4c4-05686d79cb58 1 uuid:38b4f664-9771-4d71-a6e3-9ec2d58557d8 1 uuid:3908218c-004f-44a5-9131-222ccfc080b5 1 uuid:398fd4bc-03bc-49e9-962d-3fdec51a8078 1 uuid:3a87e0b1-6b05-46ad-b927-835ea0e9ea88 1 uuid:3abb19a3-8a3c-4914-aa2d-f46014d8cd04 1 uuid:3ad866df-1ecc-44e4-b82a-76d94b22470c 1 uuid:3b251092-bb8a-432d-8a9c-789005587385 1 uuid:3bd7ea81-36be-4b84-a051-cf581f113679 1 uuid:3be9cd93-7671-4549-8e75-7858e27d6cca 1 uuid:3c1ffc57-de69-4d29-a707-2a5a1c9703ca 1 uuid:3c275e94-b714-4619-ac49-09b2315eb94a 1 uuid:3d24f03c-4325-4ee1-ba4a-870e0bba21b0 1 uuid:3d59a07b-0202-4740-ac50-edd2554e40ac 1 uuid:3d5ee3ad-2a0e-4017-95f4-db7f9d998feb 1 uuid:3de918b8-8495-4c37-a71c-daf5040fd10b 1 uuid:3e0a3377-137e-4ea0-86ab-6313c6401ccc 1 uuid:3e8b2ed5-e37f-404a-ab59-4ff9f96a74f0 1 uuid:3f365bba-4fce-4683-ae87-aabd5d2130ba 1 uuid:3f99600d-7a8f-4ef1-8fbe-32c527479ad3 1 uuid:3feb6de1-f1e3-489c-a365-b37b341ca9a5 1 uuid:41304189-1f00-4bde-824b-a17855400235 1 uuid:41e43ba5-8662-4296-b97b-83f376ce4028 1 uuid:41f51021-a80c-46d4-81e2-f5871cb89c05 1 uuid:42503284-3eaa-45e0-b25f-673433b21a74 1 uuid:42a44a56-4d80-4929-90b8-e17cee7a6c74 1 uuid:42ab5638-12ab-48d2-9aa0-99045751b68f 1 uuid:43b5b2d7-f76c-4400-86fd-10dffd65419f 1 uuid:43c3b273-ce52-4955-bd47-5024a7623091 1 uuid:4453afda-f1b1-41f5-a185-a573700dfc59 1 uuid:44b92131-35ad-4e8e-a745-debd6883a47b 1 uuid:44e80469-b2a3-42b8-91ec-b401de90e04e 1 uuid:454ced61-6d2c-45e9-ad47-9539c59b7c84 1 uuid:45a360b5-3799-49d0-be7d-32076198ddb5 1 uuid:45a8eae0-7eb9-46fc-b5c4-58e70e47a529 1 uuid:45bf6d6a-82ce-45e3-a87c-bdc8da252ec9 1 uuid:45e8a630-45fd-4fbb-8db3-5f3b03c61d98 1 uuid:46b8a8e0-60e4-4edf-9d4f-ebce6f19389f 1 uuid:46cb3ba5-de1d-4b2c-929e-e8b81d593c86 1 uuid:47053fb3-c3ae-41a7-9eeb-265caf3797c7 1 uuid:4712f64f-8c8e-49a7-9a3e-2fffcb3f9696 1 uuid:4727150c-0dc3-4712-964b-1d889bee9229 1 uuid:48999475-66b0-432b-aa4c-427211d216c5 1 uuid:48b41177-c421-46a2-8e26-643fa6c61137 1 uuid:48b7fcd4-0d7e-4cc1-a50a-42e8e845537d 1 uuid:493645bf-331e-419e-8641-718b78b21758 1 uuid:49942ac8-70a2-4321-833b-7b4b5e63ed43 1 uuid:49d47164-bdb1-4736-bb10-3910ba41b88d 1 uuid:4a731f37-c5b2-4344-916a-f959f773ab4b 1 uuid:4acaeed1-43ed-457f-a2e2-adb2d98288c9 1 uuid:4c79b300-0341-4cb8-9aae-99fc184ad1fa 1 uuid:4ce0cdc2-fa24-4cf2-9c7f-bb00a3f6f2f3 1 uuid:4ce325a5-7ec2-462c-9ccf-34b0edddee08 1 uuid:4cffd201-ddd0-4cd7-8473-408361465628 1 uuid:4dc0f1e2-2a79-4699-b4e6-796a007c4518 1 uuid:4e3b23d1-192f-47bf-8cb0-f446172616d2 1 uuid:4e83ef75-2115-46b0-8b44-475487fec45c 1 uuid:4e99926f-82cc-4122-a697-787d5b683baa 1 uuid:4f18e6d7-ffa9-4f86-b866-ce450037f849 1 uuid:4f1dce90-d2d8-40b0-ae5b-06bb104237dd 1 uuid:4fe6df87-31fc-4da1-8822-bf800d9714b1 1 uuid:50122283-b3e4-4b0b-b979-bf0d13981ef7 1 uuid:50deb054-68fb-43ed-92f3-b08bfae6ec20 1 uuid:5253f36e-dcd1-4402-97ee-8733db69098b 1 uuid:52baabe5-e145-4878-8433-5491d499c7f3 1 uuid:52cec609-a6bb-4800-8fc2-3fd78fb63938 1 uuid:5337a38c-2fba-498d-ac5a-367c09b78e89 1 uuid:5368d851-f941-4f97-b500-04cea39c7655 1 uuid:54086e4e-2975-4a2b-9d6f-0e0d83b930d9 1 uuid:546051cf-cc69-4052-8afd-2e666f77976d 1 uuid:5495efd8-7116-4603-a8c0-7a7cdb92b34e 1 uuid:54b76cf8-bfb6-4723-bec6-236bd444daf1 1 uuid:559dc5dc-6b53-4503-a8ba-0e45486b9a00 1 uuid:55cd9d85-8cc5-47e2-961a-54e3ab5235be 1 uuid:55f866b1-7ef1-4400-9c7b-a0bd364d05e3 1 uuid:5734500e-0da2-4652-916e-51d431fe7cbd 1 uuid:57de9051-2aca-4d78-b23b-2e2c92ad16e6 1 uuid:5988ca89-28f1-43c9-b2fc-f471bcceac1d 1 uuid:59ebfb8b-0c18-4636-a803-a158c7267101 1 uuid:5a2cda06-2a2a-4658-bef0-054d20a7265b 1 uuid:5bf6efea-95d4-44cf-b518-23c7fc9fd23a 1 uuid:5c31cc39-6ab9-4bb8-8e31-b03bfc10edc0 1 uuid:5cc9fbb6-4a5d-443b-b441-a32ec958e344 1 uuid:5cde0f9c-c2b3-4090-b368-3f082c866126 1 uuid:5d46bfcb-7169-44f8-892b-2ad5422e3a91 1 uuid:5d91975d-7487-4881-9700-725936d3b6ca 1 uuid:5d9e4a27-a2d0-46b7-b4a1-c9cbe7e3246f 1 uuid:5de99a86-fffb-4be2-868f-770b8fe5adbd 1 uuid:5e0acdd1-7d20-4511-8e0b-585387119e97 1 uuid:5e6c3465-7dc1-40ec-b36a-7f3cb59dc6c6 1 uuid:5ef17773-2ad1-45ae-833f-eb2be02896f8 1 uuid:5f225b0b-5366-40d8-a0bf-0560d0c6ee6e 1 uuid:5f511878-7406-4974-ad4e-1174ed992f2e 1 uuid:5fa1d1dc-c944-4696-8d32-cfc67fa68127 1 uuid:5fc9e817-0bd7-48fb-a929-b9fcc2c5ac74 1 uuid:5fec22e1-aa63-4c35-99f1-7cbef016d3ec 1 uuid:6064fc33-61c5-4c08-bc01-59305a3a73ae 1 uuid:625bab7c-d16e-499d-bea3-b663db6d1fef 1 uuid:630512a3-3472-4106-8408-e7b10711a595 1 uuid:634bbcd7-0890-4223-a9ca-48288a8f04bc 1 uuid:640a9550-b650-4559-924f-e96e89a9ba79 1 uuid:641eb41a-ffc6-4df6-a4b1-ce05b8c65ada 1 uuid:64984c3c-dd74-48e4-84a8-1b4fdc7f88c3 1 uuid:64d4a74a-4490-49fc-8938-9c9a8e0afacb 1 uuid:650e97ee-d46b-4c9a-a203-fc92cb7527dc 1 uuid:654636e9-99bd-4f80-9276-ac51acc16071 1 uuid:6590b69a-d2b4-4e45-a36e-1ab27ba12ff5 1 uuid:65f93f64-75e5-4a50-a910-954d16f59c90 1 uuid:6683f1a1-c254-4856-bc2b-1a6ded4aea2d 1 uuid:66d4b3e4-15c9-4a2e-9739-bd942e8b91a3 1 uuid:677843d5-1a0b-410c-b9ec-b1e78d299a55 1 uuid:68c80727-fa09-4553-a406-c29fa1282158 1 uuid:69ad836c-6e8a-4c2c-939e-6a8c82f319ae 1 uuid:69f1dee3-3a6d-45f6-b85d-e4cab25d6f65 1 uuid:6aca742d-66ee-41e6-828e-1f78b452cc71 1 uuid:6bde4c85-122c-4459-ae5e-7c5cae166343 1 uuid:6c5e6e9a-0b4e-4578-977a-529585943ef7 1 uuid:6d31f255-35b8-4b1f-8540-e02e87d9c10e 1 uuid:6d648669-99ab-4f4e-9378-4c7c0937105c 1 uuid:6d7d8a98-8e80-4033-acc7-04381f58b393 1 uuid:70169b6f-b43e-4ff8-8613-92a56417f4a6 1 uuid:7034b0b3-95e9-40b8-9385-951e300b4e92 1 uuid:71c0b3a5-e15c-47ff-aab9-c3bead248484 1 uuid:722ad6e6-248f-42b9-b1c7-7fc57d1fb213 1 uuid:7241a1f9-df9b-4e98-8ea1-8015ffb6ddaf 1 uuid:7262dd69-4f25-41bc-be61-be7f198be345 1 uuid:7355f529-28b6-442d-aff5-633360aa3dba 1 uuid:73ac9a08-7634-496a-ab23-14f654cbf09b 1 uuid:7459af8b-c775-4853-a274-76399e8e937e 1 uuid:769d5376-8dfe-41df-9e19-95de93db84d9 1 uuid:774144ed-bdb0-4f8c-a5a9-ee3fde96fa96 1 uuid:77739c7d-1b22-4461-abc2-a7d395464643 1 uuid:783b33ee-8623-4b29-906c-642c1f56ce4e 1 uuid:78e02387-b290-4db1-a243-7ef92e862dfc 1 uuid:79c34353-3a32-4f73-b264-8c6f8ef64786 1 uuid:7a34b13b-17f3-4c72-ab8e-774618a63f50 1 uuid:7ba23554-28d9-49c0-85df-6b0888b41dc8 1 uuid:7c564013-cf1c-4309-b733-a27df1b6e51b 1 uuid:7c59b739-9576-427a-a650-3b2ca7277554 1 uuid:7d11939c-45a1-44d4-9814-9138ecc339ed 1 uuid:7d2d9c58-5ecd-4853-ac57-689952a74cf3 1 uuid:7d359ee7-096e-49c0-a4f6-6bfceeec7e67 1 uuid:7d456b02-f3bb-48ee-ba51-4376a0d38a41 1 uuid:7d62686b-2e45-43b0-a016-e8de50e5c27b 1 uuid:7dd3fc11-8169-4171-bcfd-7cc932b79878 1 uuid:7ddb6111-bbd7-4cf6-818f-a276a670e985 1 uuid:7dfbbd0c-b3e1-437a-bf22-59d1d720af60 1 uuid:7e26ca50-28de-4598-9169-e01d43f79629 1 uuid:7e532543-ce92-4850-85c2-a9b42dcd6b99 1 uuid:7ec09e32-0e6a-4797-8f55-814bfe847a76 1 uuid:7f28e690-6543-4597-aa59-864891571f43 1 uuid:8023ae26-79a7-49b8-b375-171715139254 1 uuid:8105fa22-06dc-4f85-bd6c-6df7e5e5e524 1 uuid:8147babe-832c-43c6-8b65-fd44850e229a 1 uuid:8289e0bd-f49a-44e9-abfc-43a3b2c26dce 1 uuid:8376988e-56b4-4a46-9ad5-a3365022ccb8 1 uuid:846d55be-6d9b-45e8-8a90-78dd67d05d61 1 uuid:84ac84e8-5122-43e7-97f8-2d54cade14ce 1 uuid:84ee4432-fc03-46a7-903b-237da111be02 1 uuid:84f68c28-0044-418b-be55-a3cebdefded5 1 uuid:84ffb513-4927-4920-bfff-3646ca2877f5 1 uuid:852af6b2-7af8-4687-a118-794239f5e8c6 1 uuid:855e2546-9baa-4e36-b65c-77b1db112091 1 uuid:8675cd07-7989-444d-af68-44a82ab78c8d 1 uuid:86b33993-ffe5-43e5-b1b2-785abd9ad1f6 1 uuid:8734ced1-a2c2-4d67-9354-1d155e53565f 1 uuid:884304ba-02c0-47fa-8c8a-b01bd89a5601 1 uuid:88535907-8962-4808-88e6-dc8ba0c19d3b 1 uuid:885abde5-b7f9-45c0-9719-d8d2ccfac3e8 1 uuid:8888f1ae-c2ee-4a83-a636-c62cc9d15d7d 1 uuid:8a692e1d-a02d-4e4b-b4b5-15957fe0c21b 1 uuid:8ba6a2df-025d-42de-ad9e-755be5434e8f 1 uuid:8bbe7aa9-5e67-4cb5-9e89-8a29aefc2647 1 uuid:8d1e119d-01cb-4074-a96d-8203858a5a48 1 uuid:8d35ac40-fc19-48c8-9679-45e993704198 1 uuid:8db4ab23-dded-4617-8fda-2e9fdd2dd4b2 1 uuid:8e853bbb-d861-4a2a-8107-38072f16f79b 1 uuid:901a1ff3-e841-4fce-979c-3462fe37a661 1 uuid:9171f06b-17b5-4947-9960-c419b8e33353 1 uuid:918b37f8-aa35-4a4b-b68f-121b2837ac5c 1 uuid:91b6d222-f913-4cbf-84e2-24fc33ca15c5 1 uuid:91d42828-ac09-4629-a753-3dae3040f167 1 uuid:91d59aae-ef0a-4289-9a5f-7c8a7e1c3c54 1 uuid:91ea0f86-2978-4139-89a5-e3e7a723fef7 1 uuid:9338a5a8-845c-4db4-9c51-1d981a292f50 1 uuid:94616179-0507-41ba-9372-98d3e734f221 1 uuid:9492706a-1ab3-4517-a882-beab0b9c8b2b 1 uuid:95256fb4-3642-4c40-b88e-7c4991a89545 1 uuid:956eb4d3-1a13-4058-88a5-3f08df46f751 1 uuid:95fb5b11-9968-4013-8713-0f213e57164e 1 uuid:961e9811-f7b0-4495-971f-95a7372c2c32 1 uuid:96952b04-992b-47cd-87c4-5352ee03a852 1 uuid:9716396a-6353-4ea5-8cb9-a7addd39ac96 1 uuid:97ca712f-cc80-45cc-b2a4-a0269f1af37e 1 uuid:97de29eb-a7f3-4aee-9856-75413bd6ba4b 1 uuid:98da55ba-152e-4dda-8ce3-3ace4ba18a0c 1 uuid:990f7de7-ad22-4c96-94f8-60832ab4ef1e 1 uuid:9b10e7ec-438b-4473-8d66-330c14c91777 1 uuid:9b6da231-f594-4e59-ac9e-b62d1674b8ce 1 uuid:9bc0c0fe-7a06-44a9-8999-9780f49edce7 1 uuid:9c047a61-fc16-4ac1-9e99-0a8465ec479e 1 uuid:9c5ed5c1-9d88-4058-a8b3-51e863254761 1 uuid:9cb5a1d2-8ea6-47ff-bc30-79d8a4bf71aa 1 uuid:9d289ced-ad8a-4036-8e43-24128fed63ce 1 uuid:9e164b1c-848b-4625-a92e-75dbe71e27b8 1 uuid:9e9c550e-4d0d-4976-90ba-f43fa5e7f7fe 1 uuid:9efe023a-571f-4d88-b389-7981bf2a1d54 1 uuid:9f15e935-9d21-44b5-91c1-f0a0b109af05 1 uuid:9f2e7d74-0bed-477c-a708-9dfd46f12dbc 1 uuid:9f508baa-7f99-4102-98b6-c873e4a416ad 1 uuid:9f51394f-08ae-4fb3-829f-2b8dad8e368d 1 uuid:9fd3debb-3ce8-4059-9f5f-83c7f8cfd054 1 uuid:a09a1b1c-2d36-4441-84c8-63ede0bd02d3 1 uuid:a11d102c-3187-4293-a3f3-de7924d655ff 1 uuid:a27d2aa1-9ae4-4044-98a1-a2169038355c 1 uuid:a2840ac2-c64a-4a8c-a62c-ddc8e49e0fc2 1 uuid:a28c73c2-9484-434f-9444-8e3643ba1dbf 1 uuid:a3285d06-283b-4a98-9853-9c3e88824692 1 uuid:a3523272-6745-4c9a-9957-8f15f989b5ce 1 uuid:a3812dce-ca5e-4055-af47-ac30ef0d6947 1 uuid:a387584f-b6f1-44e6-9b3b-168429fb6d17 1 uuid:a4570b42-72f5-4610-bbc9-007f5c3fbf68 1 uuid:a52116ae-69f5-4467-a5b2-fbb316795e26 1 uuid:a59e70f3-d79c-469e-9656-a01c795f47d4 1 uuid:a6952dbf-d4f8-498a-b080-08d050b75518 1 uuid:a6cd1042-3182-46ba-ad70-e2745d66af96 1 uuid:a6dae902-ccad-422e-8ce0-a4d7f658752b 1 uuid:a755d879-050b-4b26-8e04-465ac4c4a609 1 uuid:a78a49e8-1738-4191-9b77-635d30597927 1 uuid:a8370ee3-bb5a-4b38-851a-6bb8844993f7 1 uuid:a8a47ee3-48e2-41fe-8b00-7de65bf73c01 1 uuid:a8dd8571-75de-48f7-89ec-279770183857 1 uuid:a94fa448-f1aa-42c2-9597-ffa820e7b8f0 1 uuid:a9a15864-a138-4996-9627-93a2e3cf3402 1 uuid:aaac7683-fa34-4334-894f-20714e831e6a 1 uuid:ab2cdcc4-5636-4649-bf81-63c7be89cd00 1 uuid:ab56ebda-2780-4af7-bdad-a9de299ea81b 1 uuid:ab65a245-1133-404e-a132-36575cef3a56 1 uuid:ab9ed667-a896-4d90-9e43-14516d332ca8 1 uuid:abc84f84-a7cd-4339-a7f0-e9d6c87cc9bf 1 uuid:abddae15-dbe7-4f18-bfb5-4154c3f55d1b 1 uuid:abe97bc0-f652-4a39-a98d-15d64be210ff 1 uuid:ac2fa725-6aa6-40f5-a559-d285de9f3213 1 uuid:ac92a42d-147b-44d9-8e7b-c5d17b8d3ba0 1 uuid:acb19023-dbcb-46c5-8108-ef278719bb40 1 uuid:ae3762b2-ef04-4fef-bac8-195c6bd687e8 1 uuid:afe24d73-bf67-47ea-9dc8-afc3829511d4 1 uuid:afef3123-1dd4-4eed-af6e-409147fa8d1c 1 uuid:b0a9fcb3-a010-46a2-a4b0-8f1077fce616 1 uuid:b1fce8d1-a4a5-45d4-9010-8f6b65c01a7d 1 uuid:b393ddf6-f325-491f-86e5-a02f08a8168a 1 uuid:b3cc5333-c10c-4f88-9430-e0d05e001d66 1 uuid:b4133880-6557-41f4-885e-6fa896d0dba9 1 uuid:b45e92b9-cd70-4406-a295-66ecd5b72121 1 uuid:b4a88051-b7a3-4206-b9fb-11d71e26a275 1 uuid:b4c4a4e4-0421-45f2-96c0-f444bbeeeb1b 1 uuid:b4c6ad9a-7eb7-4f3a-8d6a-d2be8879e5cb 1 uuid:b5a83ec7-41fd-454f-91cf-5fc25f5525cb 1 uuid:b63edbb0-20e0-416d-a576-51524e8d5fa5 1 uuid:b6ccb598-9f73-40b8-a0fc-5107eab9185a 1 uuid:b7dc1736-8cd6-4213-a647-4294557d274e 1 uuid:b87fa43d-10dc-46cf-b726-611cd74be3b3 1 uuid:b8ab1c36-5f7f-4346-a4ad-2d5cd7626f14 1 uuid:b983480f-c67f-45a6-922d-b528886dfe3e 1 uuid:b98b1c6c-083f-4879-9c01-f109f23bfe04 1 uuid:b9ab577e-3c7f-4b64-9ae8-1f6cc81bd47f 1 uuid:ba19ea78-9a05-4062-9a3f-d0b641d015e6 1 uuid:ba266e3b-7875-46b0-a35f-2beeaa69c484 1 uuid:bbc5cec9-0a1c-4238-ac00-4f3f550a4674 1 uuid:bc23d0fe-bcc9-4ab4-86c4-1a5fbf914468 1 uuid:bc3188b5-5ca3-4413-be51-8b9b121706c8 1 uuid:bc7c62c5-7b91-4aa4-8a00-0d6f4c2e6a28 1 uuid:bd690837-4e3c-4d9f-8baa-61218b9919cf 1 uuid:bd806441-3af8-466f-9f70-5e09114d2767 1 uuid:bd82d42c-2877-4954-9799-03b7b4a3e002 1 uuid:bdd6647b-1b23-4067-ae9b-d75007911740 1 uuid:be3d686b-7f7f-4743-96bf-54d43c1932dc 1 uuid:be4a273a-a7d1-48c1-bed7-9fed4d5784d0 1 uuid:bee17c33-03a5-432c-9708-95cc07ba8e59 1 uuid:bf4b783c-9f68-4d8e-b4e9-0b62f8c21746 1 uuid:c044346f-0e9f-4be4-be28-4ad166caaf12 1 uuid:c098de2f-f830-4a19-b1b3-e03f8f36dc40 1 uuid:c104ee4f-c84d-49c6-b826-45a38534eaa7 1 uuid:c17de66a-151a-42b9-a3dd-0d470fd43bc0 1 uuid:c1b966fc-eac3-4341-a1c1-f80c7404f5ac 1 uuid:c1ff2048-b6c2-40e2-82ba-4bf452ca3f61 1 uuid:c46fa98c-998b-483a-878c-af138394fc06 1 uuid:c49a8465-50cb-4a51-954b-f4c9ac80f1c3 1 uuid:c4c712a4-8bfc-4002-9ebc-ae3cea5877ad 1 uuid:c4ca9283-bf30-4909-b6d5-e7823c9b2ebe 1 uuid:c4fb78ce-c815-4b2d-826a-328d5d45c1be 1 uuid:c5bcbb55-edb6-4d66-b6bf-05074b66a214 1 uuid:c6496689-4767-4d21-9867-5c17f32b13ee 1 uuid:c81abc1b-d707-40a6-b019-30aaa707dade 1 uuid:c9260144-5c89-4425-a04e-646ae709845f 1 uuid:c955cb75-9e6e-4325-a4d7-1bd211ef73b2 1 uuid:c96e27eb-7056-4bee-9b7d-31abe18310f4 1 uuid:c9ad8666-c8a4-4d49-aeb5-a5e015952ece 1 uuid:c9e8ade0-2c9e-4747-ac8e-e010905c61ed 1 uuid:ca2ec971-37b5-434a-86f1-d357d86d57c8 1 uuid:ca9682c0-a930-4648-a4d0-bc3eb8de3b6e 1 uuid:cbc1c71d-7a8e-4836-9f4f-8cf2eb2f83d0 1 uuid:cbf71710-307c-49b5-8323-8d57d40496de 1 uuid:cc0f19c2-5bcd-4a1a-908f-4b300c169524 1 uuid:cda49b27-3802-4e24-b11f-944ad1c554ab 1 uuid:cdc83a1e-da16-4221-ac90-65e11e43b5f9 1 uuid:cdc93d0a-6260-4b87-87f0-a37a7992c119 1 uuid:ce2f1458-7dfb-4dc3-a023-625dc9ad8868 1 uuid:ce550f05-da9d-44bc-8515-66ea1b72341f 1 uuid:d0f4fd88-c59c-409f-8b7b-1566fa02034a 1 uuid:d10c8ac2-bb00-4a18-b318-e56c6597959a 1 uuid:d239654f-fd20-486d-b6f0-1d2f3c3373e6 1 uuid:d2467b70-3cb3-4aec-b0aa-e7d24649351f 1 uuid:d2f9c0d5-6167-4ae1-9e72-17a263fc23d1 1 uuid:d37203f0-133b-4333-a9f7-58faf8e4eafa 1 uuid:d3790f77-cb8a-4702-9ec3-cd3766d1afe1 1 uuid:d39170de-a9e9-4cbd-b4f6-2fa29fcbf4d3 1 uuid:d4d6cf64-7bf2-4640-9efa-ea76be980ed6 1 uuid:d532c60e-57d9-4ce4-95f4-bb1e88b73dda 1 uuid:d574b9e2-2db8-47cc-8236-199b97ee025b 1 uuid:d580f027-d631-41ea-98d5-dd758784e956 1 uuid:d6d57019-17d8-4582-940b-b715e2e9a293 1 uuid:d701f9bc-e110-4f80-9105-788b98618e3d 1 uuid:d74351ed-565f-4bf0-915a-758ba13ccef0 1 uuid:d8d30592-6e17-425a-a460-378d818ecefc 1 uuid:d8d4451e-de45-44de-ac64-1267d767a6ac 1 uuid:d90b1e1a-8e49-4dfa-bfd4-588963c310a2 1 uuid:da89380a-481f-45f5-9325-1e4389be9005 1 uuid:daeeda37-bd02-464b-8b22-c234dde26600 1 uuid:db71613d-03fa-4615-aaea-a7934f5b22a4 1 uuid:dbfb316e-0cfa-4c6a-acc0-1170f1c93a95 1 uuid:dcae3d80-04a3-4f37-b160-e51d68f7fd93 1 uuid:dda40116-3af1-4336-ba91-f931f9bf8b59 1 uuid:ddaa5536-7fe2-46db-b928-9ae557860e78 1 uuid:ddbd8051-fb1a-4500-83a0-750c594c1868 1 uuid:df3f0abd-59e3-4e2b-85c1-160e5290f9ee 1 uuid:dfa80cd9-1816-4b4e-82f7-4c20f7387dea 1 uuid:e00c6094-8c04-48ed-9aa2-8ca715447210 1 uuid:e13bbc30-57ee-4ad6-802a-33e83b406580 1 uuid:e2144494-5369-42c5-a587-f0c84df38cd2 1 uuid:e2e29d01-9e07-4f87-9ff4-3b8a95745822 1 uuid:e3898beb-b09e-4359-8ec6-4b6688400fd9 1 uuid:e3db38e9-44c8-4ffd-b2eb-52f79606ad36 1 uuid:e4017f83-b53f-4880-b193-afbfb296953a 1 uuid:e4325d0a-48d9-4ccc-917e-c37b7d169fa8 1 uuid:e45a9bd6-e89e-459e-b5a5-19b855131601 1 uuid:e592b5cb-cc1c-48fb-86f8-c3b9e696ba0a 1 uuid:e605b9e5-79b0-4264-9bfe-80b833819fa0 1 uuid:e60a094a-fd7e-49f9-9a8d-e3f776e6e086 1 uuid:e6184491-ab84-4ce6-9e2e-a3a24b45a2f2 1 uuid:e6a0aaa7-d9be-4e5e-9c06-4fc91c6f8cfa 1 uuid:e6f83062-9c9b-4303-86e1-6c8d38a91fbe 1 uuid:e7f1d469-3657-4219-848c-4b0e8062173d 1 uuid:e881efb3-1e2e-4201-8725-b1284223f51a 1 uuid:e88fa4b5-1b33-46f5-948f-895117981936 1 uuid:e8c15ca1-ef76-48a6-a887-c2f1282f0420 1 uuid:e97141b7-99cc-4e99-b908-f32ad21ee11c 1 uuid:e9d5d07e-a231-404a-b168-c484882a6148 1 uuid:ea1c7069-f24d-4167-a341-901cb81bb9dd 1 uuid:eb2a6c44-a41b-444f-ab53-592ccdffb968 1 uuid:eb9bcd43-6888-444c-add9-6d96d6d6ff28 1 uuid:ebf322b7-06a2-45f6-8ea9-fe305c68c22b 1 uuid:ec2426e9-82be-444a-9486-cb4cd64d95ce 1 uuid:ecc4e9fc-48a4-44f3-8ae6-de7e3b36ce56 1 uuid:edd6014c-1980-4438-94e3-5e9144abfdb6 1 uuid:ee5a2ba4-65f1-466d-b3f2-a8d821294a15 1 uuid:eec3e052-8f5d-4af6-80aa-54061230c559 1 uuid:ef20d2a8-5583-406e-89a3-84db7b095ea2 1 uuid:efde2df1-6eb1-4028-a610-dd44fe5230d1 1 uuid:f02071f2-f6f3-4a2a-9d5a-83d22eb4ab42 1 uuid:f033839d-73df-4c0f-998e-875d3451aea0 1 uuid:f092b5e0-25e9-4718-9cbc-5a8bf160808a 1 uuid:f0d19e1d-9ab3-4418-a830-177add3e6c00 1 uuid:f0eece32-a77f-450d-a75e-d34687196fe2 1 uuid:f14f490c-4ecc-4747-a5e5-0f5fdaf2d480 1 uuid:f153a98e-efe7-4d42-9ed0-49c58408162b 1 uuid:f24c4c69-38c8-4d8e-a4dc-42de90a49729 1 uuid:f2bca719-d1c4-4750-ae2e-36d41a2cc5a0 1 uuid:f3159eed-ba56-454c-8087-8ca46e15844e 1 uuid:f3c1cc94-516f-4532-be9f-194c97ee3829 1 uuid:f651249c-6f17-47b7-b73e-9d46c064b1da 1 uuid:f6589de8-82e8-45c4-904b-331ba82b3c8a 1 uuid:f6a802a7-d086-498d-800b-85f046af20fa 1 uuid:f6a8ab9e-3a65-418f-9f51-07ecdba847e2 1 uuid:f6be92ac-537f-4e7b-b160-fc2ee5993adf 1 uuid:f7aeb58a-426d-4eeb-9fef-29f0a28e5cc3 1 uuid:f7f82ed2-9f5b-4be9-a568-3a32e1703465 1 uuid:f7fda87c-c2f5-4c3b-baa4-859d183ec74b 1 uuid:f8698c3e-7233-4deb-a74c-d660d89ca388 1 uuid:f92a376d-2fac-45b9-83f6-fba0908024c7 1 uuid:f99493b1-6456-4b83-b98c-bf6f428bc99c 1 uuid:fa89467a-cca1-4308-b581-4236dc678b99 1 uuid:fa8ed434-fb8c-43b3-819b-877aff13def5 1 uuid:fb0e140c-610e-41f6-ba5b-c9e26eefbf70 1 uuid:fb82d88c-657a-4234-a548-f0060fe8793e 1 uuid:fc072215-f427-4454-a0ea-d16c30f25d87 1 uuid:fd75d958-f705-4a2e-b493-1a773a6d8ce2 1 uuid:fdbe9ded-f053-4497-8f09-481166f0fb1c 1 uuid:fddd551d-6a0e-4059-a6fd-bc4f2e709685 1 uuid:fe3e6d10-b2d3-43a9-8868-18eca399af77 1 uuid:fed92cb8-1f1f-454b-84e0-023944daa4c8 1 uuid:ff2a8757-1f6b-4e9a-95e0-d161b2c444a6 1 uuid:fff178fb-c829-4d65-b299-9ef75fe56924 1 1.1: Date of Birth Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 1923-07-01 1999-02-25 N/A 1923-07-01 1 1925-05-01 1 1928-07-15 1 1936-03-03 1 1936-07-01 1 1938-07-10 1 1939-01-16 1 1939-05-15 1 1939-08-18 1 1940-06-10 1 1941-02-15 1 1942-02-06 1 1942-02-19 1 1942-04-17 1 1942-06-01 2 1942-06-21 1 1942-08-09 1 1942-12-01 1 1943-04-22 1 1943-07-09 1 1943-07-10 1 1943-12-23 2 1944-03-05 1 1944-06-01 2 1944-09-16 1 1944-09-20 1 1945-03-24 1 1945-04-03 1 1945-07-01 1 1945-07-10 1 1945-07-11 1 1945-08-01 1 1945-09-01 1 1945-12-06 1 1945-12-24 1 1946-01-15 1 1946-01-19 1 1946-07-01 1 1946-07-15 2 1946-09-05 1 1946-12-22 1 1947-01-15 1 1947-02-24 1 1947-04-24 1 1947-04-27 1 1947-07-10 1 1947-08-26 1 1948-01-01 1 1948-01-18 1 1948-03-19 1 1948-06-01 1 1948-07-11 1 1948-07-15 1 1949-01-01 3 1949-01-15 1 1949-03-23 1 1949-07-01 3 1949-07-21 1 1950-01-01 1 1950-03-19 1 1950-04-02 1 1950-05-05 1 1950-06-02 1 1950-06-30 1 1950-07-01 1 1950-07-15 2 1951-02-01 1 1951-03-15 1 1951-03-20 1 1951-05-19 1 1951-09-12 1 1951-10-16 1 1951-10-19 1 1951-11-30 1 1951-12-01 1 1952-02-01 1 1952-02-05 1 1952-02-10 1 1952-02-13 1 1952-02-15 1 1952-03-06 1 1952-03-26 1 1952-06-01 4 1952-07-15 3 1952-08-22 1 1952-09-21 1 1952-11-02 1 1952-12-01 1 1952-12-02 1 1953-01-01 2 1953-05-23 1 1953-07-10 1 1953-07-15 2 1953-11-11 1 1953-12-02 1 1954-01-01 1 1954-01-02 1 1954-03-01 1 1954-03-11 1 1954-03-24 1 1954-06-10 1 1954-07-01 2 1954-07-10 1 1954-07-15 1 1954-10-10 2 1954-12-31 1 1955-01-01 1 1955-04-09 1 1955-05-01 2 1955-05-18 1 1955-06-01 1 1955-07-01 2 1955-07-10 1 1955-07-17 1 1955-08-01 1 1955-10-11 1 1955-12-25 1 1956-02-05 1 1956-03-18 1 1956-03-19 1 1956-03-23 1 1956-05-11 1 1956-07-01 3 1956-07-10 1 1956-09-01 1 1956-09-25 1 1956-09-28 1 1956-10-27 1 1956-12-01 1 1956-12-31 1 1957-02-07 1 1957-02-15 1 1957-02-26 1 1957-04-05 1 1957-04-22 1 1957-05-09 1 1957-05-29 1 1957-06-07 1 1957-06-22 1 1957-06-25 1 1957-07-15 4 1957-07-17 1 1957-07-25 1 1957-10-20 1 1957-12-25 1 1957-12-31 1 1958-01-01 1 1958-01-12 1 1958-02-15 1 1958-02-20 1 1958-03-15 1 1958-03-17 1 1958-03-19 1 1958-03-21 1 1958-03-23 1 1958-05-05 2 1958-05-24 1 1958-06-01 1 1958-07-01 2 1958-07-05 1 1958-10-01 1 1958-10-23 1 1958-11-05 1 1958-12-08 1 1958-12-30 1 1958-12-31 1 1959-01-01 1 1959-02-01 1 1959-02-17 1 1959-02-28 1 1959-03-07 1 1959-03-21 1 1959-06-16 1 1959-07-15 3 1959-08-08 1 1959-08-28 1 1959-09-01 2 1959-09-12 1 1959-11-11 1 1960-01-01 1 1960-01-15 2 1960-01-28 1 1960-03-09 1 1960-03-17 2 1960-03-18 1 1960-06-01 2 1960-07-01 2 1960-07-10 1 1960-07-15 1 1960-08-10 1 1960-08-15 1 1960-10-15 1 1960-11-21 1 1961-02-11 1 1961-02-18 1 1961-03-01 1 1961-03-18 1 1961-04-01 1 1961-04-04 1 1961-04-12 1 1961-05-05 1 1961-06-15 1 1961-06-16 1 1961-07-10 1 1961-07-15 2 1962-01-01 3 1962-02-02 1 1962-02-27 1 1962-03-06 1 1962-04-01 1 1962-07-01 2 1962-07-10 1 1962-08-10 1 1962-08-26 1 1962-09-26 1 1962-12-01 1 1962-12-03 1 1962-12-19 1 1963-03-17 1 1963-05-11 1 1963-05-18 1 1963-06-24 1 1963-07-01 1 1963-07-15 1 1963-07-20 1 1963-07-21 1 1963-08-01 1 1963-09-02 1 1963-10-11 1 1963-11-13 1 1963-12-20 1 1964-01-01 1 1964-04-14 1 1964-04-22 1 1964-06-10 1 1964-06-15 2 1964-07-01 2 1964-07-16 1 1964-07-23 1 1964-09-01 1 1964-09-20 1 1964-09-25 1 1964-10-30 2 1964-11-20 1 1964-11-28 1 1964-12-12 1 1964-12-31 1 1965-03-03 1 1965-04-12 1 1965-05-05 1 1965-06-22 1 1965-07-01 1 1965-07-20 1 1965-07-22 1 1965-09-20 1 1965-12-27 1 1966-01-01 1 1966-03-22 1 1966-04-04 1 1966-04-28 1 1966-06-02 1 1966-06-14 1 1966-07-01 1 1966-07-07 1 1966-07-31 1 1966-08-01 2 1966-08-10 1 1966-08-19 1 1966-09-22 1 1966-09-24 1 1966-12-12 1 1967-01-01 1 1967-01-29 1 1967-02-15 1 1967-02-26 1 1967-06-12 1 1967-06-19 1 1967-07-15 1 1967-07-17 1 1967-07-22 1 1967-07-25 1 1967-11-21 1 1967-12-12 1 1967-12-31 1 1968-03-05 1 1968-03-09 1 1968-06-16 1 1968-07-15 1 1968-08-05 1 1968-08-10 1 1968-08-11 1 1968-10-16 1 1968-12-18 1 1968-12-19 1 1968-12-25 1 1969-01-01 1 1969-01-28 1 1969-02-02 1 1969-02-22 1 1969-02-25 1 1969-03-03 1 1969-03-13 1 1969-04-14 1 1969-04-25 1 1969-05-02 1 1969-05-23 1 1969-10-28 1 1969-12-12 1 1969-12-31 1 1970-01-20 1 1970-02-05 1 1970-02-28 1 1970-03-01 1 1970-03-19 1 1970-05-13 1 1970-06-09 1 1970-06-20 1 1970-06-21 1 1970-06-23 1 1970-07-01 2 1970-07-15 1 1970-10-10 1 1970-11-02 1 1970-11-19 1 1971-01-01 1 1971-03-09 1 1971-04-24 1 1971-06-09 1 1971-08-01 1 1971-08-28 1 1971-10-11 1 1971-11-11 1 1971-11-30 1 1972-01-02 1 1972-01-03 1 1972-01-08 1 1972-01-27 1 1972-02-10 1 1972-05-01 1 1972-06-10 1 1972-07-01 1 1972-07-15 1 1972-08-28 1 1972-10-10 1 1973-01-28 1 1973-02-05 1 1973-02-07 1 1973-02-19 1 1973-03-01 1 1973-03-14 1 1973-03-15 1 1973-04-15 1 1973-07-01 2 1973-08-04 1 1973-08-21 1 1973-09-28 1 1973-10-09 1 1973-11-14 1 1973-12-21 1 1974-01-25 1 1974-02-14 1 1974-03-02 1 1974-05-26 1 1974-07-01 1 1974-07-10 1 1974-07-15 1 1974-08-26 1 1974-08-27 1 1974-10-12 1 1974-10-30 1 1974-11-01 1 1974-11-06 1 1974-11-22 1 1975-01-01 1 1975-08-03 1 1975-08-19 1 1975-08-24 1 1975-10-29 1 1975-11-26 1 1976-01-17 1 1976-02-02 1 1976-04-21 1 1976-06-11 1 1976-07-01 1 1976-07-10 1 1976-08-22 1 1976-09-04 1 1976-12-12 1 1977-01-01 1 1977-03-17 1 1977-04-16 1 1977-07-01 1 1978-01-01 1 1978-01-20 1 1978-04-24 1 1978-05-27 1 1978-07-15 1 1978-08-23 1 1978-09-03 1 1978-09-15 1 1979-01-05 1 1979-05-19 1 1979-09-24 1 1980-01-29 1 1980-02-22 1 1980-05-01 1 1980-05-13 1 1980-05-29 1 1980-06-01 1 1980-06-05 1 1980-07-01 1 1980-09-12 1 1981-03-11 1 1981-04-27 1 1981-05-01 1 1981-08-16 1 1982-03-03 1 1982-07-02 1 1982-08-01 1 1983-01-17 1 1983-02-28 1 1983-06-15 1 1983-07-01 1 1983-09-29 1 1983-10-16 1 1983-12-28 1 1984-02-19 1 1984-09-19 1 1985-10-21 1 1985-12-15 1 1986-07-01 1 1986-09-15 1 1987-05-17 1 1987-07-17 1 1987-08-23 1 1988-02-18 1 1988-03-20 1 1988-05-22 1 1988-09-07 1 1988-10-20 1 1989-04-06 1 1989-06-01 1 1989-07-01 1 1989-12-12 1 1990-05-23 1 1990-07-03 1 1990-07-10 1 1991-09-17 1 1993-05-05 1 1993-08-05 1 1993-11-22 1 1994-05-23 1 1997-07-11 1 1998-04-22 1 1998-09-04 1 1999-02-25 1 "1.1: Date of Birth" Age in Complete Years Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 23 98 58.206 12.567 N/A Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 No Education 16 2 Primary Education 208 3 Secondary Education 201 4 College/University Education 75 Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 0 No 125 1 Yes 375 Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 <40 years 39 2 40-49 years 80 3 50-59 years 135 4 60-69 years 155 5 > 70 years 91 Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 0 Greater than 6years 309 1 Less than 6years 191 Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 0 Not Insured 163 1 Insured 337 Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 0 Not History of Diabetes 233 1 History of Diabetes 267 Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Urban 380 2 Rural 120 Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Formal workers 31 2 Farmers (Small Scale and large Scale 78 3 Self Employed(Small and Large Business 162 4 Retired 14 5 Unemployed 215 Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 Catholic 104 2 Protestants 379 3 Muslims 17 Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 High SES(<5) 53 2 Low SES(>5) 447 Patients with type 2 diabetes being interviewed. N/A N/A N/A N/A Patients with type 2 diabetes 500 0 N/A 1 No Cormobidity 145 2 Hypertension 261 3 Cardiac Disease 2 4 Asthma 4 5 Chronic Liver Disease 0 6 Chronic Kidney Disease 7 7 Chronic Neurological/Neuromacular Disease 10 8 COPD/Chronic Obstructive Pulmonary Disease 1 9 HIV/AIDs 6 10 Tuberculosis 2 11 Mental Illness 1 12 Cancer 5 13 Others eg Athritis and Stroke 56